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The research contained within this thesis submitted for the degree of Doctor of 
Philosophy in Medicine investigates the role of e-learning in improving knowledge 
mastery around venous thromboemolism prophylaxis among medical students. 
Following an exhaustive literature review of venous thromboembolism epidemiology, 
pathology and prevention, educational theory, e-learning techniques and the delivery 
of education about venous thromoboembolism to medical students, the key 
deficiencies in our understanding of this disease were identified. We found multiple 
small cohort studies about the use of e-learning in medical education, but a paucity 
of randomised controlled trial data surrounding the use of e-learning platforms, and 
limited information regarding the role of instructional erongomics in e-learning 
delivery for medical education.  
 
Conducting a randomised controlled educational trial may determine the utility of e-
learning for improving student’s knowledge of venous thromboembolism 
prophylaxis. 
 
This investigation commenced with the development of e-learning modules in 
surgery, medicine, oncology, obstetrics & gynaecology and orthopaedic surgery. Two 
further assessment modules were also developed; one to measure baseline 
knowledge about venous thromboembolism prophylaxis, and one to measure post-
intervention effect. 
 
A randomised controlled trial was conducted to measure the effect of e-learning at 
improving knowledge of thromboprophyaxis guidelines. Students randomised to use 
 xiv 
the e-learning module did not demonstrate any improvement in knowledge 
surrounding VTE prophylaxis, either in comparison to the control group, or in 
comparison to their own baseline scores. Interestingly, however, students 
demonstrated a statistically significant improvement in knowledge when they were 
re-tested six months after finishing the e-learning program. 
 
This result may demonstrate that e-learning is a useful tool in a blended learning 
model of teaching, however, there is a possibility that confounding factors had played 
a role. We conducted a subgroup analysis to determine whether performance in 
certain cases within the e-learning module were predictive of final outcome, and 
whether time spent on each case was associated with final performance. We 
demonstrated that performance in the eMedici VTE Prophylaxis Module appeared to 
be associated with performance in areas of medicine in which students had prior 
experience, or were currently rotating. 
 
Finally, we were interested in examining ergononic factors related to the use of e-
learning material, particularly as one member of the group had published similar 
research examining the use of computer-aided learning when material was presented 
on CD-ROM. There is limited reporting on ergonomic data in the medical education 
literature, and we felt that this study may also help explore the possible causes of 
the results of the randomised controlled trial. This study demonstrated the 
importance of usability testing in designing online medical education resources, and 
suggests the importance of supporting online learning through the provision of 
















Chapter 1. Epidemiology of Venous Thromboembolic Disease 
 
 
Venous thromboembolism (VTE) is a syndrome composed of deep vein thrombosis 
(DVT) and, to a lesser extent, Pulmonary Embolism (PE); the terms “thrombosis” 
and “embolism” were coined by Rudolf Virchow1 in order to demonstrate a 
mechanistic link between DVT and PE.2,3 
 
Global Impact of Venous Thromboembolism 
Venous thromboembolism is the third most common cardiovascular cause of death 
in the world, resulting in more than 500,000 deaths per year in both the European 
Union and the United States of America.2,4 The annual incidence of VTE ranges from 
0.75 to 2.69 per 1000 population, and is a common condition across low-, middle- 
and high-income countries.4  Importantly, increasing age is strongly associated with 
increasing incidence of VTE; annual incidence ranges from 0.2 to 5.3 per 1000 
population between the ages of 40-69, increasing to 2 to 7 per 1000 population 
among those aged ≥70 years, and 3 to 12 per 1000 population among those aged 
≥80 years.4 
 
The burden of disease generated by VTE is also globally significant, responsible for 
7,681 Disability-Adjusted Life Years (DALY) based on World Health Organisation-
commissioned epidemiological studies, and an extensive literature review; VTE was 
the leading cause of DALYs in low- and middle-income countries, and the second-
leading cause in high-income countries.4,5 Non-fatal consequences of VTE, and 
resulting disability, were responsible for 34% of DALYs associated with VTE, 
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resulting in significant years lived with disability (YLD) and years of life lost (YLL) due 
to premature mortality.4 
Re-analysis of the Framingham Heart Study 
A retrospective analysis of the original, offspring, third generation and omni cohorts 
of the Framingham Heart Study (n=9,754) for the period 1995-2014 has provided 
further information on the incidence, associated mortality and predisposing factors 
for VTE.6 The overall unadjusted incident rate of VTE was 26.8 per 10,000 person-
years (PYs), with unadjusted incident rates of 7.8 per 10,000 PYs for unprovoked 
VTE, 10.8 per 10,000 PYs for provoked VTE (one predisposing factors other than 
cancer – surgery, fracture, hospitalization, immobilization, Hormone Replacement 
Therapy/Oral Contraceptive use, travel >4 hours or pregnancy/puerperium), and 8.3 
per 10,000 PYs for cancer-related VTE. The overall age-adjusted incident rate was 
20.3 per 10,000 PYs, and was higher in men (23.5 per 10,000 PYs) than women (17.5 
per 10,000 PYs).6 
 
Analysis of the Framingham Heart Study dataset demonstrated that the median 
number of predisposing factors for provoked VTE was 2 (range 1-4), and 1 (range 0-
4) in cancer-associated VTE.6 
 
Crude all-cause mortality in patients with any VTE was 145 per 1000 PYs, compared 
with a mortality rate of 20 per 1000 PYs for patients without VTE. The hazard ratio 
was four-fold higher in patients with VTE compared to those without (HR=4.02; 95% 
CI 3.40-4.74), and was higher in patients with pulmonary embolism vs. deep vein 
thrombosis (HR=2.55; 95% CI 2.08-3.13 vs. HR=1.45; 95% CI 1.11-1.89; p<0.05). 
There was no significant difference in hazard ratios between unprovoked and 
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provoked VTE (HR=2.38; 95% CI 1.62-3.49 vs. 2.37; 95% CI 1.78-3.16). Cancer-
associated VTE had a very high hazard ratio for mortality (HR=16.43; 95% CI 12.88-
20.94). There was no significant difference between hazard ratios for mortality 
between genders (p=0.40).6 
 
All-cause mortality amongst patients with VTE was 11.8% at thirty days, 29.6% at 1 
year and 43.1% at 5 years.6 
 
Venous Thromboembolism in Australia 
Numerous studies into the epidemiology of venous thromboembolic disease have 
been performed in Australia.7-9 A community-based study in 2008 demonstrated an 
annual VTE event rate of 0.85 per 1,000 residents in metropolitan Perth, Western 
Australia, with a crude annual incidence of 0.83 per 1,000 residents.7 The crude 
annual incidence for DVT was 0.52 per 1,000 residents, and 0.31 per 1,000 residents 
for PE.7 74.5% (102 cases) were for first-ever thrombotic event, with a VTE 
incidence of 0.62 per 1,000 population. 
 
A 2018 paper reviewed this incidence by combining inpatient data with Emergency 
Department (ED) presentations across New South Wales to provide a more 
accurate estimate of VTE incidence, and factors associated with increased post-
discharge diagnosis of VTE.8 
 
This study, by Stubbs et al, reported an incidence rate of 9.7 per 1,000 admissions, 
with a median length of stay of 8 days. DVT was the more common presentation 
(62.6%) than PE. Most hospital-acquired VTEs were diagnosed post-discharge 
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(70.6%); in-hospital diagnoses had a longer median length of stay (18 days) than VTE 
diagnosed post-discharge (6 days). The median length of time between discharge 
from original admission and a diagnosis of VTE requiring admission was 17 days.8 
 
Stubbs et al demonstrated a 9% lower risk of VTE in men than in women (Incident 
rate ratio = 0.91), and an increasing risk of VTE for both genders with increasing age. 
Factors protective against VTE were identified as Asian-born parentage, non-
emergency admission to hospital, and admission for medical or obstetric complaints. 
Risk associated with surgical admission was determined by using VTE risk for 
patients undergoing cholecystectomy as a baseline for comparison, with orthopaedic 
surgical patients experiencing a 1.79 to 3.6-fold increase in risk of hospital-acquired 
VTE. Increased rates of co-morbidity (as measured by the Charlson Comorbidity 
Index) and longer in-hospital length of stay were both associated with increased risk 
of hospital-acquired VTE. The authors reported a case fatality rate of 4.3%, with the 
majority of deaths (53.3%) caused by pulmonary embolism, and occurring during the 
index admission (57.7%).8 
 
There has been a trend towards increasing rates of venous thromboembolism since 
2010, with the incidence rate of hospital-acquired VTE increasing from 9.2 per 1,000 
patients in 2010, to 10.2 per 1,000 population in 2012; adjusted rates for in-hospital 
VTE also increased by 44% during the study period, while conversely, the adjusted 
incidence rate of post-discharge VTE declined by 9% to 6.1 per 1,000 population.8 
Factors associated with increased risk of post-discharge VTE were increasing age, 
being a medical patient, undergoing coronary artery bypass grafting, undergoing total 
knee replacement10 and total hip replacement surgery8,10 having a diagnosis of cancer 
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or chronic pulmonary disease or admission to smaller hospitals including district 




Chapter 2. Pathophysiology of Venous Thromboembolism 
 
 
In a recent review of the pathogenesis of venous thrombosis, Budnik and Brill 
describe the development of venous thrombi as a three stage process; blood flow 
stasis and hypoxia, endothelial activation, and blood cell recruitment.11 In this section 
we consider first the anatomical considerations in the pathogenesis of venous 
thrombosis, and then the pathogenesis of deep vein thrombosis in the manner 
described by Budnik and Brill.11,12 
 
Anatomical Considerations in the Pathogenesis of Venous Thrombosis 
The deep veins of the lower limbs are divided into two systems; the thigh veins and 
the calf veins, with the calf veins representing the greatest source of embolic venous 
thrombi.12 
 
While the thigh veins (iliac vein and femoral vein) are thick-walled and carry few 
venous valves, the calf veins (crural veins – posterior tibial vein, anterior tibial vein, 
peroneal vein – and intramuscular veins – soleal vein and gastrocnemius vein) are 
paired to arteries and have multiple branches and inter-venous anastomoses. The 
































Figure 2.1 Normal function of venous valves. 
In the image on the left, the valve is open and blood flows towards toward the right heart 
through a combination of transmitted pulsatility from adjacent arteries and muscular 
contraction. In the image on the right, valve closure maintains unidirectional blood flow. 
(From Bovill et al13) 
 
Consequently, thrombosis is more likely to occur in intramuscular veins that require 
active pumping and adequate valve function when there is limited calf movement (e.g. 
bed rest, prolonged air travel). Within the intramuscular veins, thrombosis is more 
likely to occur in the soleal veins rather than the gastrocnemius veins due to the 
lower frequency of venous valves (which tend to be incomplete), the location of 
venous valves at the gathering sites of thin veins, the presence of multiple 
anastamoses, and the need for sustained muscular contraction for adequate venous 




Haemostasis and Reduced Venous Oxygen Tension 
In keeping with Virchow’s triad for coagulation (blood stasis, endothelial injury and 
hypercoagulability),1 venous stasis appears to be a significant factor in 
thrombogenesis. Of particular importance is the role of venous valves and valve 
pockets in providing a site of static blood flow, venous hypoxia, and relative 
endothelial injury.2,11,13 
 
Venous valves and venous thrombogenesis 
Aside from reduced blood flow as a result of reduced muscular contraction,12 the 
presence of venous valves appears to play a significant role in the development of 
venous thrombi.2,11,13 
 
Multiple venographic and post-mortem studies have demonstrated that valve pockets 
frequently demonstrate venous stasis and contain thrombi.2,13-18 Histological 
examination of venous valves (Figure 2.2) demonstrates that thrombi appear to 
develop in areas of increased stasis and hypoxia, on the wall side of the vein sinus.13,19 
The thrombus develops in a progressive fashion, with increasing deposition of fibrin 
layers containing entrapped red cells.19 These alternate with white layers, containing 
platelets, forming the lines of Zahn.13,19 The presence of fibrin-rich red thrombus 
adjacent to the endothelial surface of venous thrombi suggests that tissue factor 




Figure 2.2 Histological section of a venous valve demonstrating valve thrombus involving 
both the valve sinus and the vessel lumen. 
Arrow (a) demonstrates valve thrombus that is considerably more organized than 
thrombus present in the vein lumen (b), indicating that it is therefore older. This is 
consistent with findings described by Sevitt.19 (d) demonstrates large platelet clumps 
distant from the vessel wall, a characteristic of venous thrombi. (e) indicates the lines of 
Zahn, alternating red cell and platelet clumps, indicating thrombus propagation. (Slide 
from the University of Alabama, Birmingham, Department of Pathology, PEIR collection, 
which is publicly available; Image reproduced from Bovill et al.13) 
 
Although stasis appears to be a key factor in venous thrombosis, valve sinus hypoxia 
has been documented in the same anatomical location as thrombus initiation.13,20 In 
the only study of its kind, Hamer et al. demonstrated that the partial pressure of 
oxygen (PaO2) decreased from approximately 5kPa to 0.1kPa (37.5mmHg to 
0.75mmHg) at four successively deeper levels, from top to bottom, of the valvular 
sinuses in the veins of dogs, after 2 hours of venous stasis.20 Hamer et al. also noted 
that the venous flow pattern in resting dog legs was streamlined, as compared to 
pulsatile when passive movement was performed.20 An extension of the study in 
dogs was performed in three veins of two human patients undergoing elective 
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surgical procedures for removal of varicose veins; in this instance, measurement of 
valvular sinus PaO2 again demonstrated decreasing oxygen tension, from 
approximately 7kPa (52.5mmHg) at the mid-vein level, to 4.3kPa (32.25mmHg) at the 
bottom of the valve pocket.20 
 
The description of streamlined flow at muscular rest has implications for blood flow 
within the valve sinus.13 As demonstrated in Figure 2.3, streamlined flow is 
demonstrated in valve sinuses during streamlined venous flow;13,21,22 as blood flows 
out of the valve leaflet, a slower, counterrotating vortex is formed at the base of the 
sinus, which correlates with the location of sinus hypoxia. Red blood cells tend to 
remain trapped in this vortex, and begin clumping;21,22 this combination of 
erythrocyte aggregation and local hypoxia then induces inflammation, endothelial cell 
activation, and activation of other pro-inflammatory cell types, including mast 
cells.11,13 These events result in the cellular adhesion receptors (intercellular adhesion 
molecule 1) and the release of Weibel-Palade bodies, stimulating the initiation of 





Figure 2.3 Venous flow and formation of basal vortices.  
Streamlined venous flow is associated with the formation of basal vortices in venous 
valvular sinuses, in areas associated with the greatest degree of sinus hypoxia.20 Small 
recesses at the base of the sinuses are evident on histological sections, and likely 
represent areas of maximal stasis and hypoxia, and consequently, the likely sites of early 
thrombogenesis.13 Image reproduced from Bovill et al.13 
 
Endothelial Activation 
The effects of endothelial activation in venous thrombosis can be explained as 
cellular recruitment, plasma hypercoagualbility and the effect of mast cells as 
intermediaries of venous thrombosis. 
 
Cellular Recruitment 
In healthy vasculature, the endothelium expresses a master regulator, Krüppel-like 
factor 2 (KLF2), which positively regulates expression of thrombomodulin and 
maintains a vaso-protective state; the endothelium lining valve pockets has a greater 
expression of thrombomodulin and endothelial protein C receptor, and reduced 
levels of von Willebrand factor (vWF) than endothelium from non-valvular sites.2 
Endothelial injury, induced by hypoxia, inflammation or altered blood flow, results in 
reduced KLF2 expression and activation of nuclear factor- kB (NF-kB), which in turn 
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induces endothelial activation and gene expression, producing a pro-coagulant 
state.2,11 
 
Activation of the endothelium and expression of NF-kB induces the expression of 
genes that promote endothelial adhesion and thrombosis, including vascular cell 
adhesion protein 1, E-selectin, the antifibrinolytic plasminogen activator inhibitor 
type 1 and procoagulant tissue factor. In addition, Weibel-Palade bodies (WPB) fuse 
with the endothelial cell plasma membrane and release von Willebrand factor (vWF) 
and P-selectin onto the cell surface membrane. P-selectin and vWF facilitate the 
binding of leucocytes and platelets, promoting thrombogenesis.2,11 
 
Endothelial activation may also occur as a direct consequence of hypoxia, as 
synthesized reactive oxygen species (ROS) induce the expression of adhesion 
receptors and promote the extravasation of leucocytes.11 In addition, ROS stimulate 
the complement system, and induce deposition of complement, particularly 
complement C3 and C5a, in vessel walls, indirectly activating the endothelium; high 




Given that the primary activator of coagulation is the tissue factor-factor VIIa 
complex, and the factor XIIa pathway, it has been theorized that plasma 
hypercoaguability may lead to increased thrombin generation; this has been 
supported by studies demonstrating an association between increased thrombin 
generation and primary and recurrent venous thrombosis.2 Animal studies have 
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demonstrated that hyperprothrombinaemia (induced by infusion of prothrombin) is 
associated with increased thrombus size and accelerated fibrin deposition in venous 
injury models.2,24 Activated endothelium enhances coagulation, and contributes to 
increased thrombosis, particularly through up-regulation of intercellular adhesion 
molecule 1 (ICAM-1).11 
 
Mast Cells as Intermediaries in Venous Thrombosis 
Mast cells are large, pro-inflammatory cells that form part of the innate immune 
system, and contain granules carrying multiple pro-inflammatory mediators and 
antithrombotic factors, including tissue plasminogen activator and heparin.11 Mast 
cells have been demonstrated to accumulate at sites of venous thrombosis, however 
their relative contribution has been unclear. Recent studies have demonstrated that 
mast-cell deficient mice are protected against deep vein thrombosis, suggesting that 
it is the pro-inflammatory effects of mast cell degranulation that most contribute to 
venous thrombosis.11,25 Similarly, reduced cell recruitment is demonstrated in mast 
cell deficient mice, suggesting that mast cells may have a role in endothelial cell 
activation, presumably via histamine release. The putative mechanism for this effect is 
mast cell activation by ROS, however a precise mechanistic relationship is yet to be 
elucidated.11,25 
 
Blood Cell Recruitment 
The recruitment of blood cells to the site of venous thrombosis is best described on 




Leucocyte recruitment and vessel wall adhesion appears to be stimulated by 
haemostasis, and to be primarily mediated by endothelial expression of P-selectin. In 
addition, increased plasma concentrations of low-density lipoproteins appear 
significant in leucocyte recruitment.11 
Neutrophils 
Neutrophils are important participants in venous thrombosis, and the absence of 
neutrophils has been demonstrated to inhibit venous thrombus formation. 
Neutrophil recruitment to the endothelium results in activation and release of 
nuclear material, stimulating the formation of neutrophil extracellular traps (NETs) 
that are composed of DNA, histones, secretory granule contents and other pro-
inflammatory components. NET formation may be triggered by the presence of P-
selectin, and activation of the P-selectin glycoprotein ligand-1, although under 
pathology-free (i.e. stasis) conditions, generation of NETs may occur via expression 
of high mobility group box 1 (HMGB1) on the surface of platelets adherent to the 
vascular wall. Neutrophil activation appears to play a more significant role in 
stenosed versus fully-closed vessels, suggesting that there is a requirement for 
residual blood flow in order for the inflammatory mechanism to operationalize; 
conversely, thrombogenesis in the setting of venous stasis may be more dependent 
on coagulation (i.e. tissue-factor related) mechanisms.11 
Monocytes 
Monocytes are a significant source of tissue factor, and therefore are major initiators 
of the extrinsic coagulation pathway, fibrin deposition and thrombosis.11 
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Toll-like receptor 9 (TLR-9) signaling is a major inhibitor of the prothrombotic 
function of leucocytes, as demonstrated in multiple studies involving mice with TLR-
9 deficiency. In this setting, these animals demonstrated increased formation of 
NETs, increased markers of necrosis and of apoptosis in a stasis-based model of 
venous thrombosis.11 Interestingly, it has been demonstrated that the lack of TLR-9 
is associated with reduced monocyte recruitment to venous thrombi, although the 
complete clinical significance of this finding is not yet clear.11,26 
Platelets 
Platelets have been demonstrated to play an important role in venous thrombosis 
through the demonstration that platelet depletion results in reduced venous clot 
formation.11,27 In venous thrombosis, platelets tend to be recruited as single cells 
adhering directly to the activated endothelium or adherent leucocytes, rather than 
forming aggregates consistent with arterial thrombosis.11 
 
Recruitment to the thrombus is primarily mediated by the action of platelet receptor 
GP1ba and its interaction with surface endothelium vWF expression, however, 
interaction between platelet membrane CLEC-2 and podoplanin (a mucin-type 
transmembrane protein expressed in the tunica media and adventitia of murine 
inferior vena cavae) has also been implicated in platelet recruitment, particularly via 
hpoxia-mediated loosening of intercellular endothelial junctions, allowing increased 
platelet penetrance to subendothelial spaces.11,28 
 
The indirect effect of platelets is as important as their direct thrombogenic actions. 
On recruitment, platelets provide pro-inflammatory stimuli via the release of 
Damage-Associated Molecular Patterns (DAMPs), namely HMGB1 and myeloid-
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related protein-14 (MRP-14). HMGB1 promotes the formation of NETs by recruited 
neutrophils, and enhances the recruitment of monocytes and their subsequent tissue 
factor-mediated activation of the extrinsic pathway. Similarly, MRP-14 enhances NET 
formation, and assists in the propagation of venous thrombi.11 It appears that there 
are factors that limit the role of platelets in venous thrombosis, including the 
interaction of apoA-1 (the major apolipoprotein in high-density lipoproteins) with 
SR-BI, an endothelial receptor scavenger. These mechanisms of limiting platelet 
activation may represent future targets for modulating the pathogenesis of venous 
thrombosis.11 
The role of erythrocytes 
Red blood cells have traditionally been thought of as passive participants in the 
formation of venous thrombi, however recent evidence suggests that this may not be 
the case; for example, red blood cell transfusion in patients with cancer is associated 
with increased rates of venous thrombosis.2 
 
The mechanisms by which erythrocytes may contribute to venous thrombosis are 
not clearly delineated, but there are two prevailing theories. First, the aggregation of 
red blood cells in the low-shear environment may contribute to increased 
haemostasis, and retention of red blood cell aggregates in the basal hypoxic 
segments of venous pockets may occur via factor XIII-mediated mechanisms.2,29 
Secondly, red blood cells may express phophatidylserine (a procoagulant) that 
supports thrombin generation and may activate the contact (tissue factor) pathway 
of coagulation. In addition, erythrocyte-mediate release of adenosine diphosphate 
may trigger platelet activation, and red blood cells may decrease clot permeability 
and reduce fibrinolysis.2 
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Summary 
The pathogenesis of venous thrombosis is a complicated process, involving 
anatomical, physical, and immune-mediated triggers for initiation. Targeting of 
immune-mediated and inflammatory pathways may represent new areas for potential 
inhibition of venous thrombosis. The mechanisms of thrombosis explain the utility of 
pharmacological and non-pharmacological interventions for VTE prophylaxis, 
however it is clear that our understanding of the pathogenesis of VTE is incomplete, 
and that multiple mechanisms interact to varying degrees depending on the cause of 
reduced venous flow (stasis versus stricture). An understanding of these processes is 
critical to understanding the methods used in the clinical setting to limit the rates of 
VTE and reduce morbidity and mortality from this important pathology. 
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Chapter 3. Venous Thromboembolism Prophylaxis 
 
Introduction 
Venous thromboembolism (VTE) is a potentially fatal condition that may result in a 
range of debilitating or disabling conditions.30 It has a demonstrated incidence of 0.83 
(95% CI 0.69-0.97) per 1000 population per year in the Australian setting7, 
accounting for 7% of all in-hospital deaths in Australia.31  
 
Aetiology & Pathophysiology 
VTE pathogenesis is a result of alterations to haemostatic mechanisms and 
haemodynamics, including reduced or altered blood flow and stasis (e.g. gyrational 
flow and associated low oxygen tension around venous valve pockets),32,33 
hypercoaguability (with increased concentration of pro-coagulant proteins, 
decreased anti-coagulant proteins and decreased fibrinogen concentration33,34), 
endothelial activation with up-regulation and expression of tissue factor and 
endothelial adhesion molecules (leading to capture of leucocytes, platelets and 
microvesicles)35 and inflammatory activation of Tissue Factor pathway and leucocyte-
mediated endothelial activation mechanisms.33,34,36  
 
Activation of these various mechanisms results in platelet adhesion to the vessel wall 
and aggregation of platelets though interactions between extracellular ligands and 
soluble proteins. Thrombin production and activation of multiple positive-feedback 
loops results in stabilisation of the thrombus.30,35 
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Options for VTE Prophylaxis 
Following assessment of risk and need for VTE prophylaxis on admission,7,37 an 
appropriate selection of pharmacological, non-pharmacological or combination 
prophylaxis should be made in the context of the patient’s presenting complaint, past 
medical history, planned therapy and risk level. 
 
Pharmacological VTE Prophylaxis 
Pharmacological thromboprophylactic agents can be classified as parenteral 
anticoagulants, oral anticoagulants, antiplatelet drugs and new antithrombotic drugs.38 
 
Parenteral Anticoagulants 
Heparin is a highly-sulfated mucopolysaccharide, with a variable molecular weight 
(3000 – 30,000 KDa, Mean 15,000KDa). Only one third of heparin molecules contain 
the unique pentasaccharide sequence that confers anticoagulant action, and it is 
these that are responsible for heparin’s anticoagulant effects.39 Heparin functions by 
catalyzing the normally-slow reaction between antithrombin III (ATIII) and factors 
Xa, IXa, Xia, XIIa and thrombin. Binding of the high-affinity pentasaccharide chain 
present on active heparin molecules results in a conformational change in ATIII, 
changing it to a high-affinity, rapid inhibitor. Once the ATIII binds to an active clotting 
enzyme, heparin dissociates from the complex and can be re-used.39 Heparin is 
administered as either a subcutaneous or intravenous injection, although higher 
initial doses should be used when administered via the subcutaneous route due to 
reduced bioavailability.  
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Unfractionated Heparin is eliminated in a rapid cellular saturatable phase 
(predominantly through endothelial cell receptor and macrophage binding with 
internalization and depolymerisation) and through slower, first order kinetics, 
predominantly through renal clearance.40,41 Consequently, the anticoagulant response 
is non-linear, with the intensity and duration of anticoagulation increasing 
disproportionately as dose increases.39 Given the importance of adequate initial 
heparin-dosing in patients with VTE (low-dosing being associated with increased risk 
of recurrence and higher rates of mortality),39,42 initial intravenous dosing should 
ideally be weight-based (80units/kg bolus and 18units/kg/hr infusion)39 or 
administered as a bolus of 5000units, with an ongoing infusion of at least 32,000 units 
per day.39 Unfractionated heparin may be administered subcutaneously, either as an 
initial IV bolus of 5000units followed by 250units/kg subcutaneously, twice daily, or 
as an initial dose of 333units/kg subcutaneously, followed by ongoing therapy with 
250units/kg twice daily.39 
  
Use of UFH requires ongoing management of the patient’s activated partial 
thromboplastin time, in order to ensure therapeutic concentrations are being 
reached, while avoiding increased risks of bleeding. Factors increasing the risk of 
bleeding while using UFH include recent surgical or interventional procedures, 
trauma, other haemostatic deficits, age >60 years, increased clotting times (greater 
than therapeutic range) and hepatic dysfunction.39 
  
Low-molecular-weight heparin, derived from UFH by enzymatic or chemical 
depolymerization, is composed of low-molecular weight fragments (MW2000u – 
9000u) of unfractionated heparin that exhibit reduced binding to proteins and cells 
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(including plasma proteins, macrophages and endothelium), and function through 
catalysis of the AT-mediated inhibition of coagulation factors.39 Again, less than one 
third of LMWH chains carry the correct pentasaccharide sequence required for 
binding antithrombin, and as the molecules are smaller, only 25-50% are long enough 
to bridge antithrombin and thrombin.39 Inactivation of Factor Xa by antithrombin is 
catalyzed by LMWH, however, as this reaction does not require bridging.39 
  
LMWH has a more predictable anticoagulant effect and greater bioavailability (90%) 
than UFH.39,43-45 LMWH has a dose-dependent half-life of 3-6 hours after 
subcutaneous injection, with peak anti-Factor Xa activity at 3-5 hours after 
administration.39 It is important to note that LMWH is predominantly renally-
cleared, and may have a longer half-life in patients with renal disease.39 
LMWH should be administered once daily, as there is no evidence that twice-daily 
dosing demonstrates improved VTE prophylaxis.46 A 2009 systematic review of 22 
randomised controlled trials comparing fixed-dose subcutaneous LMWH with 
adjusted-dose intravenous or subcutaneous UFH in established VTE47 demonstrated 
reduced rates of thrombotic complications (3.6% vs 5.4%, OR 0.68, 95% CI 0.55-
0.84), major haemorrhage (1.2% vs 2.0%, OR 0.57, 95% CI 0.39-0.83), and overall 
mortality (4.5% vs 6.0%, OR 0.76, 95% CI 0.62-0.92) in groups treated with LMWH, 
compared to those treated with UFH. Similarly, the LMWH groups demonstrated 
improved reduction in thrombus size (reduction of 53% vs 45% OR 0.69, 95% CI 
0.59-0.81).47 
  
Four systematic reviews have compared the use of LMWH versus UFH and/or 
mechanical methods in surgical VTE thromboprophylaxis, and these are summarized 
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in table 3.1. At the time of writing, Cochrane Collaboration protocols were also in 
place for systematic reviews examining VTE prophylaxis in acute spinal cord injury, 
neurosurgery, cardiac or thoracic surgery, and total hip or knee replacement or hip 
fracture repair.48,49 
  
Both UFH and LMWH have the potential to lead to heparin-induced 
thrombocytopaenia (HIT), and osteopaenia, although the risk of these complications 
is lower with LMWH.39 
  
LMWH is recommended for pharmacological VTE prophylaxis in total hip 
replacement (Grade A), hip fracture surgery (Grade B), total knee replacement 
(Grade A), lower leg fractures or injuries with lower leg immobilization (Grade B), 
gynaecological surgery (Grade B), abdominal surgery (Grade B), cardiac, thoracic or 
vascular surgery (Grade B), neurosurgery (when not contraindicated) (Grade B), and 
trauma or spinal surgery (Grade C).37 UFH is recommended for use in general 
surgery, gynaecological surgery, abdominal surgery, cardiothoracic or vascular 











Type of Surgery/ 
Patient cohort Outcome of LMWH vs UFH 
Colorectal Surgery28 LMWH and UFH equally effective in preventing DVT and/or PE (OR 0.31, 95% CI 0.67-1.52) 
Abdominal aortic 
surgery50 
Insufficient evidence to make a recommendation regarding the use of 




LMWH and UFH are equally effective in preventing DVT (OR 1.03, 95% 
CI 0.33-3.20), PE ()R 1.82, 95% CI 0.57-5.80) or fatal PE (OR 3.33, 95% 
CI 0.13-83.24) in women undergoing major gynaecological surgery. (Note: 
Review withdrawn from Cochrane Library in 2008 to be updated)32 
Trauma Patients52 
LMWH reduced the risk of DVT compared to UFH (RR 0.68, 85% CI 
0.50-0.94), however there was no statistically significant difference in the 
risk of PE (RR 3.16, 95% CI 0.13-76.91), or risk of bleeding (RR 1.62, 95% 
CI 0.63-4.22) between the two groups. 
Table 3.1 Systematic Reviews comparing the use of LMWH versus UFH and/or mechanical 
methods in surgical VTE thromboprophylaxis 
Fondaparinux is an artificial, modified analog of the antithrombin-binding 
pentasaccharide sequence of heparin. With a molecular weight of 1,728, 
fondaparinux has increased affinity for antithrombin and anti-Xa, improved specificity 
of action and a relatively longer half-life when compared with heparin.39 It induces a 
conformational change at the active site of antithrombin, improving binding to factor 
Xa. Fondaparinux is then released from the AT-Xa complex, and goes on to catalyse 
other antithrombin-factor Xa interactions.39,53 
Fondaparinux has a rapid, dose-dependent absorption profile due to its 
subcutaneous administration, with 100% bioavailability.39,53 Peak plasma concentration 
occurs 2 hours after administration.36 
  
Fondaparinux has a limited volume of distribution, close to that of plasma volume, 
and a half-life limited to 17-20 hours, allowing for once-daily dosing.53 It does not 
appear to be metabolized, and is almost completely renally-excreted.39,53 Due to this 




Fondaparinux is recommended for thromboprophylaxis in orthopaedic surgery, 
following total hip replacement, hip fracture surgery, and total knee replacement in 
Australia.37 
  
Four industry-sponsored phase III trials (PENTHIFRA, PENTAMAKS, 
PENTATHALON 2000 and EPHESUS) studied the efficacy of fondaparinux  at a dose 
of 2.5mg in patients undergoing major lower limb surgery, and one RCT examined 
the role of extended thromboprophylaxis following hip fracture surgery 
(PENTHIFRA PLUS).39 These studies reported clear superiority of fondaparinux to 
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after elective hip 
replacement)57 
48/787 (6.1%, 
95% CI 4.5-8.0) 
p = Not 
Significant 
 







after elective hip 
replacement)58 
37/908 (4.1%, 
95% CI 2.9-5.6) 
p < 0.0001 




N/A 55.9% 5.2% 
Table 3.2 Incidence of VTE in patients receiving fondaparinux versus controls, for 
orthopaedic surgery 
 
In Australia, Fondaparinux is recommended for use in total hip replacement (Grade 
B) for up to 35 days, hip fracture surgery (Grade B) fornup to 35 days and total knee 
replacement (Grade B) for up to 14 days.37 
  
Danaparoid is a mixture of glycosaminoglycans (heparin sulphate, dermatan 
sulphate and chondroitin sulphate), derived from animal mucosa.39,59,60 It is a low-
molecular weight heparinoid, that primarily mediates coagulation through AT-III 
inhibition of factor Xa, with a lesser degree of associated factor IIa inactivation.39,60 
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Danaparoid has 100% bioavailability following subcutaneous injection, with peak 
plasma concentration at 4-5 hours post-administration, and a half-life of 25 
hours.39,44,59,60 It is administered twice daily, at a dose of 750 anti-Factor Xa units. 
Product recommendation recommends use for no longer than 10 days post-
operatively.59 
  
Although Danaparoid has been shown to be effective for the prevention of VTE in 
high-risk patients,61-63 it has been withdrawn from marketing for this indication.39 As 
of 2011, Danaparoid remains indicated for the prevention of venous 
thromboembolism in general and orthopaedic surgical patients,59 however, the 2009 
NHMRC clinical practice guideline for the prevention of venous thromboembolism 
only recommend the use of danaparoid in the treatment of patients suffering from 
heparin-induced thrombocytopaenia who require VTE prophylaxis.37 
 
Oral anticoagulants  
 
Dabigatran etixelate is a direct thrombin inhibitor, administered as an oral 
prodrug and metabolized by serine esterase enzymes following gut absorption. 
Dabigatran is a concentration-dependent molecule that binds to the active site of 
thrombin in both its free- and fibrin-bound states.64 
  
Dabigatran etexilate reaches peak plasma concentrations within 0.5-2 hours of 
administration. Plasma concentrations drop by approximately 70%, within 4-6 hours, 
following initial dosing, however repeated dosing results in steady-state levels within 
2-3 days, and a stable elimination half-life of 12-17 hours. Approximately 80% of 
Dabigatran etexilate is renally-excreted.64  
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The RE-MODEL, RE-NOVATE and RE-NOVATE II studies65-67 have shown 
Dabigatran etexilate to be non-inferior to enoxaparin in total knee and total hip 
replacements,62 and current guidelines support its second-line use in patients 
undergoing these procedures.  LMWH remains the preferred means of 
anticoagulation in these cohorts, however dabigatran can be used in those unable to 
use LMWH (due to contraindications, high-risk of adverse events, or intolerant of 
repeated injection) and is particularly useful in the extended-prophylaxis setting.63 In 
cases where dabigatran is used pre-operatively, special arrangements should be 
discussed between the surgical and anaesthetic teams due to the drug’s extended 
half-life.37,64 
  
Dabigatran etexilate interacts with a number of drugs during its absorption and 
metabolism. Dabigatran etexilate requires a low acidity environment to optimize 
absorption, and concomitant administration of pantoprazole therapy has been shown 
to reduce dabigatran absorption. Dabigatran plasma concentrations are also affected 
by changes in the function of the P-glycoprotein (P-gp)cell efflux transporter. 
Amiodarone, verapamil, ketoconazole, quinidine and clarithromycin all act to inhibit 
P-gp, and consequently increase plasma dabigatrin concentrations. Similarly, 
rifampicin and St. John’s Wort induce P-gp function, and reduced plasma dabigatran 
concentrations.64,68  
  
As of October 2015, Idarucizumab has been approved by the U.S. Food and Drug 




Rivaroxaban is a selective, direct, reversible inhibitor of the active site of factor 
Xa. It inhibits free factor Xa and both prothrombinase complex- and clot-associated 
factor Xa.64,68 
 
Rivaroxaban has been demonstrated have a similar efficacy in preventing VTE in 
patients undergoing total hip arthroplasty and total knee arthroplasty as LMWH in 
the RECORD trials70, with relative risks of VTE of 0.38 and 0.77 when compared 
with 40mg daily and 30mg twice-daily subcutaneous enoxaparin dosing, respectively.  
It was found to be as safe as dabigatran and no significant increase in risk of bleeding 
was demonstrated in the studies.68,70  
 
Again, although rivaroxaban may be used (Grade 1c), LMWH remains the preferred 
means of anticoagulation in patients undergoing total hip or knee arthroplasties 
(Grade 2B). Rivaroxaban can be used, however, in those unable to use LMWH (due 
to contraindications, high-risk of adverse events, or intolerant of repeated 
injection).64,68  
  
Rivaroxaban reaches peak effect within 1-4 hours of administration. Rivaroxaban is 
predominantly cleared by the hepatobiliary system, however up to one-third of the 
drug is cleared renally. Consequently, its half life varies from 5-9 hours in young 
healthy patients,71 to 11-13 hours in elderly subjects.64,68,72 Rivaroxoban is partially 
metabolized by the cytochrome P450 3A4 system, and interactions have been noted 
when used in combination with strong CYP450 inducers and inhibitors.68 
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Apixaban is a direct factor Xa inhibitor, administered orally and actively inhibits 
free and clot-bound factor Xa, binding directly the active site and inhibiting the 
conversion of prothrombin to thrombin.68  
  
Apixaban has an oral bioavailability of 50%68 and reaches peak plasma concentrations 
within 1-4 hours of administration.68 It has a half-life of 8-15 hours.68 Apixaban is a 
highly protein-bound molecule (87%) and is predominantly excreted via 
hepatobiliary/faecal clearance and the cytochrome P450 CYP3A4/5 pathways (73%) 
with the remaining 27% being excreted renally.68  
  
In Australia, Apixaban is indicated for VTE prophylaxis in patients that have 
undergone elective total hip and total knee arthroplasties (Grade 1C); LMWH 
remains the preferred means of anticoagulation in these cohorts, however Apixaban 
can be used in those unable, or unwilling, to use LMWH (Grade 2B).  
The ADVANCE-2 and ADVANCE-3 trials73,74 demonstrated that Apixaban is non-
inferior (and in the ADVANCE-3 trial was, in fact, superior) to enoxaparin for VTE 
prophylaxis in total knee and total hip replacements, with no greater risk profile that 
enoxaparin.68,73,74  
 
The AMPLIFY-EXT study recently demonstrated that Apixaban was safe for 
extended VTE prophylaxis in patients that had undergone earlier treatment for DVT 
or PE and in whom the decision whether to cease or continue anticoagulant therapy 
was clinically ambiguous.75 The study revealed a statistically significant reduction in 
risk of VTE in either treatment group (2.5mg and 5mg twice daily) compared with 
placebo, with the 2.5mg group demonstrating a relative risk of recurrent VTE or 
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VTE-related death of 0.19 (95% CI 0.22 - 0.48) compared with placebo, and the 5mg 
group showing a relative risk of 0.20 (95% CI 0.11 – 0.34), a difference of 7.2% (95% 
CI 5.0 – 9.3) and 7.0% (95% CI 4.9 – 9.1) respectively.75 The study also demonstrated 
the safety of Apixaban in extended VTE prophylaxis; although clinically relevant non-
major bleeding rates increased with dose (placebo = 2.3%, 2.5mg Apixaban group = 
3.0%, 5mg Apixaban group = 4.2%), the rate of death from any cause was highest in 
the placebo group (1.7%) and lowest in the 5mg Apixaban group (0.5%).75 
 
Betrixiban is a novel selective Factor Xa inhibitor that is efficacious in providing 
extended-duration VTE prophylaxis in acute medical patients when commenced in-
hospital, and continued in the community for up to 35-42 days, aged >75 years or 
with ≥2 risk factors for VTE.76,77  
 
Recent reviews have suggested that the Novel Oral Anticoagulants (NOACs) may be 
considered as first-line agents for both the treatment and prophylaxis of VTE, 
although data in sub-groups of patients is limited.78.  
 
Overall NOACs are non-inferior to other anticoagulation regimens, with similar 
associated rates of bleeding, and it is reasonable to consider their use as first-line 
agents for VTE treatment and prophlyaxis, particularly as reversal agents become 
available to practitioners (e.g. idarucizumab,79 and andexanet alfa80). These agents are 
contraindicated in patients with severe renal insufficiency (creatine clearance 




Antiplatelet Agents  
Aspirin is the best-known and most widely-studied antiplatelet drug, and primarily 
acts to prevent platelet activation. Aspirin acts through dose-dependent blockade of 
the thromboxane-A2 (TXA2) pathway, with low-dose therapy preventing only the 
production of TXA2 (a promoter of platelet aggregation), and not of Prostaglandin I2 
(PGI2 – a strong platelet aggregation inhibitor). Aspirin prevents TXA2 production 
through the permanent inhibition of prostaglandin H-synthase-1 and -2 (COX-1 and 
COX-2) cyclo-oxygenase activity, thus preventing the conversion of Arachidonic acid 
to Prostaglandin H2, the immediate precursor of TXA2 and PGI2.81  
 
Aspirin is rapidly absorbed in the upper gastrointestinal tract, specifically the 
stomach and upper intestine, and platelet inhibition begins within an hour of 
ingestion. Enteric-coated aspirin has a longer rise to peak plasma concentration of 
between 3 and 4 hours.81 The half-life of aspirin is between 15 and 20 minutes, 
although the effect lasts the lifetime of the platelets due to aspirin’s permanent 
COX-1 inhibitory function in both circulating platelets and megakaryocytes, thus 
preventing platelet activation in both circulating and newly-produced platelets. 
Approximately 10-12% of platelets are replaced daily, however the non-linear 
relationship between COX-1 inhibition and TXA2 synthesis and the ability of residual 
thromboxane produced by platelets unaffected by aspirin to continue platelet 
aggregation, means that recovery of platelet function is faster than anticipated based 
on platelet production.81 
 
Aspirin has been shown to be effective in preventing VTE after major orthopaedic 
surgery,81,82 and the current American College of Chest Physicians guidelines 
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recommend its use for VTE prophylaxis in patients undergoing general, abdominal or 
pelvic surgery at high risk of adverse events from, or with contraindications to the 
use of, Low-molecular-weight heparin or unfractionated heparin (Grade 2c), those 
undergoing total-hip or total-knee arthroplasty (Grade 1c), patients undergoing hip 
fracture surgery (Grade 1c).64 In all cases, however, aspirin should not be considered 
a first-line agent for VTE prophylaxis. 
 
To date clopidogrel has not been recommended for the prevention or treatment 
or VTE, and recent guidelines support not using this drug for this indication81,83. 
 
New Anti-thrombotic Agents 
A range of new anti-thrombotic agents are being trialled that may have a future role 
in surgical VTE prophylaxis, including NAPc2, Idraparinux, Idrabiotaparinux and 
recomodulin.84 None are currently licensed for use in Australia. 
 
Summary 
A broad range of pharmacological thromboprophylactic agents is available, with new 
drugs currently undergoing trials. VTE prophylaxis will always remain an important 
aspect of peri-operative care, and correct selection of therapeutic agents in the 
context of the patient’s presenting complaint, past medical history, planned therapy 
and risk level is vital. It is important for surgeons and surgical trainees to have an 





Chapter 4. Theoretical Basis of Learning and E-Learning 
 
Learning theory underpins our understanding of how student learn, and how best to 
deliver opportunities and material for learning to students. The theories of learning 
are, however, subject to social and psychological pressures and contexts that mean 
they have evolved over time, depending on the prevailing societal constructs of the 
day. This chapter will briefly review the key learning theories of the 20th and 21st 
centuries.  
 
Learning theories can be divided into two epistemological groups; objectivist 
epistemology and constructivist epistemology. 
 
Objectivist epistemology is a predominantly 20th Century approach that includes the 
theories of behavioural, cognitive and constructivist learning. It underlies the didactic 
approach to teaching. The objectivist approach relies on the belief in an objective 
truth that is discovered over the course of time, existing outside the human mind, 
or, alternatively, outside of what an individual may or may not believe. 20th Century 
learning is categorised as behavioural, cognitist and constructivist theories.  
Conversely, constructivist epistemology (confusingly, separate from constructivist 
theory) is a 21st century approach to learning that includes the theories of 
connectivism and collaboratism.85 Although a 21st century theory, few, if any 
components of constructivist epistemology are yet practiced in medical education, 
and as such will not be discussed in this review. 
 
This section will consider each of these theories in turn, and explore recent 
developments in the theoretical basis of e-learning. 
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Behaviourist Learning Theory 
Behaviourist learning theory focuses on the observable characteristics of learning; 
developed in the late 19th century, it espouses an empirical, observable and 
measureable theory of learning. It is a learning theory that rigorously applies the 
scientific method, and only measures observable findings; that is to say, behaviourist 
learning theory considers the learner’s mind, and it’s workings, to be an irrelevant 
“black box”, instead emphasizing the study of environmental stimulus and observed 
response.85  
 
The theory emphasizes classical conditioning and operant conditioning as responses 
to environmental stimuli, embodied in the quintessential works of Pavlov86 
(behaviour becomes a reflex response to a stimulus) and Skinner87 (behaviour is 
reinforced by reward or punishment). While this holds some appeal, in terms of 
restricting the study of learning to measurable factors, amenable to randomized 
studies and clear input-output models of education, the model has limitations, 
limiting the process to learning and education to a narrow, mechanised process that 
ignores the impact of environment and social constructs. As a result, it is most 
successfully applied in the context of unambiguous learning objectives, and 
achievement of specific, agreed criteria for task-oriented performance.85 
 
Behaviourist Pedagogy 
Behaviourist pedagogy relies on the underlying principle of learning as a behaviour 
that demonstrates acquisition of knowledge or skill. Reward and punishment 
techniques are designed to promote desirable behaviour in students via positive or 
negative reinforcement. This is manifested in common classroom practices such as 
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teacher-student learning contracts, immediate consequences after a particular 
behaviour occurs, the use of positive and negative reinforcement, and the use of 
positive and negative punishment. This approach relies on the assumption that there 
is a predictable link between stimulus and response, and that such responses are 
consistent, automatic and replicable.85 
 
The earliest forms of e-learning relied upon a behaviourist pedagogy, with computer-
assisted instruction (CAI) being designed to rely upon encouragement and repetition 
to promote positive learning outcomes.85,88 In this model of e-learning, control sits 
with the program designer and not the learner, with an instructional emphasis on 
behavioural control.85 
 
Cognitivist Learning Theory 
Cognitivist learning theory emerged in the 1920s as an extension and reaction to 
behaviourist learning theory, in recognition of the importance of social inputs and 
internal mental processes to learning. Three schools of thought developed around 
cognitivist learning theory, although all subscribe to the concept of the “Mind as 
Computer”.85 
 
The Cognitive Information Processing school was the first to hold, and most strongly 
imbued with, the concept of the human mind as a computer-like information 
processor. The school saw information processing in a precise, mechanical way, 
following a formal structured pathway through storing, retrieving, transforming and 
using information, with the formation of associations as a component of learning. 
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This computer-science approach to learning, later had strong influence on the 
developers of early e-learning techniques.85 
 
The Schema Theory school argued that learning occurs when new information is 
compared to existing knowledge, and held in a representation or structure for 
retrieval. As a result, learners must develop symbolic systems to help develop new 
skills or retain new information; how these schema are developed is variable, 
however, with schema potentially existing as memory structures, abstract schema, 
networks, dynamic structures or contextual overlays.85 
 
The final cognitivist school is that of Gagné’s instructional design, based on his 
experience studying instructional techniques in the military, which presented the 
view of instruction as the transmission of information, with the role of the student as 
willing recipient, and the instructor as designer and presenter of stimuli to elicit 
appropriate student behaviour.85 
 
It is in Gagné’s work that the similarities between behaviourist and cognitivist 
theories of learning become most apparent, given that both theories subscribed to 
the concept of taxonomies of learning. The classic behaviourist example of 
taxonomies of learning is Bloom’s Taxonomy of Educational Objectives Handbook,89 
a taxonomy that related learning to the development of intellectual skills, with 
problem-solving as a higher-order skill.88 Bloom’s taxonomy ranked six key elements 
of learning, from lowest to highest order, and each element being based on the ones 
below it, namely, remembering (recognizing and retrieving information), 
understanding (constructing meaning from information), applying (executing or 
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implementing knowledge), analysing (breaking new material down into parts, and 
relating them to each other and outside structures), evaluating (judging and critiquing 
information, and using that process to evaluate decisions) and creating (putting the 
learned elements together to form a coherent whole meaning, or constructing a new 
pattern or structure).88,89 
 
Gagné built upon Bloom’s structure, and developed a new theory of instruction that 
would form the basis for cognitivist instructional design, and formed a process for 
the delviery of information to students by instructors.85,88 Gagné’s theory was 
composed of a taxonomy of learning outcomes, a list of specific conditions for each 
learning outcome, and nine events of instruction that were effectively methods and 
procedures to enable learning processes (Table 4.1).85  
 
Learning Outcomes Specific Conditions for 
Learning 
Events of Instruction 
Verbal Information Verbal Information Gaining Attention 
Intellectual Skills Intellectual Skills Informing Learner of Objective 
Cognitive Strategies Cognitive Strategies Presenting Stimulus 
Attitudes Attitudes Presenting Material  
Motor Skills Motor Skills Providing Guidance 
  Eliciting Performance 
  Providing Feedback 
  Assessing Performance 
  Enhancing Retention and Transfer 
Table 4.1 Gagné’s Theory of Instruction 
Cognitivist Pedagogy 
Cognitivist pedagogy is closely associated with behaviourist pedagogy, and can be 
viewed as an extension of the latter rather than a completely new theoretical 
foundation. 
 
Cognitivism holds that human behaviour is predictable, and therefore subscribes to 
the behaviourist theory that instruction should be prescriptive, and that learning 
 39 
outcomes are predictable based on repeated responses to the same stimulus. This 
resulted in the pedagogy of cognitivist instructional design, wherein the instructor 
attempts to determine which stimuli result in the desired response from the learner, 
and applies them in order to achieve the required outcome.85 
 
When combined with Gagné’s taxonomy (which empowered the required 
instructive approach) and the concept of learning schemata, the field of educational 
technology emerged as a key component of cognitive pedagogy, with computers 
taking on roles in intelligent tutoring systems (an extension of the earlier computer 
assisted learning approach). The intelligent tutoring system works through 
determining the student’s baseline understanding of the material, and then decides 
what the student needs to know, delivering that information through a problem-solving 
exercise.85 
 
Intelligent tutoring systems are limited by the inherent limitations of the baseline 
student learning model, and by the concept of ‘machine intelligence’, insofar as the 
machine is, in fact, following defined algorithms, rather than truly adapting to learner 
requirements. This has generated an interest in the possibility of artificial intelligence 
as an educational tool, however current technology has neither the capacity nor 
capability for the meaningful use of artificial intelligence in learning at this time.85  
 
Constructivist Learning Theory 
Constructivist learning theory emerged in the 1970s, and was a significant departure 
from the preceding theories of learning. According to constructivist learning theory, 
learned construct their knowledge and understanding through experiences and 
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reflection on their experiences. Although there are many perspectives on 
constructivist learning theory, there does appear to be general agreement that 
learning is a constructive rather than acquisitive process, with instruction having a 
supportive role in knowledge development.85,88  
 
Vygotsky has described a social constructivist theory of learning as a problem solving 
exercise, based on a social construction of solutions that occurs in a “zone of 
proximal development”, with the teacher providing the social environment in which 
learning occurs. This is similar to the theories of Dewey, who described learning as a 
series of social experiences, consisting of learning by doing, collaborating and 
reflecting with others.88 
 
Conversely, Piaget developed a cognitive constructivist theory of learning,90 focused 
on the individual, and based on four stages of cognitive development; the 
sensorimotor stage (reflex-based learning, occurring from birth to 2 years old), the 
preoperational stage (learning based on words and thoughts, and acting on objects. A 
self-oriented phase from ages 2-7 years), the concrete operational phase (a phase of 
problem solving-based learning, from age 7-11 years), and the formal operational 
phase (from age 12+ years, characterized by abstract thinking and theoretical 
reasoning). In this model, the instructor challenges the student’s pre-existing ideas 
with the aim of creating cognitive disequilibrium, the problem that the student then 
has to solve to restore a sense of cognitive balance. Thus, Piaget’s theory relied on 
the premise that knowledge is constructed in the learner’s mind, and forms a fit with 




Constructivist pedagogies focus on the learner and the needs of the learner, in the 
belief that instruction should facilitate the development of meaning and 
understanding as the learner actively constructs knowledge; this has resulted in a 
number of approaches, based around the concepts of active learning, learning-by-
doing, scaffolded learning and collaborative learning.85 
 
Active learning is a requires instructors to encourage students to participate and act 
in their learning (e.g. examining a patient, conducting an experiment); it is a student-
centred approach that requires the student to engage in an activity, reflect upon it, 
and then discuss how their understanding is changing, while the teacher uses their 
understanding of the student’s pre-existing understanding to guide the activity 
toward improving that understanding.85  
 
A constructivist approach to education requires the teacher to encourage and assist 
students in developing their knowledge of a subject, rather than transmitting 
information to be memorized. Instructors must use problem-solving and inquiry-
based activities to engage the learner as an active participant in the learning process, 
and play an active role through identifying a knowledge problem for trainees to 
assess, providing guidance in how to understand it, and guiding students toward 
appropriate resources to solve the problem.85 That problem should be an authentic, 
complex and ill-defined, and therefore reflect the real-world problems that the 
trainee will face on completion of their studies. In this model, instructors facilitate 
learning and teach by negotiation, rather than imposition.85,91 
 
 42 
‘Learning by doing’ is an approach advanced in many educational institutions. The 
classical example of this methodology is that of engaging children in the use of the 
Logo programming language developed by Papert and others at the Massachusetts 
Institute of Technology; combined with a device called the “turtle”, a programmable 
robot holding a pen, students learn the logo language in order to make the turtle 
draw geometric shapes. The key tenet in this process is that students learn to do 
something, rather than about something.85 This approach extends into other 
constructivist pedagogical approaches, including problem-based learning (students 
are presented with a scenario to resolve, with aspects of the problem presented 
from different perspectives), distributed problem-based learning (a group of students 
working on a problem-based scenario), case-based learning (in which students 
discuss specific, typically real-world, examples of a problem, engaging them in 
knowledge-building and analysis as a group of learners. In this instance, there may be 
no correct answer), inquiry-based learning (a form of self-directed learning in which 
students take a greater responsibility for directing what they need to know) and 
role-play simulation (including game-based learning, in which students act out roles in 
order to understand various perspectives around the problem to be solved).85 
 
Scaffolding is an alternative term used to refer to Vygotsky’s Zone of Proximal 
Development (ZPD); in this method, an instructor or teacher assists the learner in 
constructing knowledge until the need for support has passed. The ‘scaffold’ refers 




Finally, collaborative learning is a key principle of social constructivism. This 
pedagogy emphasises collaboration, particularly among learners, in order that 
participation and interaction produces a finished result owned by more than one 
person. This most commonly refers to small-group learning.85 
 
Constructivist pedagogies are likely to be those most commonly associated with our 
current understanding of e-learning in medicine, insofar as the technologies used are 
often referred to as learning environments. While construction worlds and 
microworlds exist in other specialty teaching areas, by far the most common use of 
constructivist learning environments in medicine is through online learning and 
course delivery platforms (e.g. Blackboard, Moodle, etc.).85 These platforms utilise 
constructivist theory in that they facilitate user-generated content and can be altered 
by the user to facilitate discussion. This describes the potential utility of these 
platforms, however, and many educators use these platforms as mechanisms for 
disseminating knowledge (in a behaviourist or cognitivist approach), rather than 
exploring the social opportunities that such platforms present; that is to say, 
constructivist designers cannot ensure that educators will use constructivist 
pedagogy in education delivery.85 
 
Summary 
Educational theory has evolved over time, from a mechanistic perspective to one of 
collaborative, constructivist learning opportunities. While new theories based 
around Massive Open Online Courses have evolved in the early part of the 21st 
Century, much of current online medical education is based on a constructivist 
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theorem. The next chapter will analyse the role of e-learning in medical education, 





Chapter 5. E-Learning in Medical Education 
 
E-learning is defined as the use of the internet for education, and may also be 
described as web-based learning, online learning, distributed learning, computer-
assisted instruction, or internet-based learning, and aims for a flexible, engaging, 
interactive, collaborative and learner-centred approach to education.92-95 Two modes 
of e-learning, distance learning and computer-assisted instruction, are commonly 
used to deliver teaching through the use of tutorials, online discussion groups and 
virtual patients.92,94 In this context, students may be situated in a variety of 
environments either at a distance, or in traditional learning settings via computer 
laboratories, operating theatres, hospitals, or any site with internet access.93 This 
provides the opportunity for the delivery of classical online teaching (i.e. the delivery 
of facts and information in stand-alone online modules or presentations), however in 
recent years this approach has broadened to include combinations of online 
educational delivery and direct contact between students and students and 
instructors, resulting in an approach described as ‘blended learning’.95,96 
 
In this context, the e-learner is any individual that mediates some learning activities 
online,93 and uses content and activities presented by instructors and material 
created by the learner or other learners.93 As a result, e-learning offers a number of 
advantages to learners over traditional approaches.92,95  
 
E-learning may occur independent of time and place, conferring flexibility in 
opportunities for learning that benefit adult learners. Similarly, the pedagogical 
process can occur over vast distances, and allows for educational opportunities for 
distant (even international) learners, and those in remote areas who may otherwise 
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lack educational opportunities. There is a significant degree of social engagement 
involved in e-learning, and the medium may permit an improvement in skills in online 
communication, including the ability to produce concise, coherent writings. This 
aspect also confers a need for a greater degree of academic and persona reflection 
than might occur in traditional academic settings, resulting in improved learning and 
competence development.94,95 Online education also permits the generation of 
perpetual resources that are easily updated (particularly important as new medical 
evidence is generated), the opportunity for novel instructional methods facilitating 
deliberate and distributed practice, and the opportunity for assessment and 
documentation of educational objectives, thus permitting immediate, customizable, 
feedback.94 
 
Online education is not without disadvantages, however, and many of these relate to 
the perceived advantages of web-based instructional delivery. 
 
Despite the potential for improved social interactions as part of e-learning, learners 
may suffer a relative increase in social isolation, often studying alone, and engaging in 
online discussion that follows a distinct social organizational structure that is 
different from in-person interactions. In addition, the anticipated benefits of 
perceived individualised learning may not be apparent, and learners may experience 
significantly less individualised instruction if the web-based learning program is not 
designed to measure and respond to learner needs.94,95 
 
E-learning is attractive to many educational institutions as a cost-saving method of 
delivering instruction, however the initial development of effective online learning 
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material can be expensive and time-consuming, and ongoing online discussions and 
student interactions require moderation by faculty members. In addition, there is an 
opportunity cost to the learner, as online study must occur in time that may have 
been devoted to other purposes, and potentially carries a significant workload that 
may not have been totally appreciated by instructors designing the learning 
program.94 This also speaks to the quality of instructional design, which may be highly 
variable in the e-learning environment; instruction in the online setting requires 
precise and dedicated preparation and implementation, and research demonstrates 
that many online learning environments do not meet these standards.94,97 
 
A key tenet of e-learning is the dependence on technology, and as a result the e-
learning environment will suffer from some form of technical problem at some point 
in time; unlike traditional pedagogical approaches, however, the dependence on 
technology in e-learning increases the impact of problems when they do occur. 
While catastrophic problems are relatively uncommon, and easily identified (e.g. the 
crashing of a server), technical problems include minor, but disruptive, issues (e.g. 
slow responses to user input) that can result in decreased learner satisfaction and 
increased cognitive load, thus impeding learning.94 
 
E-learning has been enthusiastically taken up in medical education, and many forms of 
e-learning are in use, from simple text-based websites, to case-based learning 
platforms (of which eMedici is one example) and online, virtual simulations of patient 
encounters.85,92,94,95 It is a now a component of undergraduate, graduate, paediatric, 
surgical and general medical education.98-103 
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Web-based learning takes on multiple modalities, and is perhaps most widely used in 
the instruction of medical students. Tang et al99 conducted a scoping review of the 
use of online lectures in undergraduate medical education in 2018. They found that 
online lectures have been extensively integrated into undergraduate medical 
education, across multiple subjects and levels of training. The authors demonstrated 
that medical education has been poor at incorporating principles of multimedia 
design into online lectures, despite evidence of the importance of such principles 
existing for approximately ten years. The authors attribute this lag in uptake to a 
combination of time constraints, existing standards of practice, and the likelihood 
that clinician-teachers have not received training in multimedia design principles, or 
may not have fully integrated these principles into their practice.99 Tang et al. found 
that most studies demonstrated that the use of online lectures was non-inferior to 
traditional pedagogies, with all studies reporting high student satisfaction with online 
learning and improved knowledge following its use. Interestingly, multiple studies 
reported superior learning outcomes in medical students using online lectures as 
part of their education; however, these results should be treated with caution, as it 
may not be that online learning is a superior medium, but that the conditions 
associated with e-learning (including extra learning time, ability to re-review material, 
access to resources, etc) lead to improved student learning outcomes.99 
 
Jwayyed et al conducted a review of the literature concerning the use of technology-
assisted education in graduate medical education in 2011.100 They demonstrated that 
the most commonly used modalities of online learning in graduate medical education 
were computer and internet-based methods, followed by simulation and virtual 
reality techniques. Studies were most commonly conducted in medical students, 
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followed by residents, and sought to measure knowledge gains, satisfaction and 
attitudes to educational interventions. Of the studies conducted that directly 
compared technology-assisted learning with traditional teaching methods, the 
majority found technology-assisted learning to be equal or superior to traditional 
methods, although the authors could not identify a ‘best-method’ for delivering 
technology-assisted education. Similarly, the indications and timing for using 
technology-assisted education over traditional methods could not be identified from 
the literature.100 
 
In 2018, O’Doherty et al. conducted a review of the literature with a view to 
identifying the barriers and solutions to the development and implementation of e-
learning in medical education. They identified four core themes as areas impacting on 
the production of e-learning; skills, resources, institutional strategies and support, 
and attitude.104 
 
The only identified skills-based barrier to the use of e-learning was the presence of a 
skill deficit; that is, a lack of technical skills in computing and typing, associated with 
poor infrastructure, leading to reduced engagement with online learning. The 
author’s proposed engagement as a solution to this barrier, both directly (i.e. the 
educator must make a conscious decision to try to use e-learning modalities) and 
through training via online material and the use of faculty workshops.104 
 
Time and infrastructure were identified as the principle resources barriers to the use 
of e-learning by medical educators. Educators, who already have teaching, clinical, 
research and personal commitments, have limited opportunities to spend time on 
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mastering the tools of online learning, and appear to have few incentives to engage 
with e-learning. The review demonstrated that the use of digital tools for teaching 
can, overall, increase available free time and permit increased opportunities for 
instructors to learn e-learning concepts and reflect on their practice; however the 
reviewers note the importance of developing formal mechanisms for acknowledging 
efforts and rewarding time spent by faculty on developing e-learning material. 
Conversely, access to technology and infrastructure may be significant barriers to 
the introduction of e-learning, particularly in low- to middle-income countries, 
including poor wireless internet connectivity, access to physical infrastructure, and 
access to computers. In this respect, the authors identified the use of ‘break-even 
analysis’ as a tool for determining the cost of introducing e-learning programs, and 
found that online education was more cost effective than traditional learning, 
permitting fewer enrolments for a program to reach its break-even point that 
traditional teaching methods. As a result, initial investment in e-learning technologies 
may prove to be a more cost-effective approach to education delivery in the low-
resource setting.104 
 
Institutional support for the introduction of e-learning is vital, and a component of 
this process is communication between faculty members both in the set-up and use 
phase of e-learning development. Poor institutional support and limited direction in 
the use of e-learning for Faculty may result in listless project development and poor 
communication between team members, resulting in a reduction in the active 
exchange of ideas and shared knowledge within teams, and across institutions.104 
Collaboration is a key component of the development and introduction of e-learning, 
and must be an imperative and active process, including the use mechanisms to 
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ensure dedicated human and financial resources are in place to support the project, 
and to ensure the support of all stakeholders in the project. O’Doherty et al 
recommend the use of institutional strategies to facilitate the implementation of key 
skills and methodologies when staff are working toward the introduction of web-
based learning.104 
 
The final barrier to e-learning implementation identified by O’Doherty et al. was 
culture. The use of online learning technologies imposes a learning curve on faculty 
members as they attempt to master new e-learning tools and technologies, and 
instructors may become frustrated with minor technical issues or overwhelmed by 
the development process, inducing negative attitudes towards e-learning. In this 
setting, it is critical to assist teachers in maintaining a positive attitude towards e-
learning through the development of a positive learning culture, fostering a change of 
norms and attitudes, and providing support for faculty members.104 
 
What is the efficacy of e-learning? 
There has been significant educational and research interest in the use of e-learning 
in medical education in the past 20 years, and multiple studies have been conducted, 
using various methodologies, into the efficacy of e-learning. 
 
In an attempt to answer the question of whether e-learning is more effective than 
traditional learning in licensed healthcare professionals for improving patient 
outcomes or health professionals’ skills, behaviour and knowledge, Vaona et al. 
published a Cochrane systematic review of the literature in 2018.105 
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The authors identified 16 studies from 10 countries, providing data on 5,679 
participants (4759 mixed healthcare professionals, 587 nurses, 300 doctors and 33 
childcare health consultants). All trials compared e-learning with traditional face-to-
face learning, except for two studies that compared e-learning to guideline 
dissemination or availability. 11 trials administered e-learning as a sole intervention; 
in the five remaining trials, e-learning was identified as a core facet of a multifactorial 
educational intervention. Outcomes used in the 16 studies included health 
professionals’ behaviours, patient outcomes, and knowledge, assessed through the 
analysis of administrative and patient record data, and the administration of testing, 
simulation and objective structured clinical examinations (OSCEs).105 
 
The systematic review revealed that the use of e-learning may make little to no 
difference in terms of patient outcomes when compared with traditional learning, 
and was not associated with changes positive (i.e. desired) changes in healthcare 
professionals’ behaviours, with two studies that addressed behavioural outcomes 
revealing no improvement in rates of screening or patient treatment for 
dyslipidaemia (the target pathology in the two studies) (Figure 5.1).105 
Figure 5.1 Forest plot of comparison between e-learning and traditional learning for 
healthcare professional behavioural outcomes. 
Although there is a small trend toward improved outcomes from e-learning, the effect is 
not statistically significant, and the meta-analysed measured effect crosses the line of no 
effect (From Vaona et al105) 
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The certainty of evidence surrounding the effect of e-learning on healthcare workers 
skills was assessed as low in the meta-analysis, but appeared to show no difference 
between e-learning and traditional teaching groups. One study assessed performance 
of students in cardiac arrest simulation; while the initial analysis appeared to 
demonstrate no difference between the two groups, analysis of unpublished data 
excluding students and participants with missing health professional status from the 
analysis demonstrated that the proportion of healthcare professionals passing the 
test simulation was higher in the traditional learning group than the e-learning group 
(OR 1.46, 95% CI 1.22-1.76).105 
 
Eleven studies assess the effect of e-learning on healthcare professionals’ knowledge, 
although only eight studies reported the data adequately enough to permit pooling. 
There was moderate heterogeneity between the studies, with an I2 value of 47%, so 
the authors conducted the analysis using both a fixed-effect and random-effects 
model. The meta-analysis demonstrated that e-learning made little to no difference 
to health professionals’ knowledge when compared with traditional teaching 
techniques (Figures 5.2 and 5.3).105 
Figure 5.2 Forest plot of comparison between e-learning and traditional learning for 
healthcare professional knowledge using a fixed-effect model. 
The analysis demonstrates a small trend in favour of traditional learning, however the 
marker of measured effect crosses the line of no effect (From Vaona et al.105) 
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Figure 5.3 Forest plot of comparison between e-learning and traditional learning for 
healthcare professional knowledge using a random-effects model. 
The analysis demonstrates a small trend in favour of e-learning, however the marker of 
measured effect crosses the line of no effect (From Vaona et al.105) 
 
The overall conclusion of Vaona et al. was that e-learning may lead to little or no 
difference in patient outcomes, health professionals’ behaviours and knowledge, and 
have little to no effect on healthcare professionals’ skills, when compared with 
traditional learning, although they recognise that the evidence for effect on 
outcomes, behaviours and knowledge is low-certainty evidence, while the evidence 
for effect on skills is very low-certainty. The authors conclude that e-learning was 
associated with no important benefits compared with traditional learning, and that 
the only large trial included in their study favoured traditional learning for skills.105 
 
Conversely, Jayakumar et al. conducted a systematic review of the role of e-learning 
in surgical education, published in 2015, and identified e-learning as an effective mode 
of teaching, with relevance for surgical education, although they concluded that 
further research comparing e-learning with traditional learning in surgical education 
needs to be performed.103 
 
Jayakumar et al. identified 38 studies for inclusion in their analysis, across three 
themes of e-learning; Case-based teaching (18/38 studies), e-learning to teach 
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theoretical knowledge (18/38 studies) and e-learning to teach surgical skills (2/38 
studies). 103 
 
Study quality was variable across the entire analysis. In the case-based e-learning 
theme 9/18 studies (50%) did not use a control or comparison group in analysis, and 
4 used historical controls. In the 5 studies that had concurrent control groups, 
participants were randomized to case-based teaching or traditional teaching. The 
largest study106 of the effect of e-learning in urological teaching to medical students 
demonstrated significantly higher test scores following web-based education 
compared with traditional teaching both immediately post-intervention and at 5 
months’ follow-up. In this study, students acted as their own controls, however, 
interpretation of the results is limited by variable participation rates between medical 
schools, and the effect of participants accessing online modules that they were not 
allocated to.103,106 
 
The use of e-learning for teaching theoretical knowledge in surgery was 
demonstrated to result in a statistically-significant increase in knowledge on post-
intervention testing, however the majority of studies reviewed (11/18) did not use 
control groups for comparison, nor include a pre-intervention test to determine 
baseline knowledge. Similarly, the use of e-learning to teach surgical skills in 2 studies 
(intraoperative surgical manoeuvres for thoracic and abdominal surgery,107 and 
microsurgery skills108), demonstrated improved knowledge and skills in the e-learning 
cohorts. The studies had important limitations however, with both being small 
studies (15 and 17 residents respectively), and the thoraco-abdominal surgical skills 
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program failing to use a control group for comparisons, with a pre- and post-test 
study design.103,107,108 
 
The literature appears to demonstrate little to no-efficacy of e-learning over 
traditional learning in medical education, however a number of clinical and research 
implications of these findings have been identified.105 
 
While e-learning alone may not result in improved patient or health professional 
outcomes, it is recognised that blended learning may play an important role in 
merging the benefits of e-learning with face-to-face teaching. It is possible that e-
learning and traditional learning have very similar effect sizes, and as such 
demonstrating statistically-significant superiority of one modality over another may 
require unachievably large sample sizes;105 despite this, many studies addressing e-
learning use small sample sizes,103,105 and as a result, positive findings for e-learning in 
specialty areas may represent a Type I statistical error. 
 
Importantly, trial design and outcomes were frequently poorly considered in e-
learning research. Vaona et al. suggest that future trials should focus on content, 
frequency of delivery, duration and intensity of e-learning and cost-effectiveness. 
They also suggest that studies should use randomised controlled trial designs, and 
should focus on the effect of e-learning on healthcare professionals’ behaviours and 
patient outcomes rather than knowledge or skills, while also using multiple time 
points during study follow-up to determine the persistence of e-learning effects. 
Importantly, future study designs should include pre-defined data scales and 
reporting rules in order to improve research accountability.105 
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Vaona et al. identified the need for more studies into the role of e-learning in specific 
medical areas and rare conditions, and specifically identify surgical education as a 
target area of research;105 indeed, heterogeneity in skills, educational needs, 
motivation and taught material may represent a cause for the apparent lack of e-
learning effect in pooled data analysis. 
 
E-Learning in Venous Thromboembolism Education 
This thesis focuses on the use of e-learning to deliver education regarding venous 
thromboembolism prophylaxis to undergraduate medical students. We conducted a 
literature search through PubMed and Scopus, using the terms “e-learning”, “online 
learning”, “web-based learning”, “e-training”, “online training”, “web-based training”, 
“venous thromboembolism” and “venous thrombosis”. The initial search returned 
10 results, which were then reviewed and papers that did not relate to education of 
healthcare professionals were excluded. This resulted in three papers available for 
review. The design, conclusions and limitations of these studies are included in Table 
5.1. No papers related to the use of online learning for the delivery of VTE 
education to undergraduate medical students. One paper109 addressed the use of e-
learning to teach physician assistants about venous thromboembolism, one paper110 
addressed the effect of blended learning on pharmacy student performance in a 
cardiovascular pharmacotherapy course, and one paper evaluated the use of online 
training for VTE education among surgical residents.111 The study by Soukoulis et al109 
was excluded from review, as it used an e-learning module that included both 
prophylaxis and treatment options for VTE management, focused on healthcare 
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professionals only working in the oncology setting, and was targeted at Physicians 
Assistants, a clinical role that is not present in Australia. 
 
McLaughlin et al used an online module to didactically deliver 57 slides to students, 
including a pre- and post-test, prior to attending classes related to VTE prophylaxis, 
where active learning exercises were used. They demonstrated that students that 
accessed less of the module performed more poorly in the end of unit examination 
for questions mapped to content covered by the online module. There was no 
significant difference in results for questions that were not specifically mapped to the 
module, as may be expected. Students accessing all of the online module score 
significantly higher in the post-test, compared with the pre-test (60.9% vs 53.8%, 
p=0.015), however module post-test scores were not significantly correlated with 
final examination performance. The majority of students (62%) found the use of pre-
class material useful.110 The study is limited, however, insofar as it does not contain 
any control groups, and students were not randomised to receive the new online 
module or baseline instruction. 
 
Wolpin et al111 published a paper in 2011 describing a test-retest study of the efficacy 
of an online training module for VTE prophylaxis, provided to 69 residents and 
fellows from two medical centers.111 The participants were provided access to an 
online learning module regarding VTE prevention, and the authors tested two 
hypotheses; first, that use of an online learning module would improve knowledge 
mastery, and secondly, that use of question/response case studies after review of 
static slides containing VTE prevention information would result in improved post-
test scores compared with participants that were only exposed to static slides.  
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A pre- and post-test study design was used to evaluate the first hypothesis, with 
individual participants serving as their own controls. There was no separately defined 
control group used for comparison. The mean pre-test score for participants was 
79.28%. Participants then accessed the online module (with randomisation at that 
time to either the enhanced learning or usual learning groups) and completed a post-
test at the end of the module. The mean post-test score was 82.32%. Analysis of 
these results using a two-tailed paired t test (alpha set to 0.05) revealed no 
significant difference in pre- and post-test scores (t=-1.655, p=0.102), with a small 
standardized mean difference effect size of 0.23. 111 
 
The authors reported that they then re-analysed this data using non-parametric 
methods (which may have been more appropriate, given a sample size of n=69, 
although specific methods were not described). Rates of knowledge mastery (score 
≥80%) were measured for the study cohort at pre-test (47%) and post-test (57%), 
representing a 14.5% improvement in knowledge mastery (p=0.05).111  
 
The second hypothesis was tested by randomizing participants to either an enhanced 
learning (use of question/response case studies after review of static slides containing 
VTE prevention information) group or a usual learning (review of static slides 
containing VTE prevention information only), and comparing post-test scores 
between groups. The enhanced learning group had a mean post-test score of 
79.39%, while the usual learning group had a mean post-test score of 85%. Analysis 
of covariance was performed to control for baseline knowledge in each group, and 
demonstrated no statistically significant difference in scores between the groups.111 
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Wolpin et al. acknowledge the limitations of their study in their article, including the 
small sample size and small effect size, however they raise important questions 
regarding the use of venous thromboembolism e-learning. They demonstrated an 
increase in rates of knowledge mastery among their participants, although the length 
of time this improvement persisted was not established. Although their study 
suggests that there is no improvement in knowledge following the use of the 
module, the study is underpowered to detect this change, and this may represent a 
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E-learning has been readily absorbed into medical education, and is now a key 
component of many courses, at both the undergraduate and graduate level. While 
the evidence appears to suggest that e-learning is no better than traditional learning 
methodologies (although a true non-inferiority study has not been conducted), e-
learning brings multiple non-learning based benefits, including flexibility, cost savings 
and the opportunity for deliberate and distributed practice, that traditional learning 
cannot provide. To date, there have been few high-quality studies into the role of e-
learning in specialty medical areas, and no randomised controlled trials have been 




Chapter 6. Summary of the Literature Review 
 
Venous thromboembolism (VTE) is a multi-factorial disease primarily manifesting as 
deep venous thrombosis (DVT), and less-frequently as pulmonary embolism (PE). 
The majority of deep vein thrombosis occurs in the legs, with a smaller percentage 
occurring in the arms; when it occurs most frequently in patients with cancer or in 
the presence of a central venous access device.2  
 
VTE is common and its annual incidence is consistent across Western Europe, 
North America, Australia and Argentina, with rates between 0.75 to 2.69 per 1,000 
of population. The impact of VTE is felt across the globe, with 3.5 cases hospital 
associated VTE per 1,000 of population, per annum, in high-income countries, and 
1.1 cases per 1,000 of population, per annum, in low- and middle-income 
countries.112 VTE is the third most common cardiovascular cause of death, after 
coronary artery disease and stroke.2 Hospital-associated VTE remains the leading 
cause of disability-adjusted life years lost in low- and middle-income countries, and is 
responsible for more years lost than hospital-acquired pneumonia, central-line 
associated blood stream infections and adverse drug events.112 
 
Venous thromboembolic disease represents a significant economic burden on 
healthcare systems.113 Cohoon et al demonstrated that adjusted mean predicted 
costs are 2.5-times higher for patients with VTE associated with admission for acute 
illness, and 1.5-times higher for patients admitted for major surgery, than for 
matched patients, controlled for type of surgery or cancer status, with costs greatest 
in the first three months after the VTE event date.113-115 Predicted costs were 1.9-
times higher over five years for patients with VTE and active cancer compared to 
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those with cancer, but no VTE.113,116 Perversely, adherence to global 
thromboprophylaxis guideline has decreased over time, primarily due to poor 
implementation of guidelines post-discharge,117 and educational interventions to 
improve thromboprophylaxis management on the ward have had variable and limited 
success.111,118 
 
‘E-learning’ is a term used to refer to a variety of learning and teaching modalities, 
including any computer-based delivery of learning material, internet-based delivery of 
learning materials and the use of virtual learning environments or digital social 
networks for the purposes of education.96 Environmental, social, pedagogical and 
clinical factors have encouraged the acceptance and use of e-learning in medical 
education as changes in educational venues, distribution of students and residents 
across healthcare networks, and changes in learning models towards learner-
centered, competency-based curricula drive changes in teaching delivery.92 e-
Learning has been demonstrated to promote self-directed learning, provide flexible 
learning opportunities, and engage learners in collaborative learning communities.119 
While there are many potential benefits to the use of e-learning in medical 
education, the development of online educational resources can be resource- and 
time-intensive, costly, and demand a high level of expertise for the initial design of 
delivery modalities and content.120 Maertens et al120 conducted a systematic review of 
the literature in 2016 demonstrating significant heterogeneity between learning 
platforms used in surgical e-learning. 87 randomized controlled trials were included 
in their analysis, with most (71) tools designed to teach cognitive skills, including 
knowledge or pattern-recognition, or psychomotor skills (36).120 Other studies 
focussed on the use of e-learning in non-technical skill acquisition.120 The authors 
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demonstrated that most e-learning platforms are effective teaching tools, particularly 
for cognitive processes, but online learning platforms did not demonstrate 
superiority over other educational interventions. Only two studies demonstrated 
transfer of skills to the clinical environment, and there was no evidence that the use 
of e-learning improved patient outcomes in surgery.120  
 
Wolpin et al published a paper in 2011 describing a test-retest study of the efficacy 
of an online training module for VTE prophylaxis, provided to 69 residents and 
fellows from two medical centers.111 They identified a trend for knowledge gains 
related to VTE guidelines on post-test for clinicians with a 14.5% increase in content 
mastery (p=0.05, 2-tailed). Although effect size was small (0.23), the authors noted 
an overall improvement in knowledge mastery relating to VTE prophylaxis between 
pre- and post-tests, but no additional knowledge gain through the use of 
question/response case studies.111 
 
In the late 1990s, an e-learning medical education program, “Medici” was developed 
at The University of Adelaide.121 Originally designed for delivery using a CD-ROM, 
the learning tool translated to the online learning environment in the early 2000s, 
and was re-branded “eMedici”. eMedici is a website providing an open-ended series 
of case-studies across medical and surgical specialties, primarily aimed at medical 
students.122  
 
The aim of this study was to assess the educational benefit of using an online, case-
based learning system to deliver educational material relating to VTE prophylaxis 
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across medical, surgical and critical care specialties using eMedici, and to attempt to 
validate the findings described by Wolpin et al.111 
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Chapter 7. Study Design & Technology 
 
Aims of the studies performed 
 
1. Assess the educational benefit of using an online, case-based learning system 
to deliver educational material relating to VTE prophylaxis across medical, 
surgical and critical care specialties using eMedici. 
 
2. Describe the Factors Associated With Test Performance In Venous 
Thromboembolism E-Learning. 
 
3. Attempt to validate the findings described by Wolpin et al, suggesting that the 
use e-learning systems may improve knowledge of venous thromboembolism 
prophylaxis among healthcare professionals.111 
 
4. Describe the dynamics involved in the use and apparent benefits of e-
learning. 
 
5. Identify and describe the interaction of students with an e-learning system, 
and the human factors involved during student participation in a structured 
online learning exercise. 
 
The EMedici Learning System 
 
eMedici is the online iteration of a software package developed in the Department of 
Medical Education, and now maintained in the Discipline of Surgery, at The 
University of Adelaide.123 It is an open-ended series of case studies covering various 
medical specialties, and presents material to students in the form of case scenarios, 
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in which the student is then encouraged to manage the case in a realistic way.122,123 
As students progress through the case, feedback is provided on the veracity of the 
student’s choices, encouraging in-situ reflection on clinical decision-making.122-124 
 
Students select a case, and is presented with clinical findings, clinical data and 
pathological specimens in the form of text, photographs, or video images. Students 
are then asked to choose from a selection of diagnostic, investigation or 
management options, or are invited to provide a free-text answer to the scenario. 
After submitting an answer, students are then presented with real-time responses to 
their answers, and further clinical information, prior to answering a new set of 
questions. At the completion of the case, a summarising explanation and critique of 
the problem is provided, and students receive an overall score, matched to criteria 
for competency in addressing that clinical scenario.122-124 
 
Student, instructor and author access to eMedici is via a web portal 
(http://www.eMedici.com/). Access is controlled via individual or institutional 
registration.122 
 
Cases are created by volunteer authors, who design, write and submit a case to the 
website. Once prepared, material is assessed in a peer-review process, prior to 
review at a large group session (including multiple authors and content area 
specialists). Once final editing occurs, the case is reviewed by the editorial board, 
and the case is loaded to the website for use in its intended module. As of 2018, 
there is a range of surgical modules, addressing breast/endocrine surgery, digestive 
disease, urology, vascular surgery. There are also modules containing case studies in 
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The study was designed as a randomized controlled trial, with an indwelling 
assessment of human factors affecting the utility of e-learning processes. 
 
Randomized Controlled Trial Methodology 
A randomized controlled educational trial was designed and conducted based on 
methodologies described by Wolpin et al and Farah et al.111,125 Medical Students in 
their penultimate year at The University of Adelaide were asked to participate in a 
randomized controlled educational trial. Students were eligible for participation if 
they were a fifth-year (penultimate-year) medical student at The University of 
Adelaide. 
 
Students were excluded if they met any of the following criteria: 
 
1. They refused consent to participate in the study (however, students still had 
access to the educational material). 
2. They were currently enrolled in their obstetrics & gynaecology/paediatric 
medicine semester (due to the specific and high-volume workload of this 
semester, and associated end-of-rotation assessments). 
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The online module was made available across 4 semesters, over two years. Students 
had to complete the module within a single semester. 
 
After consenting to participate in the study students were randomized to one of two 
groups (control vs. intervention) (Figures 7.1 & 7.2). A simple randomisation 
algorithm was incorporated into the eMedici program, and automatically allocated 
students to intervention or control groups, in a process that was blind to the 
investigators. 94 students were ineligible for inclusion in the study as they declined 




Figure 7.1 CONSORT Diagram. 






Figure 7.2 Graphic representation of trial process for students randomised to control and 
intervention groups. 
A, Comparison of scores between groups (Control Group-only Assessment Module 
Questions 1-10 vs the ten-question Intervention Group Baseline Assessment Module. The 
questions used to establish baseline knowledge are identical between the two groups. B, 
Comparison of scores between groups (Control Grouponly Assessment Module Questions 
11-20 vs the ten-question Intervention Group Final Assessment Module. The questions 
are identical between the two groups. C, Comparison of scores between Intervention 
Group Final Assessment Module and Intervention Group Baseline Assessment Module. D 
& E, Comparison of scores from six-month follow up with Intervention Group Final 





The control group undertook an initial baseline-assessment case of twenty questions, 
assessing their knowledge surrounding VTE prophylaxis across the specialties of 
Oncology, Surgery, General Medicine, Obstetrics & Gynaecology, and Orthopaedics. 
They were then given access to the online educational modules. 
 
The intervention group undertook a baseline assessment case composed of ten 
questions assessing their knowledge surrounding VTE prophylaxis across the 
specialties of Oncology, Surgery, General Medicine, Obstetrics & Gynaecology, and 
Orthopaedics. These were identical to Questions 1-10 completed by the control 
group. There was no difference in complexity or difficulty of questions between the 
groups. The questions across the assessment and teaching cases appeared to have 
good internal consistency, Cronbach’s a = 0.74. 
 
The intervention group were then given access to six case-based modules teaching 
the fundamentals of VTE prophylaxis in Oncology, Surgery, General Medicine, 
Obstetrics & Gynaecology, and Orthopaedics, according to national37 and 
international38 guidelines. Following completion of these modules, students 
completed a 10 question post-test, matched to questions 11-20 completed as a 
baseline assessment by the control group. 
 
Six months after completion of the course, all students were followed-up and asked 
to complete the 10 post-test questions/control group questions 11-20 again. The 
study was then completed.  
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‘No Intervention’-Controlled Study Design 
 
The choice of control condition for randomised controlled trials in educational 
research is a source of dispute in the medical education literature, with a number of 
concerns being raised regarding the use of placebo, or ‘no intervention’ controls, 
including concerns that this methodology may be unethical, impractical, unnecessary 
(in that it is better to compare interventions to usual practice), and may represent 
an attempt to generate invalid universal laws of cause and effect that do not hold 
true in the teaching setting. 126,127 
 
While it has been demonstrated that this methodology has a place in the educational 
research setting, 127-130 it is important to justify this choice of study design. 
 
The choice of no-intervention for the control condition was partly guided by ethical 
restrictions on this study, and by logistical requirements. The ethical approval for 
this study required that all students ultimately have access to identical learning 
resources (see below). As a result, comparing the use of an e-learning module to 
‘usual practice’ (e.g. a lecture or tutorial) would have required physical separation of 
the student cohort, and repeats of multiple teaching interventions, necessitating 
checks that students were not exposed to the incorrect intervention (e-learning 
module vs. tutorial) at the incorrect time. This would have necessitated either the 
recruitment and training of additional educators who were not part of the research 
team (which was prohibitively expensive), or breaking allocation blinding (which 
would have breached the ethics requirements for this study). 
 
 75 
A no-intervention control condition was also felt to be appropriate as the control 
group would ultimately have access to the learning material, after completion of the 
final assessment questions. As a result, a placebo-controlled design would help 
minimise the potential for the Hawthorne Effect, as students would not know that 
they had been part of the control or intervention group until they had completed all 
of the assessment questions, and the associated module. 129 
 
Finally, the purpose of this study was to determine the efficacy of e-learning 
techniques in providing education relating to venous thromboembolism prophylaxis. 
Previous studies in this area were retrospective cohort studies109,110 or a single, 
unblinded, randomized controlled trial that compared two methods of online 
teaching. 111 As a result there was no evidence to date that e-learning demonstrated 
any educational benefit in teaching venous thromboembolism prophylaxis. 
 
Given this gap in the medical education literature, the ethical and logistical 
complexities associated with a study comparing e-learning to ‘usual practice’, and 
evidence that such studies could be safely and ethically conducted in medical 
education, this project was subsequently conducted using a ‘no-intervention’ control 
group design. 
 
Human Factors Analysis Methodology 
Descriptive data surrounding the usability of the eMedici module was collected on 
completion of the VTE module.  
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A questionnaire was developed based on a modification of the student reaction 
questionnaire proposed by Pike and Huddleston 131. Students were asked to 
complete the questionnaire on completion of the eMedici module. The questionnaire 
covered the domains of administration and support, access, usage, technical 
performance, general usability, student expectations, content and instructional design 
and testing and assessment. At the end of the questionnaire students were asked to 
provide an overall rating for the course. Data was collected through a combination 
of Likert scales and drop-down options.  
 
Five-point Likert scales were used for the majority of questions, with a score of one 
representing total disagreement with the questions, and a score of five representing 
strong agreement. Where no answer was provided a score of zero was allocated, 
and that result was excluded from analysis. Three questions relating to location of 
study, module completion and formal assessment of the information contained 
within the module used drop-down text options. 
 
Ethics of Data Anonymization and Effect of Data Analysis 
 
Students have special requirements for protection when participating in education 
research; Christakis noted “Students might be subject to inappropriate and undue 
pressure and might participate in studies in an attempt to garner better 
recommendations, better grades, or other favors (such as summer employment). 
The rules for medical students are more stringent … because a medical student is 
less free than a random adult to refuse the request of a faculty investigator to be a 
research subject.” 132 Students are considered to be “People in dependent or 
unequal relationships” in the National Statement on Ethical Conduct in Human 
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Research, 133 and this document requires researchers to “…take special care to 
safeguard confidentiality of all information they receive, particularly in settings such 
as shared workplaces, hospital rooms or rooms in residential care.” Medical students 
represent a special cohort as participants in education research, as they are prone to 
over-research and are exposed to increased risk of privacy breaches when involved 
in research projects. Protection of privacy is more important as medical students 
progress through their training as cohorts generally become smaller and professional 
stakes increase. Boileau et al note that extra care should be taken to protect medical 
student privacy when involved in educational research. They note that “an essential 
part of safeguarding participants’ privacy relies on being very selective in determining 
what data will even be collected. The only personal information that should be 
gathered is that which is directly relevant to answering the research question.” 134 
Boileau et al recommend the anonymization or deidentification of data when 
conducting educational research, where anonymization (the irrevocable removal of 
all direct (e.g. name) and indirect (e.g. age) identifiers) is preferred, as it carries the 
least risk of re-identification. 134 
 
These factors were considered essential to the safe, ethical conduct of this research, 
and in preparing the ethics application multiple conversations were had with the 
University of Adelaide Office of Research Ethics regarding protection of medical 
student privacy. 
 
In addition to the protection of student privacy, and protection against 
discrimination and coercion, the ethics committee required that all students 
ultimately had access to the same educational material regardless of allocation to 
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intervention or control group so as to prevent the intervention group receiving 
potentially-beneficial additional teaching compared to controls, which may have then 
conferred an additional advantage in later course examination requirements. As a 
result, the educational material would also have to be available to both groups in 
parallel, i.e. educational material could not be withheld from the control group until 
completion of the study, as this would disadvantage students in the first year of the 
two-year data collection window. 
 
As a result of this study design, and the need for the use of anonymised data, 
students followed up at six months could not be identified by their previous 
allocation to intervention or control group. 
 
Statistical Analysis Plan 
All analyses were performed using SPSS version 24.0 (IBM Corp., Armonk, NY, 
USA). Statistical analysis was provided by a qualified statistician from The University 
of Adelaide, Adelaide Health Technology Assessment Data, Design and Statistics 
Service. 
 
Randomized Controlled Trial Statistical Plan 
Group comparisons were conducted using linear regression, linear mixed-effects 
models and Student’s t-tests for normally distributed data. Descriptive results are 
reported as frequencies (%), means (standard deviations) or medians [interquartile 
ranges]. Inferential statistics are presented with estimates, 95% confidence intervals 
and P values. For linear mixed-effects models (used for comparison of scores 
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between baseline questions and final-assessment questions in the intervention group, 
or questions 1-10 vs 11-20 for the control group), assumptions of a linear model 
were upheld. A mixed effects model was used as scores within student would be 
more similar, more correlated, than scores between students, leading to erroneous 
standard errors and P values if not controlled for. 
 
We also explored a novel variable, the improvement score (described by Khatib et 
al135), equivalent to the post-intervention score minus the pre-intervention score. 
For the control group this is reported as the score for questions 11-20 minus the 
score for questions 1-10, and for the intervention group the score for final-
assessment questions minus the score for baseline questions. 
 
Based on the study by Wolpin et al,111 we calculated a requisite sample size of 200-
270 participants, based on a minimum-anticipated score improvement of 14.5% 
(p=0.05). 
 
A planned a priori subgroup analysis was undertaken on completion of the 
randomized controlled trial, in order to assess the effects of results from each case 
on the overall performance of the module. 
 
Human Factors Analysis Statistical Plan 
All forms assessing human factors relating to the module were de-identified and then 
reviewed by the lead author. Descriptive statistics were used for presentation and 
analysis of ordinal data 136. Independent associations between categorical data were 
explored by the chi-square test, with statistical significance set at a p value of ≤0.05. 
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Funding for the Study 
 
This research was funded by a $12,500 education grant from Covidien (now part of 
Medtronic). The company had no input into the design, conduct, analysis, 
presentation or publication of this research. 
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Chapter 8. Venous Thromboembolism e-Learning Cases 
 
This chapter presents the case material for the eMedici module delivered to 























Case 28: Baseline Assessment Questions 
 
Question 1:  
Question Information: 
 
This section provides 20 multiple-choice questions to assess your current knowledge 
of VTE prophylaxis in different situations. Prior to completing this VTE Prophylaxis 
Module, and the pre-test questions, we would like to ask you to consent to 
participate in a study on the use of an online learning system (eMedici) to deliver a 
module on venous thromboembolism (VTE) prophylaxis to medical, nursing and 
allied health professionals and trainees, with a view to improving outcomes in 
hospital-admitted patients and reducing the incidence and prevalence of VTE. 
 
Data gathered from this study will allow us to determine the potential efficacy of 
using online educational software to improve knowledge of VTE prophylaxis 
methods in healthcare professionals, and potentially to improve application of this 
knowledge in the clinical environment. Results from this study will appear in Dr. 
Eamon Raith's Doctor of Philosophy (Surgery) thesis and in peer-reviewed medical 
journals. 
 
This study has been approved by The University of Adelaide Human Research Ethics 
Committee and by The University of Notre Dame Australia Human Research Ethics 
Committee. 
 
Participants may withdraw from the study at any time without prejudice to their 
future involvement in educational activities, or adverse impact on their medical 
education or training. Should participants wish, they may request the raw data, 
related to their cases, on completion of the study. All information provided by 
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participants (project enrolment information, survey results) will remain confidential 
and can only be accessed by the three investigators on this study.  
 
Please note that once the Module is completed, withdrawal from the study 
component of the module is not possible, as results will have been de-identified. 
 
Should any problems with the study arise, please do not hesitate to contact any 
member of the research team via the contact information below. Alternatively, you 
may contact the University of Adelaide using the independent complaints sheet 
(attached). Alternatively, if participants have any complaint regarding the manner in 
which a research project is conducted, it should be directed to the Executive Officer 
of the Human Research Ethics Committee, Research Office, The University of Notre 
Dame Australia, PO Box 1225 Freemantle WA 6959, phone (08) 9433 0943, 
research@nd.edu.au. 
 
All investigators can be contacted through; Discipline of Surgery, School of Medicine, 
University of Adelaide 08 8222 5144 Prof P. Devitt - peter.devitt@adelaide.edu.au 






Consent to participate in the assessment of an online module on VTE Prophylaxis 
education. 
 
Choice 1: I consent to involvement in the study  Score : 1 
 
Choice 2: I do not consent to involvement in the study  Score : 0 
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Question 2:  
Question Information: 
 
As part of the research component of this module, we need to ascertain your level 
of training in 2013. 
 
Question: 
In 2013 I will be working at the level of... 
 
Choice 1: A final year medical student in an undergraduate medical program   
Score : 1 
 
Choice 2: A final-year medical student in a graduate medical program   
Score : 1 
 
Choice 3: Intern   
Score : 1 
 
Choice 4: PGY-2 General Trainee   
Score : 1 
 
Choice 5: PGY-3 General Trainee   
Score : 1 
 
Choice 6: PGY-4 General Trainee   
Score : 1 
 
Choice 7: Service Registrar   
Score : 1 
 
Choice 8: Specialty-Training Scheme Registrar   
Score : 1 
 
Choice 9: Consultant   




Question 3:  
Question Information: 
 
A 57-year-old woman has recently been diagnosed with a T2, N1, M0, oestrogen-
receptor negative, carcinoma of her right breast and is being assessed for adjuvant 
therapy. Prior to her presentation with a lump in her breast three weeks ago she 
had been in good health. She noticed the lump shortly after returning from a holiday 
in Bali. Until her surgery for the breast lump she had been on hormone replacement 
therapy. She suffered a deep venous thrombosis after breaking a leg in an accident 
several years ago. She has two adult children. Her BMI is 29. Some thoughts are 




Which one of the following is the most important risk factor to take in account? 
 
Choice 1: Her BMI   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: The recent long-distance travel   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Planned radiotherapy   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Her history of DVT   
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Her HRT   
Score : 0 
Choice Feedback: Incorrect 
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Question 4:  
Question Information: 
 
A 59-year-old man is admitted to hospital for chemotherapy of a locally advanced 
carcinoma of the stomach. Two weeks ago he recovered from an episode of left leg 
cellulitis for which he was bed-bound for three days. Three years ago he had a 
myocardial infarction from which he made a good recovery. His BMI is 29. He is 
considered for some form of prophylaxis against venous thromboembolism. It is 
anticipated he will be in hospital for about one week and go home with an 
intravenous infusion of cytotoxics. 
 
Question: 
Which one of the following would be the most appropriate form of prophylaxis 
against venous thromboembolism? 
 
Choice 1: Graded compression stockings for the duration of the admission   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin for the duration of the admission   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Heparin infusion for the duration of the admission   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Enoxaparin until cessation of the intravenous infusion    
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Warfarin until cessation of the intravenous infusion   
Score : 0 
Choice Feedback: Incorrect 
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Question 5:  
Question Information: 
 
A 20-year-old man is brought to the Emergency Department with an injured right 
leg. He was tackled heavily during a football match and was unable to get up because 
of the pain in his leg. An X-ray shows an uncomplicated fracture of the tibia. A 
backslab applied and the patient subsequently reviewed in the fracture clinic. A fibre-
glass cast is applied and the patient is told that he will need to remain in the cast for 
up to six weeks. 
 
Question: 
Which one of the following is the most appropriate choice of VTE prophylaxis? 
 
Choice 1: Low-molecular weight heparin for the duration of immobilisation    
Score : 1 
Choice Feedback: Correct 
 
Choice 2: Dabigatran etexilate for the duration of immobilisation   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Rivaroxaban for the duration of immobilisation   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Fondaparinux for the duration of immobilisation   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: No pharmacological VTE prophylaxis is required   
Score : 0 
Choice Feedback: Incorrect 
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Question 6:  
Question Information: 
 
A 78-year-old man is brought to the Emergency Department following a farming 
accident. Examination reveals a patient in severe pain, with a below-knee traumatic 
amputation of the left leg. He is tachycardic, with a weak, thready carotid pulse and 
blood pressure of 70/40mmHg. His pressure improves to 90mmHg systolic following 
two 250ml boluses of 0.9% sodium chloride. 
 
Question: 
Which one of the following is the correct approach to VTE prophylaxis? 
 
Choice 1: Commence Dabigatran etexilate once adequate haemostasis has been 
achieved.   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Commence low-molecular weight heparin once adequate haemostasis has 
been achieved.    
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Commence fondaparinux once adequate haemostasis has been achieved  
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Commence use of calf-compression stockings only.   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: No VTE prophylaxis is required   
Score : 0 
Choice Feedback: Incorrect 
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Question 7:  
Question Information: 
 
Pregnancy and the puerperium increase the risk of venous thromboembolism. 
 
Question: 
During which one of the following stages is the risk greatest? 
 
Choice 1: First Trimester   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Second Trimester   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Third Trimester   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: During Childbirth   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: The puerperium   
Score : 1 
Choice Feedback: Correct 
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Question 8:  
Question Information: 
 
A 62-year-old man is admitted to hospital for management of an acute lobar 
pneumonia. He saturates at 89% on room air and has a respiratory rate of 24/min. 
His temperature is 39.2oC, blood pressure 130/92 mmHg and a heart rate of 
96/min. Despite some improvement with oxygen administered at 6L/min by Hudson 
mask and initiation of intravenous antibiotics, he is only able to mobilise from the 
bed to the toilet a couple of times per day. His biochemistry results shows a 
creatinine level of 50umol/L. He weighs 94kg. 
 
Question: 
Which one of the following is the most appropriate choice of VTE prophylaxis? 
 
Choice 1: Enoxaparin 40mg BD   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin 40mg Daily   
Score : 1  
Choice Feedback: Correct 
 
Choice 3: Fondaparinux 2.5mg daily   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Aspirin 100mg daily   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Danaparoid 3000Units loading dose, followed by graduated infusion    
Score : 0 
Choice Feedback: Incorrect 
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Question 9:  
Question Information: 
 
An 82-year-old woman is admitted to hospital with 36 hours of left-sided weakness, 
slurred speech and left facial droop. A CT scan does not demonstrate any evidence 
of intracranial haemorrhage. She is admitted to the stroke unit for further 
management. Her blood pressure is stable at 136/87 mmHg, pulse is 78/min. She has 
a medical history of a DVT successfully treated with enoxaparin 12 years ago 
following a flight from Los Angeles. At a follow up appointment 3 weeks after the 
diagnosis of her DVT her general practitioner noted a mild anaemia and low 
platelets. She also has a history of asthma, and mild hypertension, adequately 
controlled with a beta-blocker. Her GFR is >60ml/kg/hr and her weight is 78kg. 
 
Question: 
Which one of the following is the most appropriate choice of VTE prophylaxis? 
 
Choice 1: Graduated calf compression stockings   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin, 80mg daily   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Enoxaparin, 40mg BD   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Danaparoid 3000Units loading dose, followed by graduated infusion    
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Fondaparinux, 2.5mg daily   
Score : 0 
Choice Feedback: Incorrect 
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Question 10:  
Question Information: 
 
An otherwise fit 45-year-old man is admitted for a laparoscopic fundoplication for 
chronic gastro-oesophageal reflux disease. Apart from a deep venous thrombosis 
after a leg injury in his teens, he is in good health. Mechanical calf compression 
devices will be used during surgery and other means of venous thromboprophylaxis 
must be considered. 
 
Question: 
Which one of the following is the most appropriate management? 
 
Choice 1: No other prophylaxis required   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin given immediately before surgery and continued until discharge  
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Enoxaparin given immediately after surgery and continued until discharge   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Enoxaparin given immediately after surgery and continued for 10 days    
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Insertion of a caval filter   
Score : 0 
Choice Feedback: Incorrect 
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Question 11:  
Question Information: 
 
A 54-year-old man with severe dysphagia due to achalasia is booked for a 
laparoscopic cardiomyotomy. The patient is barely able to manage liquids and is 
rapidly losing weight. One month prior to the planned procedure he has a deep 
venous thrombosis in his right after a week in bed recovering from a chest infection 
brought on as the result of recurrent oesophageal regurgitation and aspiration. He 
has been started on warfarin. 
 
Question: 
Which one of the following is the most appropriate plan of management? 
 
Choice 1: Continue warfarin and proceed to surgery   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Continue warfarin and delay surgery for three months   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Stop warfarin, start intravenous heparin and proceed to surgery   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Stop warfarin, insert caval filter and proceed to surgery    
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Stop warfarin, give fresh frozen plasma and proceed to surgery   
Score : 0 






A 66-year-old man with type II diabetes is hospitalised for treatment of recently 
diagnosed acute myeloid leukaemia. Three years ago he had a myocardial infarction, 
with insertion of two stents. He is on dual antiplatelet therapy. Chemotherapy is 
started and five days later he collapses with severe chest pain. He is pale and 
sweating with a blood pressure of 80/60 mmHg. Myocardial infarction is excluded on 
the ECG and serum troponin. A CT pulmonary angiogram is performed, and 
demonstrates the presence of a pulmonary embolism. Treatment with a 
thrombolytic is considered. 
 
Question: 
Which one of the following would be the strongest indication for such an approach? 
 
Choice 1: The radiological findings   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: The presence of diabetes   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: The blood pressure   
Score : 1 
Choice Feedback: Correct 
 
Choice 4: The history of myocardial infarction   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: The dual antiplatelet therapy   
Score : 0 






A 59-year-old man is admitted to hospital for chemotherapy of a locally advanced 
carcinoma of the stomach. Two weeks ago he recovered from an episode of left leg 
cellulitis for which he was bed-bound for three days. Three years ago he had a 
myocardial infarction from which he made a good recovery. His BMI is 29. He is 
considered for some form of prophylaxis against venous thromboembolism. 
 
Question: 
Which one of the following would place him at greatest risk of such a complication. 
 
Choice 1: The underlying malignancy   
Score : 1 
Choice Feedback: Correct 
 
Choice 2: The myocardial infarction   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: His weight   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: The recent episode of cellulitis   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: The period of immobility   
Score : 0 






A 68-year-old woman is admitted to hospital with a three day history vomiting. She 
had recently been started on chemotherapy for inoperable carcinoma of the 
pancreas. Two weeks ago a biliary stent had been inserted to relieve her jaundice. 
This procedure had been complicated by a bleed from sphincterotomy site. She has 
been taking diclofenac for pain relief. The patient is cachectic and dehydrated. Her 
serum biochemistry demonstrates a markefly elevated creatinine and urea. Her LFTs 
are grossly deranged. The patient is given intravenous fluids to correct her 
dehydration. Some consideration is given to measures to be taken to reduce her risk 
of venous thromboembolism. 
 
Question: 
Which one of the following regimens would be most appropriate? 
 
Choice 1: Warfarin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Dabigatran etexilate   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Graduated calf compression stockings   
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Unfractionated heparin   
Score : 0 






A 28 year old man is brought to the Emergency Department following a motor 
vehicle accident at a low speed. He was the unrestrained passenger in the vehicle, 
striking his legs against the dashboard during the collision. Primary and secondary 
surveys reveal a stable patient with a shortened and externally rotated right leg. A 
FAST scan does not show any free intra-peritoneal or peri-cardial fluid. The chest X-
ray does not show any evidence of a pneumothorax or rib fractures, and a CT of the 
brain shows no signs of acute intracranial pathology. The patient remains 
haemodynamically stable on transfer to the orthopaedic surgery unit. 
 
Question: 
Which of the following is the most appropriate choice of pharmacological 
prophylaxis? 
 
Choice 1: Low molecular weight heparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Fondaparinux   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Rivaroxaban   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Dabigatran etexilate   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Aspirin   
Score : 0 






A 73-year-old man is retrieved from a rural property following an accident on his 
ride-on lawnmower. He was trapped, face-down, beneath the vehicle for 2 hours 
prior to extrication. He was stabilised at the scene and retrieved to the nearest 
major trauma centre. On examination he has a severe crush injury of the left hand, 
multiple rib fractures, and fluid in Morrison’s pouch. The patient is supported in a 
pelvic brace. His blood pressure is 83/54 mmHg despite 2 litres of 0.9% NaCl. He is 
scheduled for emergency surgery. 
 
Question: 
Which one of the following is the most appropriate approach to post-operative VTE 
prophylaxis? 
 
Choice 1: Commence fondaparinux once adequate haemostasis has been achieved   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Commence use of calf-compression stockings only   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: No VTE prophylaxis is required   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Commence low-molecular weight heparin once adequate haemostasis has 
been achieved.    
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Commence Dabigatran etexilate once adequate haemostasis has been 
achieved.   
Score : 0 






A 30-year-old woman who is G2P1 presents at 37 weeks gestation with a two day 
history of pain and swelling in her right calf. She has also noticed some breathless 
during this time. Her previous pregnancy was uneventful. There is some tenderness 
and redness of the calf and examination of the chest is unremarkable. 
 
Question: 
Which one of the following is the most appropriate initial investigation? 
 
Choice 1: CT Pulmonary Angiogram   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Ventilation-Perfusion Scan   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Chest X-Ray   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Duplex scan of the lower limbs   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: D-dimer   
Score : 0 






A 40-year-old man is admitted to the medical ward for intravenous antibiotics to 
manage an uncomplicated cellulitis of his left calf. An ultrasound scan shows no 
evidence of DVT. He is otherwise healthy and mobilises around the ward; he can 
often be found outside of the hospital talking to other patients. He is a non-smoker 
and drinks 1-2 standard drinks per week. He weighs 98kg. 
 
Question: 
Which one of the following is the most appropriate choice of VTE prophylaxis? 
 
Choice 1: Graduated calf compression stockings   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: No VTE prophylaxis is required   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Aspirin 100mg PO daily   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Enoxaparin, 100mg daily, subcut   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Low-dose unfractionated heparin   
Score : 0 






A 73-year-old man is hospitalised with an haemorrhagic stroke, proven on CT scan. 
As part of the rehabilitation program, consideration must be given to prophylaxis 
against venous thromboembolism. Immediately prior to the stroke the patient 
enjoyed an active life, although he had hurt his back recently and had been taking 
paracetamol immediately prior to his admission. Apart from some right-sided motor 
weakness in his arm, hand and leg, the physical examination is unremarkable. His 
serum biochemistry is shown: Haemoglobin 128 g/L (130 - 175) Platelets 130 x 
10^9/L (150 - 450) 
 
Question: 
Which one of the following regimens would be most appropriate? 
 
Choice 1: Calf compression stockings   
Score : 1 
Choice Feedback: Correct 
 
Choice 2: Aspirin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Enoxaparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Dabigatran   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Warfarin   
Score : 0 






An otherwise fit 64-year-old man is about to undergo a partial gastrectomy for 
carcinoma. He will require some measures to minimise the risk of venous 
thromboembolic complications during his hospitalisation. 
 
Question: 
Which one of the following is the most appropriate intervention? 
 
Choice 1: Pneumatic calf compression during surgery only   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Sequential calf compression stockings until discharge   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Enoxaparin starting at commencement of surgery until discharge   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Enoxaparin starting immediately after surgery and given until discharge   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Enoxaparin given immediately after surgery and continued for 14 days 
after discharge   
Score : 1 






A 35-year-old woman is admitted for an elective laparoscopic cholecystectomy, 
planned as a day case procedure. Apart from an episode of biliary colic two months 
earlier, she is in good health and there is nothing of note in the past medical history. 
She is on the oral contraceptive pill. With regard to minimising the risk of venous 
thrombo-embolic (VTE) complications, graded calf compression stockings will be 
applied before and during the operation. Measures need to be taken to reduce her 
risk of a venous thrombo-embolic event 
 
Question: 
Which one of the following is the most appropriate management? 
 
Choice 1: Intraoperative pneumatic calf compression and perioperative enoxaparin 
until mobile    
Score : 1 
Choice Feedback: Correct 
 
Choice 2: Intraoperative pneumatic calf compression and postoperative enoxaparin 
for two weeks   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Intraoperative pneumatic calf compression and postoperative enoxaparin 
for four weeks   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: No additional measures are required   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Pneumatic calf compression devices during surgery   
Score : 0 






A 72-year-old man is about to start a course of chemotherapy for a recently 
diagnosed small cell carcinoma of the lung. Consideration is being given to the most 
appropriate chemoprophylaxis to reduce his risk of VTE. Apart from his lung cancer 
the patient does not have any other apparent health issues and is still leading an 
active life. His pre-chemotherapy laboratory results are reviewed. His Hb was 98g/L, 
his leucocyte count 12.5x10^9/L and his platelet count was 450x10^9/L. 
 
Question: 
Which one of the following regimens would be most appropriate choice of 
anticoagulant drug? 
 
Choice 1: Warfarin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Unfractionated heparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Dabigatran   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Aspirin   
Score : 0 
















Case 441: VTE Prophylaxis in Oncology 
 
Authors and Affiliations 
Dr Eamon Raith MBBS 
Clinical Lecturer 
Discipline of Surgery 
The University of AdelaideThis case study takes the user through some of the issues 
involved in the assessment and management of thromboprophylaxis in the medical 
patient. This includes hospital admission and outpatient setting and in particular, for 




Please note that, where available, staff should abide by local venous 
thromboembolism (VTE) prophylaxis and management policies, as these may take 
into account local clinical and economic factors that cannot be anticipated by the 
material in this module. 
 
Learning Objectives 
• Identify the patient suffering from neoplastic disease at risk of venous 
thromboembolic disease 
• Assess the risk of venous thromboembolism in the patient suffering from 
neoplastic disease 
• Assess the risk of bleeding in the patient suffering from neoplastic disease 
that is a candidate for VTE prophylaxis 
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• Correctly select an appropriate means of VTE prophylaxis for the patient 
suffering from thrombogenic neoplastic disease 








Problems associated with venous thromboembolism are not confined to the surgical 
patient. Many patients whose primary problem is medical are at increased risk of a 
venous thromboembolic complication either during their illness, the treatment of the 
illness or during recovery. One group in which there is significant risk is the patient 
with cancer. There are some well recognised risks in this group. 
 
Question: 
Concerning the risk of VTE, which of the following statements are correct? 
 
Choice 1: Cancer confers a four- to six-fold increased risk compared with age- and 
sex-matched control groups   
Score : 1 
Choice Feedback: Correct. Neoplastic disease markedly increases the risk of 
thrombosis through tumour-based activation of prothrombotic mechanisms, 
including; - procoagulant, fibrinolytic and proaggregating factors, - tumour-cell-
derived pro-inflammatory and pro-angiogenic cytokines and, - direct cell-cell 
interactions between tumour cells and healthy cells (Refs: 4, 23, 24). 
 
Choice 2: The incidence is the same in cancer and non-cancer patients undergoing 
similar surgical procedures   
Score : -1 
Choice Feedback: Incorrect. Patients undergoing surgery while suffering from 
neoplastic disease have approximately twice the incidence of VTE compared to 
patients without cancer undergoing the same procedure. This is likely due to the 
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increased pro-coagulant effects of tumorigenesis, and the physiological haemostatic 
response to surgical intervention. 
 
Choice 3: Cancer patients with a history of VTE are likely to have recurrent 
episodes of thromboembolism   
Score : 1 
Choice Feedback: Correct. Patients suffering with cancer and a history of previous 
VTE have 2-3 times the rate of VTE recurrence compared with patients without 
cancer. Indeed there is evidence that the cumulative incidence of recurrent VTE in 
patients with cancer may be as high as 20.7%, and risk of recurrence appears to be 
related to cancer severity (Refs: 23, 24). 
 
Choice 4: There is a high incidence of late thrombosis in surgical cancer patients   
Score : 1 
Choice Feedback: Correct. The @RISTOS study demonstrated that up to 40% of 
VTE events in cancer patients that had undergone surgery occurred more than 21 













Ingrid McCrystal is a 54-year-old woman who is brought to the Emergency 
Department by her family as she has been unable to cope at home after a recent 
course of chemotherapy. For the last three days she has had severe nausea and 
vomiting. She feels very weak and has barely been able to get out of bed and only 
then to the toilet, with the assistance of her husband. She has recently been 
diagnosed with Stage 2, oestrogen-receptor positive, adenocarcinoma of the breast. 
Two weeks ago she completed her initial course of chemotherapy. She has started 
tamoxifen and has been prescribed metoclopramide and paracetamol by her 
oncologist. 
 
Unfortunately, these medications have not helped her over the last three days. Apart 
from her recent diagnosis of breast cancer, Mrs McCrystal does not have any other 
current medical problems, although she notes that she did need treatment for a 
deep venous thrombosis in her right leg after a long flight from an overseas holiday 
when she was in her 30s. She did use the oral contraceptive pill for about ten years. 
Mrs McCrystal a slender woman who is clearly dehydrated with reduced skin turgor, 
sunken eyes and dry oral mucosae. The rest of the physical examination is 
unremarkable. She requires admission for correction of her fluid loss and treatment 
of her nausea and vomiting. Consideration must also be given to any possible 









Which of the following factors increase her baseline risk of VTE? 
 
Choice 1: Age   
Score : 1 
Choice Feedback: Correct. The incidence of VTE in cancer patients increases with 
each decade over the age of 40 years (Ref: 18). 
 
Choice 2: Active cancer   
Score : 1 
Choice Feedback: Correct. Active cancer increases the risk of VTE 4-6-fold, due to 
the procoagulant activities of tumour-mediated coagulation factors, cytokines and 
cell-cell interactions (Refs: 3, 7, 20, 23, 24). 
 
Choice 3: Previous VTE   
Score : 1 
Choice Feedback: Correct. Cancer patients with a history of prior VTE have 6-7 
times the risk of developing a VTE compared to those with no history of VTE (Refs: 
3, 28). 
 
Choice 4: Prolonged severe immobility   
Score : 1 
Choice Feedback: Correct. The patient has been bed-bound for three days, with 
minimal movement, suggesting that she has been immobile for a prolonged period of 
time (Ref: 28). 
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Choice 5: Pregnancy and the puerperium   
Score : -1 
Choice Feedback: Incorrect. Perhaps correct in other circumstances - but this 
patient is not pregnant. 
 
Choice 6: Marked obesity   
Score : -1 
Choice Feedback: Incorrect. Whilst obesity in itself is a risk factor for VTE, the 
description of this patient being a "slender woman" would suggest her BMI is 
probably less than 20. There is no existing evidence that she is suffering from 
obesity. 
 
Choice 7: Active treatment of her cancer   
Score : 1 
Choice Feedback: Correct. Systemic chemotherapy increases the risk of VTE by 6-7 
times. Use of hormonal manipulation therapies significantly increases the risk of VTE, 
with tamoxifen specifically increasing risk of VTE by 2-5 times. This risk is even 
higher when selective oestrogen receptor modulators are combined with 
chemotherapy in post-meopausal women. The use of aromatase inhibitors has been 
associated with approximately half the risk of SERMs. Other agents, including 
angiogenesis inhibitors and thalidomide and lenalidomide, all increase risk of VTE, 
especially when combined with chemotherapy or high-dose dexamethasone 
(References: 7, 8, 10, 12, 15, 16, 20, 25, 28). 
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Choice 8: General anaesthesia   
Score : -1 
Choice Feedback: Incorrect. There is no evidence of the use of anaesthetic in her 
recent history. 
 
Choice 9: A concurrent, pro-thrombogenic medical condition   
Score : -1 
Choice Feedback: Incorrect. There is no evidence of acute or acute-on-chronic 
chest infection, heart failure, AMI, ischaemic stroke or acute inflammatory bowel 
disease. These conditions, in themselves are risk factors for VTE - but none of them 
are present in Mrs McCrystal. 
 
Choice 10: The type of malignancy   
Score : 1 
Choice Feedback: Correct. The type of malignancy is important in the assessment of 
VTE risk in patients with neoplastic disease. Risk of thromboembolic disease is 
highest in malignant brain tumours, adenocarcinomas of the lung, ovary, pancreas, 
colon, stomach, prostate, kidney and haematoligic malignancies (Refs: 6, 20). 
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Question 3:  
Question Information: 
 
Mrs McCrystal has several risk factors for VTE and these include: 
• Her age 
• The breast cancer 
• History of dvt 
• The current treatment of her breast cancer with chemotherapy 
• Recent immobility 
 
An intravenous line is inserted and an infusion of isotonic saline started. Blood 
samples are taken for laboratory analysis and Mrs McCrystal is admitted to the ward. 
Her haemoglobin on admission is 95g/L, with a platelet count of 200x10^9/L and a 
normal white cell count. Her pre-chemotherapy blood results are available for 
comparison and show: - Hb 120g/L - Plt 400x10^9/L - WCC: normal. Her 
biochemistry results correspond with moderate to severe dehydration. The risk that 
she will develop a thromboembolic complication need to be considered. It should be 



















Discuss how such a risk might be calculated. (Free text answer option) 
 
Feedback: 
A VTE risk score specific to cancer patients was developed in 2008 by Khorana et al, 
using 5 clinical and laboratory variables common to all cancer patients, to generate a 
score that correlates with cumulative risk of developing a VTE over the following 6 
month period. Patient Characteristics Risk Score: 
• Site of cancer - Very high risk (stomach, pancreas) 2 
• High risk (lung, lymphoma, gynaecologic, testes, bladder) 1 
• Prechemotherapy platelet count >/=350x10^9/L 1 
• Haemoglobin level <100g/L or use of red cell growth factors 1 
• Prechemotherapy leucocyte count >11x10^9/L 1 BMI >35 1 
 
This scoring system has been validated twice, once by the original authors and a 
second time by an independent research team. The score is cumulative, and can be 
interpreted thus: 
• High risk: Score >/= 3 (6.7-7.1% risk) 
• Intermediate risk: Score 1-2 (1.8-2.0% risk) 




References: 5, 15. 
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Question 4:  
Question Information: 
 
Apart from correction of her dehydration and treatment of the nausea, 
consideration must be given to risk reduction against venous thromboembolism. The 
use of VTE prophylaxis must be balanced against the risk of an haemorrhagic event. 
There are a number of factors which might increase the risk of bleeding in this 
patient with recently diagnosed carcinoma of the breast. 
 
Question: (Free text answer option) 
Discuss the factors which increase bleeding risk in patients with neoplastic disease. 
 
Feedback: 
Factors increasing bleeding risk that are of specific concern in patients with 
neoplastic disease include: 
• Significant renal impairment (due to decreased clearance of renally-cleared 
anticoagulants e.g. Warfarin) 
• Current active major bleeding (defined as requiring transfusion of at least two 
units of packed red cells or other blood products within a 24hr period) 
• Current chronic, clinically significant, measurable bleeding over 48 hours 
• Inherited or acquired bleeding disorders 
• Severe platelet dysfunction or thrombocytopaenia (platelets <50,000/ul) (in 
neoplastic disease, often related to to uraemia or myelodysplasia secondary 
to disease process or medication effects) 
• Recent central nervous system bleeding 
• Intracranial or spinal lesion at high risk of bleeding 
• Recent major surgical procedure of high bleeding risk 
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• Concomitant use of medications that may affect clotting 
• Neuraxial block or recent lumbar puncture 
 
Patients also remain at risk from the other factors increasing the likelihood of 
bleeding with pharmacological VTE prophylaxis, however these are not specifically 
increased in patients with neoplastic disease: 
• Active peptic ulcer disease or ulcerative gastrointestinal disease 
• Liver failure or prolonged obstructive jaundice 








Once Mrs McCrystal has been re-hydrated she begins to feel better and her nausea 
subsides. Plans for VTE risk reduction are discussed with her. It might be practical to 
considered some form of mechanical prophylaxis. 
 
Question: 
Which of the following would contraindicate the use of mechanical prophylaxis? 
 
Choice 1: Any factor preventing correct fitting of stockings   
Score : 1 
Choice Feedback: Correct. Any ill-fitting of thromboembolic deterrent stockings is 
likely to result in incorrect pressure graduation across the venous system of the 
lower leg and would not only be ineffective at preventing DVT, but would increase 
the risk of thrombosis. Therefore, any factor that prevents the correct fitting of 
mechanical prophylaxis is a contraindication to its use. 
 
Choice 2: Inflammatory conditions of the leg   
Score : 1 
Choice Feedback: Correct. Caution must be used in patients with inflammatory 
conditions of the lower limb and rheumatoid arthritis as these patients may have 
small vessel disease, and application of graduated compression stockings may result 
in pressure necrosis. 
 
Choice 3: Severe peripheral arterial disease   
Score : 1 
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Choice Feedback: Correct. The use of graduated compression stockings or 
intermittent pneumatic compression devices is contraindicated in peripheral artery 
disease as compression should not be allowed to impede already-compromised 
arterial flow. 
 
Choice 4: Severe lower limb oedema   
Score : 1 
Choice Feedback: Correct. The use of compression stockings in severe lower limb 
oedema is contraindicated as tight bands, particularly in poorly-fitting stockings, can 
induce ulceration. Similarly, the use of stockings in severe oedema can induce heart 
failure through rapid return of fluid to the central circulation, and consequent 
cardiac overload. 
 
Choice 5: Lymphoedema   
Score : -1 
Choice Feedback: Incorrect. Lymphoedema is a result of either congenital or 
acquired deficiencies in lymphatic return-flow to the central venous circulation. The 
use of graduated compression stockings is indicated in the conservative management 
of lymphoedema. 
 
Choice 6: Diabetic neuropathy   
Score : 1 
Choice Feedback: Correct. Caution must be used in patients with diabetes mellitus 
as these patients may have small vessel disease and application of graduated 





Mrs McCrystal has some arthritic changes in her ankles and it is decided that 
mechanical measures might not be an appropriate form of VTE prophylaxis. 
 
Question: (Free text answer option) 




Ms McCrystal is a patient suffering from carcinoma of the breast, undergoing 
hormonal anti-neoplastic therapy. Based on her clinical history and current clinical 
status, she can be assessed as being at intermediate risk using the Khorana Risk 
Assessment tool for VTE in patients with cancer. The patient is relatively immobile 
and is recovering from dehydration and a recent acute illness. She is unlkely to 
mobilise rapidly and some form of chemoprophylaxis would be appropriate. She has 
contraindications to the use of pharmacological prophylaxis, although given her low 
platelet count, the use of pharmacological prophylaxis should be reviewed frequently 
throughout her admission. Current evidence supports the use of either low-
molecular weight heparin or unfractionated heparin as appropriate pharmacological 
VTE prophylaxis, however there is currently no definitive evidence to support the 
use of one drug over the other. In the absence of definitive evidence supporting one 
pharmacological agent over another, it would be appropriate to use either the drug 
recommended by local policy guidelines and protocols, or in the absence of such 
guidelines, low-molecular weight heparin, due to its ease of dosing and 






Whilst the indications for some form of mechanical or chemical prophylaxis have 
been reasonably well defined and validated for cancer patients with recognised risk 
factors, the place of VTE prophylaxis is not so clear for the ambulatory patient in a 
routine clinical setting. 
 
Question: 
With regard to the ambulatory patient receiving chemotherapy, which of the 
following statements are generally considered correct? 
 
Choice 1: Pharmacoprophylaxis will not reduce the risk of central venous catheter-
associated thrombosis   
Score : 1 
Choice Feedback: Correct. Whilst some form of VTE-related complication occurs in 
about 4% of cancer patients who have an indwelling venous access line, there is no 
good evidence that any form of pharmacoprophylaxis will prevent this complication 
(Ref 30). Current international guidelines do not recommend thromboprophylaxis 
for this group of patients. 
 
Choice 2: The risk of bleeding with chemoprophylaxis would outweigh any risk 
reduction of VTE   
Score : -1 
Choice Feedback: Incorrect. The overall benefits on the use of chemoprophylaxis in 
medical in-patients with cancer and in particular, the low molecular weight heparins, 
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is not clear. Whilst the benefits in the overall medical in-patient populations have 
been shown in terms of reduction of risk of VTE, this must be balanced against the 
risk of bleeding. A 1% risk of a major bleeding event in patients treated with low 
molecular weight heparins has been reported. 
 
Choice 3: Enoxaparin is not associated with increased bleeding risks when used to 
treat advanced pancreatic cancer   
Score : 1 
Choice Feedback: Correct. A prospective evaluation of enoxaparin in patients 
receiving chemotherapy for advanced carcinoma of the pancreas found that this low 
molecular weight heparin was safe in terms that there was no increased incidence of 
major bleeding events. The patients were treated with agents known to be 
associated with an increased risk of VTE, such as cisplatin and no increased rates of 
severe bleeding events were noted (Ref: 27). 
 
Choice 4: Chemoprophylaxis will reduce the incidence of VTE in high risk cancers   
Score : 1 
Choice Feedback: Correct. A report in the Lancet 2009 showed that the use of a 
low molecular weight heparin would reduce the incidence of VTE-related problems 
in patients with high and very high risk categories of cancer patients. The risk of a 
bleeding bleeding event was low and consistent with the use of these heparins in 
other, similar settings (Ref: 2). 
 
Currently there are no international guidelines recommending the routine use of 
thromboprophylaxis in the ambulatory setting for cancer patients.  
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Synopsis 
Epidemiology of VTE 
 
Cancer confers a four- to six-fold increased risk of thrombosis compared with age- 
and sex-matched control groups, with patients undergoing surgery on a background 
of neoplastic disease having approximately twice the overall risk of developing a 
venous thromboembolism, and a 40% risk of a late (>21 days) post-operative VTE 
event. Cancer also confers a marked risk of recurrence of VTE, with oncology 
patients having a VTE recurrence rate of 2-3 times that of patients with no history of 
cancer. Risk of venous thromboembolism is also significantly increased by the 
therapies for cancer, including hormonal, chemo- , and radio-therapy. Newer anti-
neoplastic agents, including anti-angiogenic and cytokine therapies similarly increase 
the risk of VTE. 
 
Pathophysiology of VTE in Cancer 
 
Fibrin and normal coagulation compounds have been found to be important factors 
in tumour adhesion and metastasis, with the presence of thrombotic plugs at sites of 
tumour growth suggesting a significant role in tumour growth and metastasis. The 
pro-thrombotic mechanisms of tumours can essentially be separated into general 
pro-thrombotic mechanisms (i.e. those that occur as part of a normal response to 
disease) and tumour-specific mechanisms (i.e. those that occur directly as a result of 
suffering from neoplastic disease). General pro-thrombotic mechanisms in neoplastic 
disease represent the host response to cancer, and consist of generic mechanistic 
responses to disease including the acute phase response, production of paraproteins, 
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inflammation, necrosis and haemodynamic disturbance, each of which serve to 
induce a pro-coagulant state. 
 
Patients with cancer have been shown to have markedly elevated levels of Factors V, 
VIII, IX and XI and significantly increased markers of coagulation activation (eg. D-
Dimers, FDP etc). In association with this increased generalised response to 
neoplasia, tumours themselves exert a considerable thrombogenic effect through 
their use of coagulation triggers, factors and mechanisms to perpetuate their own 
growth and survival. This occurs through cellular production of procoagulant, 
fibrinolytic and pro-aggregating factor production (Tissue factor, IL-1B, TNFa, VEGF, 
urokinase-type and tissue-type plasminogen activators, plasminogen-activator 
inhibitors 1 and 2 and plasminogen-activator receptor, ADP, and thrombin); release 
of pro-inflammatory and pro-angiogenic cytokines; and direct interaction with blood 
and vascular cells (endothelium, erythrocytes, leucocytes, platelets) through the 




Admission Criteria. In line with the assessment of baseline VTE risk for all patients 
presenting to hospital for admission, the reason for the admission of Oncology 
patients should be reviewed in order to determine if they warrant VTE prophylaxis 
for any of the following high-risk procedures or injuries: 
• Abdomino-pelvic, thoracic or orthopaedic surgery 
• Major joint surgery and curative surgery for cancer 
• Leg injury requiring surgery or prolonged immobilisation 
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• Prolonged surgery and/or prolonged immobilisation 
 
Risk Assessment - Assessment of patient and condition-based risk factors 
 
Oncology patients must be assessed for the full range of VTE risk factors as outlined 
in the NHMRC Summary Prevention of Venous Thromboembolism (VTE) in Patients 
Admitted to Australian Hospitals: Guideline Summary", however specific questioning 
must be directed towards cancer-specific risk factors, including: 
• Previous VTE 
• Active cancer 
• Age (>40) 
• Presence of: 
• Malignant brain tumours 
• Adenocarcinomas of the lung, ovary, pancreas, colon, stomach, prostate, 
kidney; 
• Haemtaologic malignancies 
• Use of non-surgical therapies for cancer including: Chemotherapy, Hormonal 
manipulation, Angiogenesis inhibitors, Thalidomide and Lenalidomide 
• Presence of a CVC (particularly left-sided CVCs) 
• Chest radiotherapy 
 
 
The Khorana Risk Assessment score is a useful, clinically-validated method of 
assessing VTE risk specific to cancer patients. 
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Risk Assessment - Assess the risk of bleeding or contraindications to 
pharmacological prophylaxis. Assess the patient for: 
• Significant renal impairment 
• Current active major bleeding (at least 2 units RBC or other products/24hr) 
• Current chronic, clinically significant, measurable bleeding over 48 hours - 
Inherited or acquired bleeding disorders 
• Severe platelet dysfunction or thrombocytopaenia (Plts <50,000/ul; Severe 
platelet dysfunction; Uraemia; Medications; Myelodysplasia) 
• Recent CNS bleeding 
• Intracranial or spinal lesion 
• Recent major surgical procedure of high bleeding risk 
• Active PUD or ulcerative gastrointestinal disease 
• Liver failure or prolonged obstructive jaundice 
• Concomitant use of medications that may affect clotting 
• Neuraxial block or recent lumbar puncture 
• Intracranial or spinal lesion at high risk of bleeding 
• High risk of falls 
 
 
Risk Assessment - Assess the patient for any contraindications to mechanical 
prophylaxis. Patients should be assessed for: 
• Any factor preventing correct fitting of stockings - Inflammatory conditions of 
the lower leg - Severe peripheral arterial disease - Diabetic neuropathy 
• Severe lower limb oedema 
• Severe lower limb deformity or inability to correctly fit stockings 
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• Peripheral arterial disease or arterial ulcers. 
 
 
Selection of appropriate thromboprophylaxis in VTE patients 
 
In patients with cancer undergoing abdominal surgery, evidence shows a similar 
efficacy for both LMWH and UFH with no difference in the incidence of side effects 
(haemorrhage, haematoma formation or need for transfusion) with studies showing 
that a four-week post-operative course of prophylaxis further reduces late VTE 
events. 
 
In patients undergoing neurosurgery for cancer, evidence shows that neither LMWH 
or UFH are associated with serious haemorrhage and are more effective at 
preventing VTE that mechanical prophylaxis alone. Studies have shown that, while 
patients with glioma have a high incidence of delayed VTE, extended post-operative 
VTE prophylaxis is associated with a high risk of post-discharge bleeding, and is not 
recommended. 
 
Patients with head and neck cancer experience a higher risk of VTE compared to 
patients undergoing maxillo-facial surgery for non-neoplastic disease, however they 
appear to remain relatively low-risk overall. Given the importance of haemostasis 
and vascular patency to the success of maxillo-facial procedures, staff should 




In non-surgical cancer patients, evidence suggests that the use of LMWH VTE 
prophylaxis in inpatients results in a 50-70% reduction in VTE events. Consequently, 
the recommended practice is to commence inpatient medical oncology patients in 
LMWH or UFH at admission, and continuing until discharge. Current guidelines 
recommend the use of graduated compression stockings as mechanical prophylaxis 
in surgical and non-surgical oncology patients with contraindications to 
pharmacological thromboprophylaxis. 
 
Management of established VTE in Oncology Patients 
 
Current international guidelines recommend that patients with active cancer and 
confirmed proximal DVT or PE, be commenced on LMWH and continue the LMWH 
for 6 months. At 6 months the patient should be reviewed and the risks and benefits 
of continuing anticoagulation assessed. Similarly, international guidelines recommend 
that all patients diagnosed with unprovoked DVT or PE who are not already known 
to have cancer are offered the following investigations for malignancy: 
• History and targeted physical 
• Chest X-ray 




Consider further investigations for cancer with an abdomino-pelvic CT scan (and a 
mammogram for women) in all patients >40y/o who present with a first unprovoked 
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Case Overview 
This case study looks at some of the issues surrounding risk-management of venous 
thromboembolism (VTE) in surgical patients. The vignette starts with the 
presentation of a patient with an acute surgical problem and then focuses on 
measures that need to be considered to reduce the risk of VTE. The case is a real 
one - where the names and precise circumstances have been changed. 
Learning Objectives 
• An understanding of the risk factors associated with venous 
thromboembolism (VTE) 







Mrs Jurinac is a 57-year-old woman who presents to the Emergency Department 
with a six hour history of severe upper abdominal pain radiating around to the back. 
She feels nauseated and wants to vomit but is unable to do so. She has difficulty 
giving this history and is acutely distressed. She is pale and sweating, with a blood 
pressure of 110/70 mmHg, pulse rate of 120/min and temperature of 37.4C. Her 
trachea is midline and breath sounds are clear on the left side but are reduced 
towards the right base. The percussion note has increased resonance at the right 
base. An intravenous line is inserted and blood samples collected for baseline 









Which one of the following is the most appropriate next step in management? 
 
Choice 1: Chest tube and underwater-seal drain   
Score : 0 
Choice Feedback: Incorrect. The chest X-ray shows a large air-filled gastric bubble in 
the right chest. 
 
Choice 2: Tube thoracostomy   
Score : 0 
Choice Feedback: Incorrect. This air-filled sac in the chest certainly needs 
decompression - but it would be achieved more effectively through the passage of a 
nasogastric tube. 
 
Choice 3: Passage of a nasogastric tube   
Score : 3 
Choice Feedback: Correct. This is the classical appearance of a gastric volvulus. The 
stomach has volved around its long axis (organoaxial volvulus) with the proximal 
stomach above and hiatal defect and situated in the right chest, with the distal 
stomach visible below the diaphragem. 
 
Choice 4: CT scan chest   
Score : 0 
Choice Feedback: Incorrect. There is already sufficient information to establish a 
diagnosis and institute a plan of management. 
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Choice 5: Electrocardiogram   
Score : 0 






A nasogastric tube is passed and a large quantity of air is released, giving Mrs Jurinac 
immediate symptomatic relief. This is followed by a litre of blood-stained gastric 
contents. Mrs Jurinac is now able to give a history and says that she has known for a 
long time about her hiatus hernia, but it has never given her much bother. She had a 
chest X-ray performed about two years earlier (Images 1, 2) when she had 
developed chest pain after a blood clot had developed in her right leg. Duplex 
ultrasonography at that time confirmed the presence of a DVT and a CT pulmonary 
angiogram did not show any evidence of pulmonary embolus. Three years before 
that she had pneumonia and a chest X-ray then had shown the hernia. (Images 3, 4) 
 
The condition of the patient has now improved considerably. Her abdominal pain has 
settled and she now longer feels nauseated. Her blood pressure is 124/80 mmHg and 
her pulse rate 90/min. Her abdomen is soft to palpation. 
 
 


































Which one of the following is the most appropriate plan of management? 
 
Choice 1: Discharge home with urgent surgical appointment   
Score : 0 
Choice Feedback: Incorrect. Whilst the intrathoracic component of the para-
oesophageal hernia has been decompressed, more information is required on 
whether the obstruction has been relieved. 
 
Choice 2: Barium meal   
Score : 3 
Choice Feedback: Correct. More information is required about her upper digestive 
tract. She still may be obstructed and it would be helpful to delineate the anatomy of 
the stomach as surgery will almost certainly be required. 
 
Choice 3: Endoscopy   
Score : 0 
Choice Feedback: Incorrect. This will not give as much useful information about the 
anatomy of the upper digestive tract and any possible site of obstruction as a 
contrast study. 
 
Choice 4: CT scan chest and abdomen   
Score : 0 
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Choice Feedback: Possibly correct. A conventional contrast study will probably yield 
more useful information about the anatomy of the upper digestive tract and any 
possible site of obstruction. 
 
Choice 5: Admit for gut rest   
Score : 0 
Choice Feedback: Incorrect. 






Arrangements are made to admit Mrs Jurinac to a surgical bed and a contrast study 
is performed (Images 1 - 3). This shows a coiled nasogastric tube in the proximal 
component of the chest. There is complete obstruction with no contrast flowing 
into the distal stomach. The site of obstruction is at the oesophageal hiatus. 
Arrangements are made for prompt surgical intervention. An assessment must be 
made of the risk factors for postoperative complications including venous 
thromboembolism. Different measures will be required according to her risk 
category. The risk categorisation will take into account: 
• The individual risk factors of the patient 
• The planned procedure 
 









































Which of the following procedures would be classified as high risk? 
 
Choice 1: Total knee replacement   
Score : 1 
Choice Feedback: Correct. Many forms of orthopaedic surgery are considered major 
risk for VTE. Some form of thromboprophylaxis must be used for patients 
undergoing total knee replacement. See the case study on orthopaedic surgery for 
more details. 
 
Choice 2: Partial gastrectomy for carcinoma   
Score : 1 
Choice Feedback: Correct. It has been estimated that one third of patients 
undergoing surgery for malignancy will have venographic evidence of deep venous 
thrombosis (2). Abdominal surgery for any malignant process is defined as high risk 
for VTE and some form of thromboprophylaxis must be employed. 
 
Choice 3: Laparoscopic cholecystectomy in a 25-year-old woman   
Score : -1 
Choice Feedback: Incorrect. In an otherwise fit and healthy person with no risk 
factors for VTE, a laparoscopic cholecystectomy would be considered a low risk 
procedure. Most of these procedures take less than 45 minutes to perform. 
 
Choice 4: Laparoscopic fundoplication in a 30-year-old   
Score : 0 
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Choice Feedback: Partially correct. According to international guidelines (6) a high 
risk procedure is one where there is major surgery in any patient aged over 40 
years. Major surgery is defined as any form of intra-abdominal surgery or any 
operation of greater than 45 minutes duration. Many laparoscopic surgeons would 
probably not agree with this categorisation as most of these patients are relatively fit 
and are home within two days of the procedure. 
 
Choice 5: Inguinal hernia repair in a 25-year-old man with a BMI of 32   
Score : 1 
Choice Feedback: Correct. Whilst inguinal hernia surgery might be considered a 
minor risk in terms of VTE occurrence, a BMI greater than 30 increases the risk 
substantially. In such circumstances the patient would be categorised as high risk. 
 
Choice 6: Laparoscopic appendicectomy in a 20-year-old   
Score : -1 
Choice Feedback: Incorrect. Whilst this is obviously an abdominal procedure, in 
most instances it is a relatively minor one and can be classified as low risk. Most 
laparoscopic abdominal procedures where there is rapid recovery could be classified 
as low risk. 
 
Choice 7: Laparoscopic appendicectomy in a 25-year-old with Crohn's disease   
Score : 1 
Choice Feedback: Correct. Inflammatory bowel disease is associated with an 
increased risk for first-time VTE. Unprovoked episodes of recurrent VTE in these 
patients is about 30% within five years of the initial episode. When considering long-
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term anticoagulation in this group of patients, the risks of recurrent VTE must be 
balanced against the risks of haemorrhage (7). 
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Question 4 : 
Question Information: 
 
Mrs Jurinac's planned procedure is categorised as high risk. She is booked for a 
laparoscopic reduction and repair of her obstructed para-oesophageal hernia - which 
has volved. In addition to the type of procedure, there may be other factors that put 
her at increased risk of VTE. 
 
Question: 
Which of the following are accepted risk factors for VTE? 
 
Choice 1: Morbid obesity   
Score : 1 
Choice Feedback: Correct. Obesity (BMI greater than 30) and its heavier cousin, 
morbid obesity (BMI greater than 40), is an important risk factor to take into 
account when looking at an individual's fitness for surgery. 
 
Choice 2: Age greater than 60   
Score : 1 
Choice Feedback: Correct. Patients aged 60 and over undergoing a surgical 
procedure have their age as an individual risk factor for VTE. 
 
Choice 3: Diabetes mellitus   
Score : -1 




Choice 4: History of deep venous thrombosis   
Score : 1 
Choice Feedback: Correct. This is an important individual risk factor for VTE. 
 
Choice 5: Ulcerative colitis   
Score : 1 
Choice Feedback: Correct. Any patient with inflammatory bowel disease who is 
planned for any type of surgical intervention is at increased risk of VTE. A study 
published in the Archives of Surgery reported a significant increase in the incidence 
of DVT and pulmonary embolus in patients with inflammatory bowel disease 
undergoing surgery compared with patients without inflammatory bowel disease 
undergoing similar procedures (5). 
 
Choice 6: Prolonged immobility two months prior to planned procedure   
Score : -1 
Choice Feedback: Incorrect. Any prolonged immobility within four weeks of the 
planned procedure would be considered an increased risk factor for VTE - but that 
risk diminishes as the time of immobility increases between the two events. 
 
Choice 7: Hormone replacement therapy (HRT)   
Score : 1 
Choice Feedback: Correct. The risk of VTE is increased in patients taking HRT, 
particularly in the first year of treatment. A systemic review showed that HRT was 
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an independent risk factor (3). Similar risks exist for woman taking the oral 
contraceptive pill. 
 
Choice 8: Cholangitis   
Score : 0 
Choice Feedback: Cholangitis per se is not a risk factor - but severe sepsis is an 
independent risk factor for VTE. What defines severe sepsis might be difficult to 
describe, but any patient who is hospitalised with a septic problem should probably 






Mrs Jurinac is at increased risk of VTE. She is about to undergo major abdominal 
surgery - although from a patient's viewpoint the procedure is often relatively minor 
as it can usually be undertaken laparoscopically and will only require two or three 
days in hospital before discharge home. Some measures must be taken to reduce the 
risk of VTE. It is standard practice for this type of surgery for patients to wearing 
sequential compression devices and have intermittent calf compression devices 
applied for the duration of the procedure. 
 
Dependent venous pooling is real issue in these patients for two reasons. First, the 
raised intra-adbominal pressure of a laparoscopic procedure will hamper venous 
return and second, a considerable amount (up to 45 degrees from the horizontal) of 
reverse Trendelburg tilt is use to help access under the diaphragm. (Image) Used by 
themselves elastic graded compression stockings will reduce the postoperative 
incidence of DVT by up to 60% and when used in combination with pneumatic 
compression devices or low molecular weight heparin can reduce the incidence of 








Which of the following are contraindications to the use of mechanical compression 
devices? 
 
Choice 1: Suspected presence of a DVT   
Score : 1 
Choice Feedback: Correct. If the patient is thought to have a DVT, then use of a 
compression device would increase the risk of dislodgement of that clot. 
 
Choice 2: Intermittent claudication   
Score : 1 
Choice Feedback: Essentially correct. Mechanical compression devices must be used 
judiciously in patients with severe peripheral vascular insufficiency. Perhaps the 
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presence of intermittent claudication per se is not a contra-indication, but such 
symptoms must alert the clinician to the possibility of precipitating serious occlusion 
if such devices are used. 
 
Choice 3: Varicose veins  
Score : -1 
Choice Feedback: Incorrect. The risk of VTE can be increased with varicose veins 
and these patients should have some sort of mechanical compression device applied 
during any surgical procedure. 
 
Choice 4: Dependent oedema   
Score : 1 
Choice Feedback: Correct. Depending on the severity of the oedema, any decisions 
on the use of mechanical compression devices must be carefully thought through. 
Calf compression could potentially worsen any pre-existing oedema. 
 
Choice 5: Recent skin graft   
Score : 1 
Choice Feedback: Correct. Any recent surgery to a lower limb would pose potential 
problems for mechanical compression devices, such as direct trauma to the 
operative site or impaired wound healing through reduced (albeit temporary) blood 
supply to that site. 
 
Choice 6: Severe leg deformity   
Score : 1 
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Choice Feedback: Correct. Any prolonged pressure over an area of acute angulation 
could risk tissue damage through pressure necrosis. 
 
Choice 7: Lower limb psoriasis   
Score : 0 
Choice Feedback: Yes and no. Use of a pressure device would depend on the extent 
and severity of any underlying skin problem. A small patch of psoriasis would be of 
little consequence, but a large area of severe dermatitis might be aggravated with the 






Mrs Jurinac does not have any contraindications for the use of mechanical 
compression devices and arrangements are made for graded compression stockings 
to be fitting prior to surgery. In addition, pharmacological thromboprophylaxis 
should be considered. On the assumption that some form of thromboprophylaxis 
will be used in the immediate post-operative period (i.e. while the patient is still in 




In addition to a prophylactic regimen in the immediate postoperative period, which 
of the following regimens would be appropriate for discharge? 
 
Choice 1: Low molecular weight heparin for four weeks after discharge   
Score : -1 
Choice Feedback: Incorrect. It is now becoming standard practice to prescribe post-
discharge pharmacological thromboprophylaxis for high risk groups of patients. This 
is done on the realisation that many patients remain relatively immobile and bed-
bound for some time after discharge from hospital. Such patients include those 
undergoing hip or knee arthroplasty and it is recommended that these patients are 
maintained on some form of chemoprophylaxis for 28-35 days after surgery (ANZ 
Working Party). Mrs Jurinac has undergone major surgery - but a procedure with an 
expected rapid recovery to normal mobility - and has a history of DVT and is thus 
categorised as high risk. Some form of prophylaxis would be appropriate for the 
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postoperative period and a nominal period of a low molecular weight heparin for 14 
days after discharge from hospital is recommended. 
 
Choice 2: Enoxaparin started several hours after surgery and continued for 10 days   
Score : 1 
Choice Feedback: Correct. Use of a low molecular weight heparin would be 
appropriate and this should be continued for 10 days after the time of surgery. In 
other words, the chemical thromboprophylaxis must be continued for a period of 
time during convalescence at home. 
 
Choice 3: Dabigatran for four weeks post surgery   
Score : -1 
Choice Feedback: 
Incorrect. Even if it was decided to use a direct thrombin inhibitor rather than a low 
molecular weight heparin, the patient would not require its administration for more 
than two weeks. 
 
Choice 4: Dalteparin for one week after discharge   
Score : 1 
Choice Feedback: Correct. This regimen would probably be appropriate. Assuming 
that the surgery can be done laparoscopically, the patient will spent a further two or 
three days in hospital and will required a total of about ten days of pharmological 
thromboprophylaxis. 
 
Choice 5: Fondaparinux for one week after discharge   
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Score : 1 
Choice Feedback: Correct. This regimen probably could be used, although this 
synthetic pentasaccharide Factor Xa inhibitor tends to be favoured for 
thromboprophylaxis in orthopaedic patients where the risks of VTE are greater and 
the patients tend to be given longer courses of preventative treatment. This longer 
time frame would theoretically increase the risk of heparin-induced 






The timing of commencement will be influenced by certain factors such as the use of 
epidural or spinal anaesthesia. There are no guidelines for the timing of 
administration of pharmacological thromboprophylaxis with regard to the insertion 
or removal of epidural catheters. However, it is common practice to delay the use of 
anticoagulants for at least 12 hours after the insertion of the catheter. In certain 
circumstances the use of pharmacological thromboprophylaxis may not be 
appropriate and other solutions must be sought, such as insertion of a caval filter 
(Images 1 - 3). With respect to this case, there might be some situations in which 














In which of the following circumstances might use of a caval filter be appropriate? 
 
Choice 1: Serum creatinine of 120 umol/L   
Score : -1 
Choice Feedback: Incorrect. Such a creatinine is borderline and would not 
necessarily be seen as renal impairment. If renal impairment was present, use of 
pharmacological prophylaxis would need to be judicious and whilst the factor Xa 
inhibitors might be contra-indicated, almost certainly this patient would still be 
suitable for a low molecular weight heparin. 
 
Choice 2: Recent pulmonary embolus  
Score : 1 
Choice Feedback: Correct. Any patient being considered for surgery must be fully 
assessed for risk factors for VTE - and a recent pulmonary embolus is a very real risk 
for further problems. In such circumstances - and particularly if clot is still present in 
the dependent venous systems, some form of mechanical filter would be most 
appropriate. Such a patient would usually still be on some form of treatment 
(typically warfarin) for the pulmonary embolus, and this would need to be stopped 
for the period of surgical treatment of the gastric volvulus - thereby increasing the 
need for some other form of prophylaxis. 
 
Choice 3: Recent haemorrhagic stroke   
Score : 1 
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Choice Feedback: Correct. In such circumstances any form of pharmacological 
thromboprophylaxis would increase the risk of a further bleed and must be avoided. 
As the patient is at high risk of VTE, insertion of a caval filter to reduce the risk of 




Issues related to venous thromboembolism (VTE) occur with relative frequency in 
the surgical patient and are an important cause of post-operative morbidity. 
Hospitalised patients are over 100 times more likely to develop a DVT or pulmonary 
embolus compared with the rest of the community. Problems associated with VTE 
have a significant burden in Australia with approximately 30,000 people hospitalised 
each year as a consequence of VTE and an estimated 2,000 die from VTE . 
Pulmonary embolus remains the most common preventable cause of death in 
hospital. All surgical patients must be considered at increased risk for venous 
thromboembolic problems and the element of risk calculated on an individual basis. 
Risk assessment is made on the basis of: 
• The nature of the planned procedure 
• lndividual factors pertinent to that patient 
• The prophylactic measure to be considered 
 
Surgical risk is judged to be either high or low. High risk procedures include: 
• Hip and knee arthroplasty 
• Cancer surgery 
• Any intra-abdominal procedure 
• Any procedure taking longer than 45 minutes 
 
Individual risk factors include: 
• Increasing age 
• Previous venous thromboembolic problems 
• Obesity 
 163 
• Malignancy (including its treatment) 
• Medications, including oestrogen therapy 
• Sepsis 
• Varicose veins 
• Inflammatory bowel disease 
• Dehydration 
• Thrombophilia 
• Prolonged immobility 
 
Thromboprophylaxis comprises two main methods- mechanical and pharmacological 
prophylaxis. The most commonly used pharmacological agents in Australia are the 
heparins (low molecular weight heparin and unfractionated heparin sodium). 
Postoperative enoxaparin dose regimens may need to be varied according to the 
type of surgery and the general state of health of the patient. Co-morbidities such as 
renal impairment will determine the type of agent and dose to be used. For example, 
burnt and other critically ill patients have been documented with inadequate 
antifactor Xa levels and with conventional doses of prophylactic enoxaparin can 
result in increased risks of VTE. One study monitored antifactor Xa concentrations 
in burns patients and increased enoxaparin doses to meet target levels such that 
some patients required 70 mg enoxaparin every 12 hours. No adverse haemorrhage 
events were observed and the incidence of VTE events was reduced (4). 
 
The place of the newer anticoagulants (direct thrombin inhibitors and factor Xa 
inhibitors) have yet to be defined in general surgical practice. Agents such as 
dabigatran and rivaroxaban have been shown to be as efficacious as the heparins in 
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the reduction of VTE risk in major joint replacement surgery and may prove more 
cost-effective. Data is still lacking as to any role these agents may have in other areas 
of surgery. 
 
Mechanical prophylaxis options include thigh or knee length graduated compression 
stockings, pneumatic venous pumping devices that intermittently compress the calf 
muscles and devices that stimulate lower-limb muscle contraction. These devices are 
commonly used intra- and post-operatively and there are only a few circumstances 
in which their use might be precluded. These include: 
• Dermatitis 
• Gangrene 
• Recent skin graft 
• Severe peripheral vascular disease 
• Severe lower limb oedema 
• Proven or suspected DVT 
 
The use of pharmaceutical and/or mechanical prophylactic measures and their 
planned use to reduce the risk of VTE must be balanced in terms of efficacy, cost-
effectiveness and convenience. With the increasing recognition of the need to 
continue prophylaxis well into the convalescent period, a critical assessment of the 
various measures is required. The convenience of oral or subcutaneous preparations 
must be made on an individual basis and the risks of a serious bleeding event be 
weighed up against the risk of VTE. There are a number of contraindications to 
pharmacological prophylaxis and these include: 
• Recent central nervous system bleeding 
 165 
• Intracranial or spinal lesion at high risk for bleeding 
• Current active major bleeding, defined as requiring at least two units of blood 
or blood products to be transfused in 24 hours 
• Current chronic, clinically significant and measurable bleeding over 48 hours 
• Thrombocytopenia (platelets less than 50,000/Î¼l) 
• Severe platelet dysfunction 
• Recent major surgical procedure at high risk for bleeding 
• Underlying coagulopathy or coagulation factor abnormalities 
• Regional axial anaesthesia or recent lumbar puncture for any reason 
• High risk of falls 
 
Vena caval filters are an important alternative in high risk patients when 
anticoagulation is contraindicated. Current evidence indicates that IVC filters are 
largely effective with breakthrough pulmonary emboli occurring in only between 0% 
to 6.2% of cases. Indications for vena caval filters include: 
• Concurrent bleeding diatheses or active hemorrhage 
• Recurrent VTE and PE despite conventional treatment 
• Inability to achieve or maintain therapeutic anticoagulation or poor 
compliance with anticoagulant medications 
• Pelvic surgery in the presence of extensive DVT 
• Concurrent VTE and need to discontinue anticoagulation therapy before 
surgery 
• High risk DVT- e.g. proximal spread of DVT 
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• Prophylaxis for patients at high risk of developing a VTE, where even a minor 
PE could be fatal. (e.g. severe trauma, hypercoaguable states, prolonged 
immobilization, severe cardiopulmonary disease) 
• Any form of surgery on the 'super-obese' patient 
 
Despite their increased use in trauma patients, a recent retrospective study did not 
find that use of caval filters did not lead to any reduction in mortality in an analysis of 
451 trauma patients (14). Contraindications to implantation of IVC filters include: 
• Lack of venous access 
• Caval occlusion 




• Misplacement or embolization of the filter 
• Vascular injury or thrombosis 
• Pneumothorax 
• Air emboli 
 
Long term IVC risks include: 
• Recurrent PE 
• IVC thrombosis 
• Filter migration 
• Filter fracture 
• Penetration of the caval wall 
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Since caval filters only hinder clot migration and do not inhibit clot formation, all 
these patients should receive (unless contraindicated) some form of anticoagulation 
for a period appropriate to the thrombotic disorder. 
 
Risk assessment models 
Being alert to the potential problems of VTE, identifying risk factors (both general 
and individual), undertaking preventative measures, when combined with early post-
operative mobilisation will produce a substantial reduction in the incidence of venous 
thromboembolic complications in surgical patients (9). Various risk assessment 
models for VTE exist. Software systems have been developed that identify at-risk 
hospitalised patients and warn the physician of the need to consider some form of 
VTE prophylaxis. In a study of one such system, the computer-alert system reduced 
the risk of a VTE-related complications by 41% (10). This model, developed by 
Kucher, was effective in identifying high risk patients (those with at least four of eight 
defined risk factors), but was less efficient in picking up the low risk patients - where 
20% of patients with four or less factors did have a VTE-related complication. 
Another model is that devised by Rogers et al, which defines 15 variables which are 
associated with an increased risk of VTE (11). These variables can be used to predict 
a risk of VTE, but the complexity of the scoring system limits its applicability. Caprini 
developed a risk assessment model based on 30 variables, which can accurately 
stratify the risk for low and high-risk patients (12). However, it is a complex system 
to use and subsequent analysis has shown that some of the variables are not specific 
for VTE. In an effort to simplify these systems, Pannucci defined seven risk factors: 
• History of VTE 
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• Current malignancy 
• Age >60 
• Male 
• BMI >40 
• Sepsis/septic shock/systemic inflammatory response syndrome 
• Family history of VTE 
 
This model is much simpler to apply and appears to stratify patients appropriately 
(13). A recent analysis of 13 studies, involving 14776 patients, found that 
chemoprophylaxis reduced the overall risk rate for postoperative VTE by 34% (15). 
However, the benefit only applied to those with a Caprini score of 7 or more. Some 
75% of patients in these studies had a Caprini score of 6 or less - suggesting that 
many patients have unnecessary chemoprophylaxis - and this might expose them to 
the risk of bleeding complications. These data suggest that a more individualised 
approach should be taken to the use of chemoprophylaxis in patients with increased 
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Case 869: VTE Prophylaxis in Medical Patients 
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Case Overview 
This case will take the user through the assessment, choice and application of VTE 
prophylaxis in medical patients admitted to hospital. 
 
Please note that, where available, staff should abide by local VTE prophylaxis and 
management policies, as these may take into account local clinical and economic 
factors that cannot be anticipated by this module. 
 
Learning Objectives 
• Identify the medical patient at risk of venous thromboembolic disease 
• Assess the risk of venous thromboembolism in the medical patient 
• Assess the risk of bleeding in the medical patient that is a candidate for VTE 
prophylaxis 
• Correctly select an appropriate means of VTE prophylaxis for the medical 
patient 








A 68-year-old man presents to the Emergency Department with a 12 hour history of 
cough and shortness of breath. Mr Benson has had these symptoms have been 
present for about two months, but got suddenly worse overnight. Other symptoms 
include worsening dyspnoea of exertion and ankle swelling. The medical officer of 
the general medical unit rostered for emergency admissions is asked to see the 
patient. 
 
One of the considerations to be made will be the place of some form of prophylaxis 
to reduce the risk of venous thromboembolism (VTE) during the admission of this 
patient. The risk factors for VTE need to be considered. There are many patients 
with an acute medical illness who might be at increased risk of venous 
thromboembolism. These patients need to be identified early in the course of their 
illness and appropriate prophylaxis instituted. 
 
Question: 
Which of the following would be at increased risk of VTE? 
 
Choice 1: Age over 40   
Score : 1 
Choice Feedback: Correct. Age per se is not a risk factor, but when combined with 
an acute medical illness and reduced mobility, patients in this age group must be 




Choice 2: Stroke   
Score : 1 
Choice Feedback: Correct. These patients are at high risk. They are often elderly 
and immobile. A distinction between ischaemic and haemorrhagic stroke must be 
made early and the risk of haemorrhagic transformation be made before considering 
VTE prophylaxis. 
 
Choice 3: Acute heart failure   
Score : 1 
Choice Feedback: Correct. Patients in the NYHA III/IV groups are at increased risk. 
 
Choice 4: Acute respiratory failure   
Score : 1 
Choice Feedback: Correct. The patient who needs ventilatory support will be at 






In addition to the immediate and precipitating cause for the admission, the patient 




Which of the following are recognised risk factors for VTE? 
 
Choice 1: Hormone therapy   
Score : 1 
Choice Feedback: Correct. Medications such as the oral contraceptive pill and 
hormone replacement therapy put the patient at increased risk of VTE. 
 
Choice 2: Dehydration   
Score : 1 
Choice Feedback: Correct. The patient who is admitted with a several day history of 
being unwell leading up to an acute admission might well be dehydrated - thereby 
increasing the risk of VTE. 
 
Choice 3: Previously treated malignancy   
Score : 1 
Choice Feedback: Correct. Any previously treated malignancy - even though now 
cured and something of the past, leaves the patient at increased risk of VTE. 
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Choice 4: BMI of 25   
Score : -1 
Choice Feedback: Incorrect. This BMI is in the normal range. Those patients with a 
BMI of over 30 are at increased risk of VTE. 
 
Choice 5: History of VTE   
Score : 1 
Choice Feedback: Correct. This is perhaps the most important risk factor to seek. 
 
hoice 6: Varicose veins  
Score : 1 
Choice Feedback: Correct. Patients with varicose veins (venous stasis) are at 
increased risk of VTE events 
 
Choice 7: Immobility prior to admission   
Score : 1 
Choice Feedback Correct. Among hospitalized patients, 50-75% of VTE events, 






Returning to the case of Mr Benson - he now provides some further information. 
His worsening of breathing occurred whilst lying in bed this morning. He does not 
have any fever, cough, palpitations or chest pain. He has had hypertension for 20 
years and takes enalapril 5mg bd. He has a 40 pack-year smoking history and enjoys 
several glasses of beer with his friends at weekends. On examination he looks 
unwell, with a temperature of 37.4C, a tachypnoea of 18/min, blood pressure of 




Which of the following diagnoses should be considered at this point? 
 
Choice 1: Acute myocardial infarction (AMI)   
Score : 1 
Choice Feedback: Correct. AMI is characterised by symptoms including cardiac chest 
pain, nausea and vomiting, syncope, dyspnoea and fear of impending doom. Cardiac 
chest pain may radiate to the epigastrium, throat, arms and back. Although there is 
no chest pain in this case, one should never rule out AMI in such presentation, 
patients could present with exertional or resting dyspnoea due to impairment of the 
contractility of the left ventricle. The lack of pain could be due to underlying diabetic 
neuropathy impairing the normal pain sensation. The smoking history and 
hypertension are risk factors for coronary artery disease. 
 
Choice 2: Acute pulmonary embolism    
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Score : 1 
Choice Feedback: Correct. Common features of a pulmonary embolism (PE) include 
dyspnoea, pleuritic chest pain, tachypnoea, tachycardia and cough. Other features 
may include haemoptysis and cyanosis. Other symptoms of deep vein thrombosis 
such as leg swelling, leg pain may be present. Although he did not have a history of 
recent travel and had no chest pain, pulmonary embolism cannot be ruled out as a 
possible diagnosis. 
 
Choice 3: Congestive heart failure (CCF)   
Score : 2 
Choice Feedback: Correct. The presentation is typical of CCF with progressive 
exertional dyspnoea, dyspnoea at rest and ankle swelling. Further physical 
examination and imaging will confirm the diagnosis. 
 
Choice 4: Acute asthma exacerbation   
Score : -1 
Choice Feedback: Incorrect. Asthma can cause difficulty breathing. But with no 
previous history of asthma, no wheezing and cough, this is unlikely in this case. 
(Asthma is generally characterised by reccurent episodes of dyspnoea, wheezing, 
cough and chest tightness). 
 
Choice 5: Cardiac tamponade   
Score : 1 
Choice Feedback: Correct. Typical presentation include dyspnoea, chest pain and 
palpitations. Cardiac tamponade can be caused by trauma, myocardial rupture 
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(related to myocardial infarction), infection (e.g. TB), malignancy, dissecting thoracic 
aortic aneurysm. 
 
Choice 6: Pneumothorax   
Score : -1 
Choice Feedback: Incorrect. Spontaneous pneumothorax can cause sudden-onset 
chest pain and breathlessness. With a gradual presentation of dyspnoea for two 
months, this diagnosis is unlikely. 
 
Choice 7: Pneumonia   
Score : -1 
Choice Feedback: Incorrect. Pneumonia is usually dominated by systemic features 
including fever, rigors, shivering, cough with productive sputum. Chest pain, 
anorexia, breathlessness may occur. Without fever, cough or any constitutional 






On further examination Mr Benson has a JVP of 7cm, and his apex is displaced 1cm 
lateral to the mid-clavicular line in the 6th intercostal space. Heart sounds are 
normal with no murmurs. On auscultation there are bibasal crepitations. Some sacral 
oedema is evident, as is bilateral ankle oedema. He does not have any hepatomegaly 
or ascites. Some investigations must be now be considered. 
 
Question: 
Which of the following investigations would be appropriate? 
 
Choice 1: ECG   
Score : 1 
Choice Feedback: Correct. An ECG is valuable in looking for evidence of old 
myocardial infarction, acute ischaemia (such as AMI), arrhythmias and heart blocks. 
 
Choice 2: Chest X-ray   
Score : 1 
Choice Feedback: Correct. A chest X-ray may show evidence of pulmonary 
congestion or oedema, cardiomegaly oe pleural effusion. It may rule out and a 
pneumothorax or pericardial effusion. 
 
Choice 3: Complete blood examination   
Score : 1 
Choice Feedback: Correct. A CBE may provide evidence of anaemia exacerbating 
heart failure, or a raised WCC indicating infection. 
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Choice 4: Electrolytes, urea and creatinine   
Score : 1 
Choice Feedback: Correct. EUCs are important for the assessment of renal function, 
electrolyte disturbance and hyperkalaemia related to ACE inhibitor usage. 
 
Choice 5: Troponin T/I   
Score : 1 
Choice Feedback: Correct. Troponin T/I is essential to rule out acute myocardial 
damage (e.g. acute coronary syndrome, NSTEMI or STEMI). 
 
Choice 6: CT pulmonary angiogram (CTPA)   
Score : -1 
Choice Feedback: Incorrect. CTPA is not indicated in this case as there is no 
evidence of VTE or pulmonary embolism (no history of immobilisation, no risk 
factors for VTE, no chest pain, and no ECG evidence (e.g. RV strain or S1Q3T3), no 
unilateral leg swelling). CTPA would also subject the patient to unnecessary 
radiation. 
 
Choice 7: V/Q Scan   
Score : -1 
Choice Feedback: Incorrect. V/Q scan is not indicated in this case as there is no 
evidence of VTE or pulmonary embolism (no history of immobilisation, no risk 
factors for VTE, no chest pain, and no ECG evidence (e.g. RV strain or S1Q3T3), no 
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unilateral leg swelling). V/Q scan would also subject the patient to unnecessary 
radiation. 
 
Choice 8: Echocardiogram  
Score : 1 
Choice Feedback: Correct. An echocardiogram is useful to look for underlying 
valvular abnormality (e.g. mitral stenosis or regurgitation, aortic regurgitation) 
causing congestive heart failure, assessing myocardial (left ventricular function) and 




















Which one of the following is the most likely diagnosis? 
 
Choice 1: Acute myocardial infarction (AMI)    
Score : 0 
Choice Feedback: Incorrect. The chest radiograph shows pulmonary congestion and 
cardiomegaly. There is no pleural effusion. The findings are compatible with the 
diagnosis of congestive heart failure. 
 
Choice 2: Acute pulmonary embolism    
Score : 0 
Choice Feedback: Incorrect. The chest radiograph shows pulmonary congestion and 
cardiomegaly. There is no pleural effusion. The findings are compatible with the 
diagnosis of congestive heart failure. The chest radiograph of acute pulmonary 
embolism will show relative oligaemic lung fields with normal CTR. 
 
Choice 3: Congestive heart failure   
Score : 1 
Choice Feedback: Correct. The chest X-ray shows an increased cardiothoracic ratio, 
pulmonary congestion and the presence of Kerley B lines. These findings are 
consistent with congestive cardiac failure. 
 
Choice 4: Cardiac tamponade    
Score : 0 
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Choice Feedback: Incorrect. In cardiac tamponade, the chest radiograph will show a 
globular heart with clear lung fields; the raised pressure of the tamponade results in 
compression to the atria and therefore reducing pre-load and right ventricular 
output to the lungs, hence producing clear lung fields. 
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Question 6:  
Question Information: 
 


















What does the ECG show? 
 
Choice 1: Acute STEMI   
Score : 0 
Choice Feedback: Incorrect. There is no ST elevation. The ECG showed fibrillatory 
waves (absence of discrete and normal P waves) and irregular QRS that is typical of 






Choice 2: First degree heart block   
Score : 0 
Choice Feedback: Incorrect. There is no P wave seen in the ECG and no prolonged 
PR intervals. The ECG showed fibrillatory waves (absence of discrete and normal P 
waves) and irregular QRS that is typical of atrial fibrillation. Here is an example of 






Choice 3: Sinus tachycardia   
Score : 0 
Choice Feedback: Incorrect. In sinus tachycardia the ECG will show normal P waves 
followed by regular QRS and a normal PR interval. This ECG showed fibrillatory 
waves (absence of discrete and normal P waves) and irregular QRS that is typical of 
atrial fibrillation. 
 
Choice 4: Atrial fibrillation   
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Atrial flutter   
Score : 0 
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Choice Feedback: Incorrect. In atrial flutter the ECG will show a typical sawtooth 
pattern of flutter waves in between QRS. Atrial rate will usually be between 250-300 




Choice 6: S1Q3T3 pattern   
Score : 0 
Choice Feedback: Incorrect. This pattern could be seen in acute pulmonary 






Mr. Benson is managed in the Emergency Department and transferred to the general 
medical ward. He is commenced on 40mg IV frusemide and low-dose potassium and 
magnesium supplementation. His condition slowly improves over the next three 
days, but the patient finds it difficult to mobilise and Mr Benson rarely leaves his bed 
during this time. 
 
Question: (Free text answer option) 
Describe how the risk of Mr. Benson developing a VTE can be predicted? 
 
Feedback: The Padua Risk Prediction Score can be used to predict risk of VTE in 
hospitalised medical patients. It is used to estimate baseline risk for patients with low 
and high VTE risk. A high risk is a score of greater than, or equal to 4, based on the 
following scoring system: 
• Active cancer =3 (Patients with local or distant metastases and/or in whom 
chemotherapy or radiotherapy had been performed in the prvious six 
months) 
• Previous VTE (with exclusion of superficial vein thrombosis) =3 
• Reduced mobility = 3 (anticipated bed rest with bathroom privileges [either 
because of patient limitations or on physician orders] for at least 3 days) 
• Already known thrombophilic condition = 3 (carriage of defects of 
antithrombin, protein C or S, factor V Leiden, G20210A prothrombin 
mutation, antiphospholipid syndrome) 
• Recent (<1mo) trauma and/or surgery = 2 
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• Elderly age (>70) = 1 
• Heart and/or respiratory failure = 1 
• Acute myocardial infarction or ischaemic stroke = 1 
• Acute infection and/or rheumatologic disorder = 1 
• Obesity (BMI >30) = 1 








Mr. Benson clearly has a Padua Risk Score of 4, constituting a high risk of VTE. Given 
this risk, it is clear that some form of VTE prophylaxis will be required. 
 
Question: 
Which one of the following would be the most appropriate form of 
chemoprophylaxis? 
 
Choice 1: Low molecular weight heparin   
Score : 2 
Choice Feedback: Correct. This is the most appropriate option. Comparison of low 
molecular weight heparin (LMWH) with no treatment for VTE prophylaxis in 
medical patients across six randomised controlled trials demonstrated significantly 
lower rates of symptomatic PE in those receiving LMWH than those receiving no 
treatment. In three other trials, patients receiving LMWH had significantly lower 
rates of proximal DVT compared with no treatment. Evidence-based guidelines 
currently recommend the use of anticoagulant thromboprophylaxis with LMWH for 
hospitalised patients at increased risk. These patients should be given either low-
dose unfractionated heparin two or three times daily, or fondaparinux. For those 
patients at low risk of VTE, guidelines recommend against the use of pharmacologic 
or mechanical prophylaxis. For those patients who are actively bleeding, or at 
increased risk of bleeding, (e.g. patients suffering haemorrhagic stroke) the 
recommendation is for use of optimised mechanical prophylaxis. Current evidence 
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does not support the use of extended post-discharge pharmacological 
thromboprophylaxis in a acutely ill medical patients. 
 
Choice 2: Unfractionated heparin   
Score : 1 
Choice Feedback: Correct. Recommendations for the use of VTE prophylaxis with 
unfractionated heparin (UFH) are dependent upon the inclusion and exclusion of 
particular studies. An analysis of four randomised controlled trials (RCTs) comparing 
UFH with no treatment did not demonstrate a clearly significant benefit to its use in 
prophylaxis. However, exclusion of one particular study that used autopsy to identify 
DVT in patients with infection resulted in a significant improvement in outcomes in 
the heparin-treated cohort. Similarly, two RCTs examining the use of UFH to 
prevent PE demonstrated a clear benefit in the heparin-treated group versus the 
not-treated controls. 
 
Choice 3: Fondaparinux  
Score : 0 
Choice Feedback: Incorrect. Fondaparinux appeared to reduce rates of 
asymptomatic distal DVT in patients greater than 60 years of age, but not the rates 
of symptomatic DVT in one randomised controlled trial, with no difference between 
fondaparinux-treated and non-treated groups with regards to rates of bleeding or 
death. As a result, fondaparinux is one of the three available choices for 
anticoagulation in patients at risk of VTE in the medical setting, with choice of 
therapy made based on cost, patient compliance and local protocol. 
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Choice 4: Mechanical prophylaxis   
Score : 0 
Choice Feedback: Incorrect. For those patients who are actively bleeding, or at 
increased risk of bleeding, (e.g. patients suffering haemorrhagic stroke) the 
recommendation is for use of optimised mechanical prophylaxis. There is not 
enough evidence to currently recommend the routine use of mechanical prophylaxis 





Medical patients have tended to be a neglected group when it comes to matters 
concerning their risk of a VTE complication during hospitalisation and convalescence. 
Many of these patients face an eight-fold increase in the risk of VTE during 
hospitalisation. The risks include: 
• Any surgical procedure undertaken during that admission 
• Previous VTE 
• Active cancer 
• Age > 40 (markedly increased risk when aged >70 years) 
• Prolonged severe immobility 
• Pregnancy and puerperium 
• Marked obesity 
• Oestrogen-containing HRT or OCP 
• Certain types of thrombophilia 
• Current use of a non-steroidal anti-inflammatory agent 
• General anaesthesia 
• The following medical conditions: 
• Acute/acute on chronic chest infection 
• Heart failure 
• Respiratory failure 
• Myocardial infarction 
• Ischaemic stroke with immobility 
• Some forms of cancer chemotherapy 
• Acute inflammatory bowel disease 
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Patients with medical conditions require assessment of their risk of VTE using a 
validated scoring system (Caprini RIsk Assessment Model; Padua Prediction Score). 
Once their risk has been determined, an appropriate choice of VTE prophylaxis 
based on a comparison of risk of bleeding versus risk of VTE events needs to be 
made. In medical patients, the most-appropriate pharmacological forms of VTE 
prophylaxis are low-molecular weight heparin and unfractionated heparin. There are 
some important caveats in the use of pharmacological prophylaxis in medical 
patients. 
 
Patients presenting with haemorrhagic stroke should not receive any form of 
pharmacologic prophylaxis due to the devastating consequences of intracranial 
haemorrhage in these patients. SImilarly, patients suffering a myocardial infarction 
will most likely be on some form of anticoagulant or antiplatelet therapy to treat 
pre-existing, and treat further, thrombosis. If cardiac patients require additional 
anticoagulation, the most appropriate choice of thromboprophylaxis is 
unfractionated heparin, as this drug can be readily reversed with protamine should 
operative or procedural (i.e. catheter) intervention be required. There is currently 
little evidence for the use of mechanical prophylaxis in medical patients, however 
each patient should be assessed for the use of graduated compression stockings 
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Case Overview 
This case looks at prophylaxis of deep vein thrombosis (DVT) and venous 
thromboembolism (VTE) in an uncomplicated pregnancy. It reviews the important 
parts of an obstetric history and risk factors that may influence the pregnancy and 
puerperium. The management of prophylaxis in the setting of ceasarean section is 
also addressed. 
 
Please note that, where available, staff should abide by local VTE prophylaxis and 
management policies, as these may take into account local clinical and economic 
factors that cannot be anticipated by this module.  
 
Learning Objectives 
• Risk factors of VTE during pregnancy  
• Mechanism of VTE development during pregnancy  
• Management of thromboprophylaxis in normal vaginal delivery 






Mrs Maria Galvany is a 32-year-old G3P1 who presents for her first antenatal triage 
appointment. You take a full medical history and discover that she has asthma and 
has previously undergone a laparoscopic appendicectomy. Her pregnancy began 
whilst she was still taking the combined oral contraceptive pill, however she has now 
ceased this medication. Her previous pregnancy was uneventful and she progressed 
to a spontaneous delivery of a healthy baby girl at 39+4 gestation. She has a 
significant family history of type two diabetes in her mother and maternal 
grandmother and her grandfather had a DVT following an orthopaedic procedure. 
As part of the current examination, Maria's weight and height measurements give her 
a BMI of 38. 
 
Question: 
Which of the above factors in her history most put Maria at an increased risk for 
VTE? 
 
Choice 1: BMI 38  
Score : 3 
Choice Feedback: Correct. Increased BMI >30 is associated with an increased risk of 
VTE, with a risk that increases proportionally to BMI. Some studies also suggest a 
higher risk of associated pulmonary embolism with deep vein thrombosis with 
elevated BMI. 
 
Choice 2: Gestational state   
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core : 3 
Choice Feedback: Correct. Purely by being pregnant Maria places herself at an 
increased risk of VTE over the coming 9 months. Normal changes in the 
haematological system will results in hypercoagulability and compression on pelvic 
veins will result in peripheral stasis. 
 
Choice 3: Age   
Score : -1 
Choice Feedback: Incorrect. Advanced maternal age is not considered an 
independent risk factor for VTE until 35. 
 
Choice 4: Family history of DVT   
Score : -1 
Choice Feedback: Incorrect. Maria has reported a family history of a provoked deep 
vein thrombosis occurring in a second degree relative. This history does not increase 
her risk of VTE. 
 
Choice 5: Combined oral contraceptive pill use  
Score : -1 
Choice Feedback: Incorrect. Whilst use of the COCP will give Maria a 3-fold 







Following the thorough history and questions regarding her grandfather’s DVT, 
Maria would like to know some further statistics about her own risk for developing 
VTE during this pregnancy. 
 
Question: 
Which one of the following incidence ratios most accurately represents the 
likelihood of Maria developing a VTE-related problem? 
 
Choice 1: 5 cases per 100,000 woman/years   
Score : -1 
Choice Feedback: Incorrect. This is the background risk of VTE in woman of 
reproductive age who are not using hormonal contraception. 
 
Choice 2: 15 cases per 100,000 woman/years   
Score : -1 
Choice Feedback: Incorrect. This is the risk of VTE for non-pregnant women using 
combined oral contraception. 
 
Choice 3: 60 cases per 100,000 woman/years   
Score : 3 
Choice Feedback: Correct. This is the risk of VTE during pregnancy. Due to the 
physiological changes of pregnancy, the risk of VTE is 12 times that of the 
background population risk. 
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Question 3:  
Question Information: 
 
In addition to her standard antenatal care, Maria is briefed on the risks of VTE in 
pregnancy and reassured that she is not at any increased risk compared with any 
other pregnant woman - but perhaps her obesity might slightly increase her risk. 
Maria continues to have routine antenatal care over her coming pregnancy. 
Unfortunately, Maria’s baby is breech at 37 weeks. The patient and her partner 
decide to have an elective lower segment caesarean section. 
 
Question: 
Which of the following would be appropriate methods of thromboprophylaxis in 
preparation for theatre in this setting? 
 
Choice 1: Heparin infusion  
Score : -1 
Choice Feedback: Incorrect. Maria has not had any thromboembolic complications 
throughout her pregnancy and does not need to be maintained on 
thromboprophylaxis prior to surgery. In cases where a heparin infusion is utilized 
due to events throughout the pregnancy, the infusion will still need to be stopped 6-
8 hours prior to scheduled caesarean section for patient safety. 
 
Choice 2: Graduated compression stockings   
Score : 3 
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Choice Feedback: Correct. Graduated compression stockings are recommended for 
use within pregnancy and puerperium when fitted appropriately and should be placed 
on the patient prior to theatre. 
 
Choice 3: Mechanical calf stimulators   
Score : 2 
Choice Feedback: Correct. Maria does have an increased risk of VTE due to her 
elevated BMI and the use of mechanical calf stimulators may be used throughout the 
surgery at the obstetric team’s discretion. 
 
Choice 4: Aspirin   
Score : -1 
Choice Feedback: Incorrect. Aspirin is not used for anticoagulant purposes in the 






Maria undergoes a lower segment caesarean section under spinal anaesthesia. The 
procedure is performed quickly and easily and she is presented with a healthy baby 
boy with Apgar scores of 9 and 10. She is returned to the ward with an indwelling 
catheter and patient controlled anaesthesia. Some form of thromboprophylaxis 
should now be considered? 
 
Question: 
Which one of the following would be most appropriate? 
 
Choice 1: Graduated compression stockings only   
Score : 0 
Choice Feedback: Incorrect. Whilst appropriately fitted graduated compression 
stockings do play a role in thromboprophylaxis after caesarean section, they will be 
inadequate to completely cover Maria, who is at slightly increased risk of VTE due to 
her elevated BMI. 
 
Choice 2: Graduated compression stockings and enoxaparin 40mg SC daily for 7 
days   
Score : 3 
Choice Feedback: Correct. This is the recommended treatment for patients 
undergoing caesarean section. 
 
Choice 3: Enoxaparin 40mg SC daily for 6 weeks  
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Score : 0 
Choice Feedback: Incorrect. Although this is the prophylactic dosage of enoxaparin, 
Maria is not at substantially increased risk to require thromboprophylaxis for the 
entirety of her puerperium. 
 
Choice 4: Enoxaparin 100mg SC daily until mobilizing   
core : -1 
Choice Feedback: Incorrect. This is a therapeutic dosage of enoxaparin. Maria 





Deep vein thrombosis (DVT) and associated venous thromboembolism (VTE) are 
common complications of pregnancy within the Australia community, complicating 
13 in 10 000 deliveries (Level B)( 1). Although DVT and VTE can occur at any stage 
throughout pregnancy, the incidence is highest in the third trimester and first 6 
weeks of the postnatal period (Level A) (2). The increased incidence of VTE in 
pregnancy can be explained through the use of Virchow’s triad, with an observed 
hypercoaguable state, venous stasis and endothelial dysfunction in the gravid state. 
During pregnancy, the haematological system is preparing for multiple tasks including 
implantation and placentation, with resultant changes leading to a systemic 
prothrombotic state. Circulating levels of fibrinogen, factors VII, VIII, IX, X and XII 
and von Willebrand factor are markedly elevated, whilst free protein S is seen to 
dramatically decrease. 
 
Physical changes within the peripheral venous system result in venous stasis 
secondary to compression of the inferior vena cava and pelvic veins from the gravid 
uterus (3). In addition to this naturally increased risk from pregnancy itself, there are 
multiple factors that should alert the physician of further risk to the patient of VTE. 
Pre-existing factors include a personal history of VTE, thrombophilia, 
antiphospholipid syndrome, age >35, obesity and smoking. Obstetric risk factors 
include caesarean section, pre eclampsia, multiple pregnancy, PPH >1 litre and 
requiring transfusion and prolonged labour (4). All potential risk factors should be 
screened in the first trimester triage visit through a detailed history. Patients who 
are identified to be at increased risk of DVT or VTE throughout their pregnancy 
 206 
should be reviewed by a consultant obstetrician as early as possible in their 
pregnancy and the role of thromboprophylaxis planned (5). 
 
The exact method and regimen of thromboprophylaxis should be managed by an 
obstetric team and will be determined by the identifiable risk factors within each 
case. Heparins are almost always the medication of choice as, unlike Warfain, they 
will not cross the placenta and thus have minimal effect on the unborn fetus (6). 
 
In low risk women who have undergone a normal vaginal delivery, early mobilization, 
maintaining adequate hydration and compression devices (e.g. graduated 
compression stockings) are usually sufficient. In cases subjected to high risk profiles, 
thromboprophylaxis consisting of subcutaneous low molecular weight heparin may 
be initiated at any time during the pregnancy and continued for up to 6 weeks 
following the pregnancy. At this time, the patient’s ongoing VTE risk outside of 
pregnancy will need to be reviewed (4). Finally, patients undergoing caesarean 
section should be considered individually for thromboprophylaxis. There is minimal 
data on the success of thromboprophylaxis in this group due to difficulty in 
establishing and recruiting for significant trials, however it is theorized that women 
undergoing ceasarean section may be up to 5 times more likely to develop venous 
thromboembolism than those progressing to vaginal deliveries (Level A and B) 
(1,7,8). These women should all be considered for graduated compression stockings 
before and after the procedure, mechanical calf stimulators in theatre, and 
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The recommended guidelines for this topic are: 
• Prevention of Venous Thromboembolism (VTE) in Patients Admitted to 
Australian Hospitals: Guideline Summary. National Health and Medical 
Research Council. Clinical practice guideline for the prevention of venous 
thromboembolism (deep vein thrombosis and pulmonary embolism) in 
patients admitted to Australian hospitals. Melbourne: National Health and 






Case 886 VTE Prophylaxis in Orthopaedic Surgery Patients 
 
Authors and Affiliations 
Dr Eamon Raith 
Discipline of Surgery 
University of AdelaideThis case study takes the user through some of the issues 
involved in the assessment and management of thromboprophylaxis in the 





• Identify the orthopaedic surgery patient at risk of venous thromboembolic 
disease 
• Assess the risk of venous thromboembolism in the orthopaedic surgery 
patient 
• Assess the risk of bleeding in the orthopaedic surgery patient that is a 
candidate for VTE prophylaxis 
• Correctly select an appropriate means of VTE prophylaxis for the 











You are working as the ward doctor on a busy city-based orthopaedic surgery unit. 
A number of patients have required elective admission, transfer from the Emergency 
Department and post-operative follow-up, all of whom require assessment and 
management of their risk of venous thromboembolism. Mr. Harvey is a 69-year-old 
man who has returned from the high dependency unit following a total replacement 
of his right hip two days ago. He has a background history of myocardial infarction 
five years ago, which was managed with two bare metal stents, although he has not 
had any recurrence of his anginal symptoms since he was treated. 
 
Question: 
Which one of the following is the most important next step in management? 
 
Choice 1: Enoxaparin   
Score : 0 
Choice Feedback: Incorrect. In order to prescribe a low-molecular weight heparin 
for prophylaxis, one must first consider the risk of the patient bleeding. Only then 
can the risks associated with VTE be weighed against the risks of prescribing an 
anticoagulant. 
 
Choice 2: Mobilisation and cessation of any earlier VTE prophylaxis   
Score : 0 
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Choice Feedback: Incorrect. Patients with total hip replacements are at high risk of 
VTE, and should continue VTE prophylaxis beyond the immediate post-procedure 
period, regardless of mobilisation. 
 
Choice 3: Assessment of renal function and risk of bleeding   
Score : 1 
Choice Feedback: Correct. Mr. Harvey should be assessed for his risk of bleeding 
prior to the administration of any anticoagulant. Certain conditions impose a higher 
risk of bleeding on those patients potentially requiring thromboprophylaxis, including 
significant renal impairment, active major bleeding, chronic, active and clinically 
significant bleeding over 48 hours, inherited or acquired bleeding disorders, and 
other medical conditions. 
 
Choice 4: Unfractionated heparin (UFH)   
Score : 0 
Choice Feedback: While UFH is a useful and readily-reversible anticoagulant, it 
should not be prescribed for use in VTE prophylaxis, without there at first being 






Mr. Harvey states that other than his heart attack a few years ago, he has no other 
significant problems. He has never suffered any allergies and has never had an 
adverse reaction to heparin, although the first time that he used it was during his 
heart attack. Mr. Harvey normally takes aspirin 100mg daily, on the advice of his 
cardiologist, although this had been held perioperatively. He also regularly takes 
atorvastatin 40mg nocte, and metoprolol 25mg BD, for a "funny rhythm thing" that 
began after his stents were placed. He has no history of bleeding diatheses, renal 
disease, hepatic dysfunction or haematological malignancy. 
 
His examination reveals a generally relatively-fit looking man, clearly post-operative, 
resting comfortably in bed. His legs are neurovascularly-intact bilaterally, and there is 
no calf-swelling, tenderness or peripheral oedema. His chest and abdominal 
examinations are clear, although palpation of peripheral pulses and auscultation 







Which of the following are important risk factors for bleeding to consider in the 
orthopaedic surgery patient requiring pharmacological prophylaxis? 
 
Choice 1: Current active major bleeding   
Score : 1 
Choice Feedback: Correct. Any patient with active bleeding, or requiring transfusion 
of at least two units of red cells or other blood products in 24 hours is considered 
to be at significant risk for continued bleeding with pharmacological VTE prophylaxis. 
 
Choice 2: Bleeding disorders   
Score : 1 
Choice Feedback: Correct. Bleeding disorders, such as haemophilia, are significant 
risk factors for increased bleeding with pharmacological VTE prophylaxis. 
 
Choice 3: Thrombocytopaenia (platelets less than 70,000/ul)   
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Score : -1 
Choice Feedback: Incorrect. While thrombocytopaenia with a platelet count of less 
than 50,000/ul is considered a significant patient-related risk factor for bleeding with 
pharmacological VTE prophylaxis, those patients with a higher platelet count would 
warrant further investigation and assessment of their VTE risk, as they may still 
qualify for VTE prophylaxis. Consideration also needs to be given to choice of 
pharmacological agent in these patients, as the use of heparin may be contraindicated 
if there is history of heparin-induced thrombocytopaenia. 
 
Choice 4: Clinically significant bleeding over 36 hours   
Score : -1 
Choice Feedback: Incorrect. Chronic, clinically significant bleeding over 48 hours is a 
relative contraindication to pharmacological VTE prophylaxis, however bleeding risk 
and thrombosis risk must be individually assessed for each patient, and the role of 
chronic bleeding considered in light of other patient factors. 
 
Choice 5: Concomitant use of anti-platelet, anti-clotting, selective- and non-selective 
non-steroidal antiinflammatory drugs or thrombolytic agents   
Score : 1 
Choice Feedback:Correct. Concomitant use of agents that also affect the coagulation 
and haemostatic mechanisms could lead to severe bleeding through a number of 
mechanisms, including potentiating the effect of the other drug, reduced metabolism 






Mr. Harvey has undergone a procedure that is known to increase risk for venous 
thromboembolism, however the choice to use pharmacological prophylaxis in this 
patient is confounded by his cardiac and medication history. 
 
Question: 
What is the risk of Mr. Harvey developing a post-operative venous thrombosis? 
Choice 1: 10-20%   
core : 0 
Choice Feedback: Incorrect. Mr. Harvey has an age within the range of 61-74 years 
old, and has experienced a hip fracture. According to the Caprini Risk Assessment 
Tool, a scoring system validated in the assessment of VTE risk in surgical patients, 
Mr. Harvey has a "Highest Risk" level for VTE development, with a risk incidence of 
40-80%. 
 
Choice 2: 10-20%   
Score : 0 
Choice Feedback:Incorrect. Mr. Harvey has an age within the range of 61-74 years 
old, and has experienced a hip fracture. According to the Caprini Risk Assessment 
Tool, a scoring system validated in the assessment of VTE risk in surgical patients, 
Mr. Harvey has a "Highest Risk" level for VTE development, with a risk incidence of 
40-80%. 
 
Choice 3: 20-40%   
 216 
Score : 0 
Choice Feedback: Incorrect. Mr. Harvey has an age within the range of 61-74 years 
old, and has experienced a hip fracture. According to the Caprini Risk Assessment 
Tool, a scoring system validated in the assessment of VTE risk in surgical patients, 
Mr. Harvey has a "Highest Risk" level for VTE development, with a risk incidence of 
40-80%. 
 
Choice 4: 40-80%   
Score : 1 
Choice Feedback: Correct. Mr. Harvey has an age within the range of 61-74 years 
old, and has experienced a hip fracture. According to the Caprini Risk Assessment 
Tool, a scoring system validated in the assessment of VTE risk in surgical patients, 







Given Mr. Harvey is at high-risk of VTE post-operatively, it is decided that he should 
receive VTE prophylaxis. 
 
Question: 
Which of the following pharmacological, non-pharmacological or combination 
therapies is most appropriate for this patient? 
 
Choice 1: Fondaparinux 2.5mg SC daily injection for 35 days  
Score : 0 
Choice Feedback: Incorrect. While Fondaparinux is one of the two recommended 
anti-thrombotic agents for VTE prophylaxis post-hip fracture surgery, and if initiated 
should be continued for up to 35 days post-operatively, it is not the most 
appropriate choice in this patient. Given his history of cardiac disease, and pre-
operative use of aspirin to manage these issues, it is most appropriate to commence 
Mr. Harvey on Enoxaparin 40mg SC daily and aspirin 100mg daily (his pre-operative 
dose). His enoxaparin dosing should continue for 35 days post-operatively. While 
non-pharmacological prophylaxis (i.e. use of a foot pump, intermittent pneumatic 
compression device or TED stockings) is often prescribed to patients post-
orthopaedic surgery, there is no evidence to support their use in addition to 
pharmacological prophylaxis. 
 
Choice 2: Aspirin, 100mg once daily   
Score : 0 
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Choice Feedback: Incorrect. Aspirin alone, especially at doses of less than 
160mg/day, has not been shown to be effective in venous thromboembolism 
prophylaxis. Given his history of cardiac disease, and pre-operative use of aspirin to 
manage these issues, it is most appropriate to commence Mr. Harvey on Enoxaparin 
40mg SC daily and aspirin 100mg daily (his pre-operative dose). His enoxaparin 
dosing should continue for 35 days post-operatively. While non-pharmacological 
prophylaxis (i.e. use of a foot pump, intermittent pneumatic compression device or 
TED stockings) is often prescribed to patients post-orthopaedic surgery, there is no 
evidence to support their use in addition to pharmacological prophylaxis. 
 
Choice 3: Low molecular weight heparin, 40mg SC Daily for 35 days  
Score : 0 
Choice Feedback: Incorrect. While LMWH is one of the two recommended agents 
for VTE prophylaxis post-hip fracture surgery, it is not the most appropriate therapy 
in this patient. Given his history of cardiac disease, and pre-operative use of aspirin 
to manage these issues, it is most appropriate to commence Mr. Harvey on 
Enoxaparin 40mg SC daily and aspirin 100mg daily (his pre-operative dose). His 
enoxaparin dosing should continue for 35 days post-operatively. While non-
pharmacological prophylaxis (i.e. use of a foot pump, intermittent pneumatic 
compression device or TED stockings) is often prescribed to patients post-
orthopaedic surgery, there is no evidence to support their use in addition to 
pharmacological prophylaxis. 
 
Choice 4: Fondaparinux 2.5mg SC daily injection for 35 days and Intermittent 
Pneumatic Compression   
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Score : 0 
Choice Feedback: Incorrect. Use of intermittent pneumatic compression is 
warranted if there are contraindications to the use of pharmacological prophylaxis. 
There is no evidence to support their sole use, or use in combination therapy, when 
options for pharmacological prophylaxis are available. Given his history of cardiac 
disease, and pre-operative use of aspirin to manage these issues, it is most 
appropriate to commence Mr. Harvey on Enoxaparin 40mg SC daily and aspirin 
100mg daily (his pre-operative dose). His enoxaparin dosing should continue for 35 
days post-operatively. While non-pharmacological prophylaxis (i.e. use of a foot 
pump, intermittent pneumatic compression device or TED stockings) is often 
prescribed to patients post-orthopaedic surgery, there is no evidence to support 
their use in addition to pharmacological prophylaxis. 
 
Choice 5: Use of intermittent pneumatic compression devices   
Score : 0 
Choice Feedback: Incorrect. Use of intermittent pneumatic compression is 
warranted if there are contraindications to the use of pharmacological prophylaxis. 
There is no evidence to support their sole use, or use in combination therapy, when 
options for pharmacological prophylaxis are available. Given his history of cardiac 
disease, and pre-operative use of aspirin to manage these issues, it is most 
appropriate to commence Mr. Harvey on Enoxaparin 40mg SC daily and aspirin 
100mg daily (his pre-operative dose). His enoxaparin dosing should continue for 35 
days post-operatively. While non-pharmacological prophylaxis (i.e. use of a foot 
pump, intermittent pneumatic compression device or TED stockings) is often 
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prescribed to patients post-orthopaedic surgery, there is no evidence to support 
their use in addition to pharmacological prophylaxis. 
 
Choice 6: Low molecular weight heparin, 40mg SC Daily for 35 days and Aspirin 
100mg PO Daily   
Score : 1 
Choice Feedback: Correct. Given his history of cardiac disease, and pre-operative 
use of aspirin to manage these issues, it is most appropriate to commence Mr. 
Harvey on Enoxaparin 40mg SC daily and aspirin 100mg daily (his pre-operative 
dose). His enoxaparin dosing should continue for 35 days post-operatively. While 
non-pharmacological prophylaxis (i.e. use of a foot pump, intermittent pneumatic 
compression device or TED stockings) is often prescribed to patients post-
orthopaedic surgery, there is no evidence to support their use in addition to 
pharmacological prophylaxis. 
 
Choice 7: Low molecular weight heparin, 40mg SC Daily for 35 days and 
Intermittent Pneumatic Compression   
Score : 0 
Choice Feedback: Incorrect. Use of intermittent pneumatic compression is 
warranted if there are contraindications to the use of pharmacological prophylaxis. 
There is no evidence to support their sole use, or use in combination therapy, when 
options for pharmacological prophylaxis are available. Given his history of cardiac 
disease, and pre-operative use of aspirin to manage these issues, it is most 
appropriate to commence Mr. Harvey on Enoxaparin 40mg SC daily and aspirin 
100mg daily (his pre-operative dose). His enoxaparin dosing should continue for 35 
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days post-operatively. While non-pharmacological prophylaxis (i.e. use of a foot 
pump, intermittent pneumatic compression device or TED stockings) is often 
prescribed to patients post-orthopaedic surgery, there is no evidence to support 





Mr. Harvey completes his post-operative physiotherapy, and is discharged home with 
supports to the care of his daughter eight days after his operation. Visits from the 
Hospital at Home service are arranged to assist with his enoxaparin administration 
over the remaining 27 days of pharmacological VTE prophylaxis that he requires. 
 
Orthopaedic surgery patients are amongst some of the highest-risk patients for the 
development of VTE due to the advanced age of the patient, multiple peri-operative 
co-morbidities, the frequent presentation with pre-operative trauma, and the nature 
of the surgical insult that patients experience. Novel medications available for 
pharmacological thromboprophylaxis in orthopaedic surgery include: 
 
• Fondaparinux, a synthetic Factor Xa inhibitor that acts by binding 
selectively to antithrombin III and increasing it's inherent rate of natural 
inhibition of Factor Xa by approximately 300 times. 
• Rivaroxaban, a highly-selective, direct Factor Xa inhibitor, thus modifying 
FXa-mediated conversion of prothrombin to thrombin via the 
prothrombinase complex. The drug acts to prevent or terminate the 
explosive burst of thrombin generation that occurs with prothrombinase-
bound FXa (300,000 x greater than free FXa). 
• Dabigatran etexilate, a novel prodrug that is metabolised to dabigatran 
in the blood and liver. It is a competitive and reversible direct thrombin 
inhibitor (inhibiting free and fibrin-bound thrombin, and thrombin-induced 




Recommendations for orthopaedic surgery patients 
 
Current guidelines note the high risk (40-80% incidence) of VTE in patients not 
receiving thromboprophylaxis when having orthopaedic surgery. All patients 
undergoing orthopaedic surgery for hip or knee replacement, or surgery for hip 
fracture, or those being treated for fracture of the lower limb requiring 
immobilisation, require VTE prophylaxis. Current guidelines recommend the use of 
low-molecular weight heparin, or fondaparinux sub-cutaneous injections, or 
rivaroxaban or dabigatran oral therapy for the provision of pharmacological 
prophylaxis, based on patient suitability, cost, supply and local protocols. 
 
Some caution continues to be advised on the use of rivaroxaban and dabigatran, as 
these drugs are relatively new on the market and are not yet as well-validated as 
MWH and fondaparinux. Current guidelines recommend the use of either 
enoxaparin or fondaparinux, in the absence of contraindications, for up to 35 days 
following surgery for hip fracture, or the use of LMWH, fondaparinux, rivaroxaban 
or dabigatran for 35 days following elective total hip replacement. If LMWH is to be 
used, it has been demonstrated that the addition of low-dose aspirin provides 
additional thrombo-prophylactic benefits. In patients undergoing total knee 
replacement, use of LMWH, fondaparinux, rivaroxaban, or dabigatran is 
recommended for 14 days following surgery, unless contraindicated, with care again 
being taken to ensure correct dosing the older patients, those with weight less than 
50kg or those with impaired renal function. Patients undergoing elective knee 
arthroscopy do not require VTE prophylaxis, unless they are immbolised in some 
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way. For patients with lower leg fractures requiring immobilisation, the current 
recommendation is for the use of pharmacological prophylaxis for the entire period 
of immobilisation of the limb, ceasing on removal of the cast or brace. 
 
Care must be taken with the use of pharmacological prophylaxis in patients weighing 
less than 50kg, the elderly, and in patients with renal impairment. This is particularly 
true for the newer thromboprophylactic agents, due to increased risks of bleeding. 
Non-pharmacological thromboprophylaxis. Some patients (i.e. those at increased risk 
of bleeding, those with co-morbidities precluding the use of pharmacological 
thromboprophylaxis, or those sensitive to the effects of pharmacological 
prophylactic agents) will require non-pharmacological interventions to reduce their 
risk of VTE. Current guidelines recommend the use of foot pumps, intermittent 
pneumatic compression and TED stockings in orthopaedic surgery patients unable to 
receive pharmacological thromboprohylaxis. 
 
There is little evidence to suggest that their concomitant use with pharmacological 
thromboprophylaxis confers added benefit, however there is no evidence that 
intercurrent use with medications confers any additional risk to patients. Before 
using mechanical prophylaxis, patients should be assessed to ensure that they do not 
have any contraindications, including: 
• Suspected or proven peripheral arterial disease 
• Peripheral arterial bypass grafting 
• Peripheral neuropathy or other causes of sensory impairment 
• Local conditions in which stockings may cause damage e.g. fragile tissue paper 
skin, leg ulcers, dermatitis, gangrene or recent skin graft 
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• Known allergy to material of manufacture 
• Cardiac failure 
• Massive leg oedema 
• Pulmonary oedema from congestive cardiac failure 
• Unusual leg shape or size 
• Major limb deformity preventing correct fit. 
 
At all times, decisions regarding appropriate choice of thromboprophylaxis should be 
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These questions constitute the final assessment in the VTE prophylaxis module. On 








A 59-year-old man is admitted to hospital for chemotherapy of a locally advanced 
carcinoma of the stomach. Two weeks ago he recovered from an episode of left leg 
cellulitis for which he was bed-bound for three days. Three years ago he had a 
myocardial infarction from which he made a good recovery. His BMI is 29. He is 
considered for some form of prophylaxis against venous thromboembolism. 
 
Question: 
Which one of the following would place him at greatest risk of such a complication. 
 
Choice 1: The underlying malignancy   
Score : 1 
Choice Feedback: Correct 
 
Choice 2: The myocardial infarction   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: His weight   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: The recent episode of cellulitis   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: The period of immobility   
Score : 0 






A 68-year-old woman is admitted to hospital with a three day history vomiting. She 
had recently been started on chemotherapy for inoperable carcinoma of the 
pancreas. Two weeks ago a biliary stent had been inserted to relieve her jaundice. 
This procedure had been complicated by a bleed from sphincterotomy site. She has 
been taking diclofenac for pain relief. The patient is cachectic and dehydrated. Her 
serum biochemistry demonstrates a markefly elevated creatinine and urea. Her LFTs 
are grossly deranged. The patient is given intravenous fluids to correct her 
dehydration. Some consideration is given to measures to be taken to reduce her risk 
of venous thromboembolism. 
 
Question: 
Which one of the following regimens would be most appropriate? 
 
Choice 1: Warfarin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Dabigatrin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Graduated Compression Stockings  
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Unfractionated heparin   
Score : 0 






A 28 year old man is brought to the Emergency Department following a motor 
vehicle accident at a low speed. He was the unrestrained passenger in the vehicle, 
striking his legs against the dashboard during the collision. Primary and secondary 
surveys reveal a stable patient with a shortened and externally rotated right leg. A 
FAST scan does not show any free intra-peritoneal or peri-cardial fluid. The chest X-
ray does not show any evidence of a pneumothorax or rib fractures, and a CT of the 
brain shows no signs of acute intracranial pathology. The patient remains 
haemodynamically stable on transfer to the orthopaedic surgery unit. 
 
Question: 
Which of the following is the most appropriate choice of pharmacological 
prophylaxis? 
 
Choice 1: Low molecular weight heparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Fondaparinux   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Score : 0 
Choice Feedback: Incorrect 
 
Choice 4:  
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Aspirin   
Score : 0 






A 73-year-old man is retrieved from a rural property following an accident on his 
ride-on lawnmower. He was trapped, face-down, beneath the vehicle for 2 hours 
prior to extrication. He was stabilised at the scene and retrieved to the nearest 
major trauma centre. On examination he has a severe crush injury of the left hand, 
multiple rib fractures, and fluid in Morrisons pouch. The patient is supported in a 
pelvic brace. His blood pressure is 83/54 mmHg despite 2 litres of 0.9% NaCl. He is 
scheduled for emergency surgery. 
 
Question: 
Which one of the following is the most appropriate approach to post-operative VTE 
prophylaxis? 
 
Choice 1: Commence fondaparinux once adequate haemostasis has been achieved   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Commence use of calf-compression stockings only   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: No VTE prophylaxis is required   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Commence low-molecular weight heparin once adequate haemostasis has 
been achieved.    
Score : 1 
Choice Feedback: Correct 
 
Choice 5: Commence Dabigatran etexilate once adequate haemostasis has been 
achieved.   
Score : 0 






A 30-year-old woman who is G2P1 presents at 37 weeks gestation with a two day 
history of pain and swelling in her right calf. She has also noticed some breathless 
during this time. Her previous pregnancy was uneventful. There is some tenderness 
and redness of the calf and examination of the chest is unremarkable. 
 
Question: 
Which one of the following is the most appropriate initial investigation? 
 
Choice 1: CT pulmonary  
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Ventilation-perfusion scan   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Chest X-ray    
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Duplex scan of lower limbs   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: D-dimer   
Score : 0 






A 40-year-old man is admitted to the medical ward for intravenous antibiotics to 
manage an uncomplicated cellulitis of his left calf. An ultrasound scan shows no 
evidence of DVT. He is otherwise healthy and mobilises around the ward; he can 
often be found outside of the hospital talking to other patients. He is a non-smoker 
and drinks 1-2 standard drinks per week. He weighs 98kg. 
 
Question: 
Which one of the following is the most appropriate choice of VTE prophylaxis? 
 
Choice 1: Graduated calf compression stockings   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: No VTE prophylaxis is required   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Aspirin, 100mg PO daily   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Enoxaparin, 100mg Daily, subcut   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Low-dose unfractionated heparin   
Score : 0 






A 73-year-old man is hospitalised with an haemorrhagic stroke, proven on CT scan. 
As part of the rehabilitation program, consideration must be given to prophylaxis 
against venous thromboembolism. Immediately prior to the stroke the patient 
enjoyed an active life, although he had hurt his back recently and had been taking 
paracetamol immediately prior to his admission. Apart from some right-sided motor 
weakness in his arm, hand and leg, the physical examination is unremarkable. His 
serum biochemistry is shown. (Image) Haemoglobin 128 g/L (130 - 175) Platelets 130 
x 10^9/L (150 - 450) 
 
Question: 
Which one of the following regimens would be most appropriate? 
 
Choice 1: Calf compression stockings    
Score : 1 
Choice Feedback: Correct 
 
Choice 2: Aspirin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Enoxaparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Dabigatran   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Warfarin   
Score : 0 






An otherwise fit 64-year-old man is about to undergo a partial gastrectomy for 
carcinoma. He will require some measures to minimise the risk of venous 
thromboembolic complications during his hospitalisation. 
 
Question: 
Which one of the following is the most appropriate intervention? 
 
Choice 1: Pneumatic calf compression during surgery only   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Sequential calf compression stockings until discharge   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Enoxaparin starting at commencement of surgery until  
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Enoxaparin starting immediately after surgery and given until discharge   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Enoxaparin given immediately after surgery and continued for 14 days 
after discharge   







A 35-year-old woman is admitted for an elective laparoscopic cholecystectomy, 
planned as a day case procedure. Apart from an episode of biliary colic two months 
earlier, she is in good health and there is nothing of note in the past medical history. 
She is on the oral contraceptive pill. With regard to minimising the risk of venous 
thrombo-embolic (VTE) complications, graded calf compression stockings will be 
applied before and during the operation. Measures need to be taken to reduce her 
risk of a venous thrombo-embolic event 
 
Question: 
Which one of the following is the most appropriate management? 
 
Choice 1: Intraoperative pneumatic calf compression and perioperative enoxaparin 
until mobile    
Score : 1 
Choice Feedback: Correct 
 
Choice 2: Intraoperative pneumatic calf compression and postoperative enoxaparin 
for two weeks   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 3: Intraoperative pneumatic calf compression and postoperative enoxaparin 
for four weeks   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: No additional measures are required   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Pneumatic calf compression devices during  
Score : 0 






A 72-year-old man is about to start a course of chemotherapy for a recently 
diagnosed small cell carcinoma of the lung. Consideration is being given to the most 
appropriate chemoprophylaxis to reduce his risk of VTE. Apart from his lung cancer 
the patient does not have any other apparent health issues and is still leading an 
active life. His pre-chemotherapy laboratory results are reviewed. His Hb was 98g/L, 
his leucocyte count 12.5x10^9/L and his platelet count was 450x10^9/L. 
 
Question: 
Which one of the following regimens would be most appropriate choice of 
anticoagulant drug? 
 
Choice 1: Warfarin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 2: Enoxaparin   
Score : 1 
Choice Feedback: Correct 
 
Choice 3: Unfractionated heparin   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 4: Dabigatran   
Score : 0 
Choice Feedback: Incorrect 
 
Choice 5: Aspirin   
Score : 0 











Chapter 9. Online Learning In Venous thromboembolism Education: A 
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Introduction: A venous thromboembolism prophylaxis (VTE) e-learning module 
was developed and a randomised controlled educational trial was conducted to 
investigate its educational benefit in improving knowledge of thromboprophylaxis 
guidelines. 
 
Methods: Medical students were randomised into control (n=144) and 
intervention (n=148) groups. Pre- and post-test scores were compared within and 
between groups. Students were retested six months later. 
 
Results: 292 Students completed the study. Mean baseline scores were similar 
between groups (40.8% vs. 41.6%, p=0.750; control vs. intervention). No statistically 
significant improvement was observed between groups (41.1% vs. 44.7%, p=0.242; 
control vs. intervention) or between baseline and post-intervention scores in the 
intervention group (41.6% vs. 44.7%, p= 0.241). Re-testing at six months 
demonstrated improvement in all scores. 
 
Conclusion: Use of an online learning module was not immediately associated with 
improved scores relating to knowledge of thromboprophylaxis. Scores improved six 














Venous thromboembolism (VTE) is a common, multi-factorial disease, with incidence 
rates between 0.75 to 2.69 per 1,000 of population. Adherence to global 
thromboprophylaxis guidelines has decreased over time, primarily due to poor 
implementation of post-discharge guidelines.117 Educational interventions to improve 
thromboprophylaxis management have had variable and limited success.111,118 
 
e-Learning has been demonstrated to promote self-directed learning, provide flexible 
learning opportunities, and engage learners in collaborative learning communities,119 
however, only two studies demonstrated transfer of skills from e-learning to the 
clinical surgical environment, and there is no evidence that the use of e-learning 
improves patient outcomes in surgery.120  
 
Wolpin et al published a paper in 2011 describing a the efficacy of an online training 
module for VTE prophylaxis, provided to 69 residents and fellows from two medical 
centers.111 They identified a trend for knowledge gains related to VTE guidelines on 
post-test for clinicians with a 14.5% increase in content mastery (p=0.05). Although 
effect size was small (0.23), the authors noted an overall improvement in knowledge 
mastery relating to VTE prophylaxis between pre- and post-tests, but no additional 
knowledge gain through the use of question/response case studies.111 
 
The aim of this study was to assess the educational benefit of using an online, case-
based learning system to deliver educational material relating to VTE prophylaxis 
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A randomised controlled educational trial was designed and conducted based on 
methodologies described by Wolpin et al and Farah et al.111,125 A six-month online 
course on venous thromboembolism prophylaxis was provided to fifth year medical 
students at The University of Adelaide for each six-month semester, for two 
consecutive years. All fifth year medical students were enrolled in the course 
(published on www.emedici.com) in each year, and the content of the course was 
examinable in the end of year ‘barrier’ examination. Enrolment in the course was not 
contingent upon participation in the study, and all students ultimately had access to 
the same learning material.  
 
Students were eligible for participation in the RCT if they were a fifth-year 
(penultimate-year) medical student at The University of Adelaide. 
 
Students were excluded if: 
 
1. They refused consent to participate in the study (however, students still had 
access to the educational material). 
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2. They were currently enrolled in their obstetrics & gynaecology/paediatric 
medicine semester (Students were able to enrol in the course and the study 
in the alternate semester). 
 
The online module was made available to two annual cohorts of students, across 4 
semesters, over two years. Students had to complete the module within a single 
semester. 
 
Five case-based learning modules teaching the fundamentals of VTE prophylaxis in 
Oncology, Surgery, General Medicine, Obstetrics & Gynaecology, and Orthopaedics, 
according to national37 and international38 guidelines. In addition, twenty assessment 
questions were constructed. These were divided into three modules; the “Baseline 
Assessment Module” and the “Final Assessment Module”, each composed of ten 
questions, with equal representation of the taught specialty areas, and a Control 
Group-only Assessment Module containing all twenty questions. 
 
Students were enrolled into the course at the beginning of the semester. They had 
six months to complete the learning material, in their own time and at their own 
pace. Once enrolled in the course students were shown an introductory page at 
their first login. This page explained the study that was being conducted, the 
principles around data collection for the study, and emphasized that all students 
would receive equal access to the learning material regardless of participation. 
Students were then invited to consent to participate in the study. Participating 




Figure 9.1 CONSORT Diagram. 
Recruitment and allocation of subjects to control and intervention groups 
 
Students randomised to the control group were required to complete the ‘Control-
Group-only Assessment Module’ (labelled ‘Baseline Assessment Questions’ on their 
screen). Once completed, they then had free access to the learning modules.  
 
Students randomised to the intervention group completed ten baseline assessment 
questions (the same as questions 1-10 in the Control Group-only Assessment 
Module) then had access to the learning material. At the completion of the learning 
material, students in the intervention group then completed a Final Assessment 
Module of ten questions (the same as questions 11-20 in the Control Group-only 
Assessment Module) (Figures 9.2 & 9.3).  
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Figure 9.2 Graphic representation of trial process for students randomised to control and 
intervention groups. 
A, Comparison of scores between groups (Control Group-only Assessment Module 
Questions 1-10 vs the ten-question Intervention Group Baseline Assessment Module. The 
questions used to establish baseline knowledge are identical between the two groups. B, 
Comparison of scores between groups (Control Grouponly Assessment Module Questions 
11-20 vs the ten-question Intervention Group Final Assessment Module. The questions 
are identical between the two groups. C, Comparison of scores between Intervention 
Group Final Assessment Module and Intervention Group Baseline Assessment Module. D 
& E, Comparison of scores from six-month follow up with Intervention Group Final 





Questions were grouped in this way to allow comparison between intervention and 
control groups at baseline and following intervention group completion of the 
learning material (Figure 9.3, red groups and arrows), and to allow comparison 
within the intervention group pre- and post-intervention (Figure 9.3, blue arrows). 
 
 
Figure 9.3 Breakdown of questions between control and intervention groups. 
Both groups undertook all twenty questions. The control group undertook all twenty 
questions in the Control Group-Only Assessment Module; they then had access to the 
learning material. This approach provided a baseline for pre- and postintervention 
comparison between the control and intervention groups. The intervention group 
completed the ten-question Intervention Group Baseline Assessment Module, which is 
equivalent to questions 1-10 in the Control Group-Only Assessment Module. After 
accessing the learning material, the Intervention group completed the ten-question 
Intervention Group Final Assessment Module, which is equivalent to questions 11-20 
completed in the Control Group-Only Assessment Module. Comparison of scores was then 
performed between intervention and control groups at baseline and following the 
intervention group’s completion of the learning material (red groupings and red arrows). 




Six months after completion of the course, all students were followed-up and asked 
to complete the Final Assessment Module questions (Control Group-only Questions 










The primary outcome was difference in mean scores between the intervention 
group versus control group for final-assessment questions (Control Group-only 
assessment questions 11-20). 
  
Secondary outcomes were; 
  
1) Differences in mean scores between baseline assessment questions and final 
assessment questions in the intervention group. 
 
2) Differences in mean scores between questions 1-10 and 11-20 in the control 
group. 
 
3) Differences in mean score between questions 11-20 in the Control Group and 
repeat Final Assessment Module questions/Control Group-only Questions 11-20 
conducted at 6-months follow-up, and  
 
4) Differences in mean scores between Intervention Group final-assessment 
questions and repeat Final Assessment Module questions/Control Group-only 








All analyses were performed using SPSS version 24.0 (IBM Corp., Armonk, NY, 
USA). Group comparisons were conducted using linear regression, linear mixed-
effects models and Student’s t-tests for normally distributed data. Descriptive results 
are reported as frequencies (%), means (standard deviations) or medians 
[interquartile ranges]. Inferential statistics are presented with estimates, 95% 
confidence intervals and P values. For linear mixed-effects models (used for 
comparison of scores between baseline questions and final-assessment questions in 
the intervention group, or questions 1-10 vs 11-20 for the control group), 
assumptions of a linear model were upheld. A mixed effects model was used as 
scores within student would be more similar, more correlated, than scores between 
students, leading to erroneous standard errors and P values if not controlled for. 
 
We also explored a novel variable, the improvement score (described by Khatib et 
al135), equivalent to the post-intervention score minus the pre-intervention score. 
For the control group this is reported as the score for questions 11-20 minus the 
score for questions 1-10, and for the intervention group the score for final-
assessment questions minus the score for baseline questions. 
 
Based on the study by Wolpin et al,111 we calculated a requisite sample size of 200-






386 students were eligible for participation in the study. 94 students declined to 
participate, resulting in a total cohort of 292 students. No students actively 
withdrew from the study. Completion of modules was variable; some students 
completed all modules and cases, some completed only the initial module, regardless 
of randomization. Given that this likely represents real-world engagement with an e-
learning tool all analyses were completed on the basis of intention-to-treat. Mean 
scores and mean time-per-module are presented in table 1. 
  
144 students were randomised to the control arm of the study. Mean score for 
baseline questions 1-10 was 0.408 (40.8%) (SD, 0.175), and for baseline questions 11-
20 was 0.411 (41.1%) (SD, 0.215). 148 students were randomised to the intervention 
group. Mean score for baseline questions (equivalent to control-group baseline 
questions 1-10) was 0.416 (41.6%) (SD, 0.180), and mean score for final-assessment 





















 Control Group Intervention Group Six Month 
Follow-Up 
Group 







students, n 144 148 155 
 
Mean Score, n, 














scores, n (%) 
     
0% 4 (2.8%) 15 (10.4%) 3 (2%) 34 (23%) 0 (0%) 
10% 7 (4.9%) 3 (2.1%) 5 (3.4%) 1 (0.7%) 0 (0%) 
20% 14 (9.7%) 15 (10.4%) 13 (8.8%) 7 (4.7%) 1 (0.6%) 
30% 23 (16%) 16 (11.1%) 33 (22.3%) 14 (9.5%) 9 (5.8%) 
40% 36 (25%) 24 (16.7%) 35 (23.6%) 23 (15.5%) 20 (12.9%) 
50% 35 (24.3%) 35 (24.3%) 34 (23%) 34 (23%) 42 (27.1%) 
60% 17 (11.8%) 20 (13.9%) 12 (8.1%) 22 (14.9%) 36 (23.2%) 
70% 4 (2.8%) 9 (6.3%) 5 (3.4%) 10 (6.8%) 30 (19.4%) 
80% 2 (1.4%) 6 (4.2%) 5 (3.4%) 1 (0.7%) 16 (03%) 
90% 1 (0.7%) 1 (0.7%) 1 (0.7%) 2 (1.4%) 1 (0.6%) 
100% 1 (0.7%) 0 (0%) 2 (1.4%) 0 (0%) 0 (0%) 
 













Table 9.1 Descriptive and frequency data for control, intervention and follow-up groups.  
aSD represented Standard Deviation. bTime to completion of questions was unable to be 
collected for the follow-up group. Data collection occurred in a group setting; as a result, 
data was collected in an off-line format, with a 30-minute time limit for the entire group. 
 
  
Among the control group’s first ten questions (baseline questions 1-10), the median 
score was 0.4 (40%), as it was for questions 11-20. For questions 1-10 in the control 
group, the most frequent score was 0.4 (40%), representing 25% of all scores. 4 
(2.8%) students scored zero, one student (0.7%) scored 100%. For questions 11-20 
the most frequent score was 0.5 (50%), obtained by 35 students (24.3%). 15 students 
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(10.4%) scored zero in questions 11-20; 1 student (0.7%) scored 90% in questions 
11-20. No student scored 100% (Table 9.1).  
  
In the intervention group’s baseline questions, the median score was 0.4 (40%) for 
the baseline questions, and 0.5 (50%) for the final-assessment questions. The most 
frequent result was 0.4 (40%) (35 students, 23.6%). 3 students (2%) scored zero. 2 
students (1.4%) scored 100%. For the intervention group’s final-assessment 
questions, the most frequent results were zero and 0.6 (60%) (34 students, 23%, 
respectively). 2 students (1.4%) scored 100% (Table 9.1). 
 
Student’s t-test for paired samples was used to compare mean scores between pre- 
and post-test questions, within groups. An independent Student’s t-test was used for 
comparison of mean scores between groups (Table 9.2). There was no statistically-
significant difference between any set of pre- or post-test questions, or between 
intervention and control groups. The difference between mean scores for questions 
11-20 in the control group and mean scores for questions 1-10 in the control group 
was 0.003 (t(143)= 0.163, 95%CI, 0.034-0.04; p=0.871). The difference between 
mean baseline scores for the intervention group and the mean score for questions 1-
10 of the control group was 0.008 (t(290)= 0.379, 95%CI, -0.033-0.049; p=0.705). 
The difference between mean scores for the final-assessment questions versus the 
baseline questions in the intervention group was 0.030 (t(147)= 1.176, 95%CI, 0.02-
0.08; p= 0.241). The difference between mean scores between the final-assessment 
questions for the intervention group versus questions 11-20 for the control group 





































Linear regression modelling demonstrated no statistically significant difference 
between mean scores for questions 1-10 in the control group and baseline questions 
in the intervention group. Both mean scores were 0.4 (40%) (p=0.70). Similarly, 
there was no significant difference between mean scores for questions 11-20 in the 
control group and final-assessment questions in the intervention group. Both mean 
scores were 0.4 (40%) (p=0.22). 
  
The improvement score135 was calculated for the control and intervention groups, as 
described above. The mean improvement score for the control group was 0.003 
(SD, 0.20). The mean improvement score for the intervention group was 0.03 (SD, 
0.31). Student’s t-test was used to compare means between intervention group 
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improvement scores and control group improvement scores. The difference was 
0.03 (95% CI, 0.03-0.09; p=0.33). 
  
A linear mixed effects model was used to investigate the association between 
performance in questions 1-10 and scores for questions 11-20 in the control group. 
There was no significant difference between mean score for questions 1-10 and 
questions 11-20, adjusted for clustering on student; both scores were 0.4 (40%) 
(p=0.90). 
  
The same analysis was performed for the intervention group, examining the 
association between score in the baseline questions and score in the final-assessment 
questions. There was no significant difference between mean scores; in both cases 




After completion of the study, students were followed up, and asked to re-sit the 
final-assessment questions in order to assess knowledge retention after six months. 
155 students participated in the follow-up questions. 
  
The mean score was 0.57 (57%) (SD, 0.14), the median score was 0.5 (50%). The 
most frequent score was 0.5 (50%), attained by 42 students (27.1%). 1 student (0.6%) 
scored 0.20 (20%), the lowest score. The highest score, 0.9 (90%), was attained by 
one student (0.6%). 
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To investigate the association between Question 11-20 score for the control group 
and all scores at six months follow-up, a linear regression model was used. There is 
a statistically significant difference between mean Question 11-20 score in the 
control group versus scores at six months follow-up (global P value<0.0001) (Table 
9.3). Mean q11-20 score for the control group is 0.41 and for the follow-up group is 
0.57. Mean q11-20 score is 0.16 units lower in the control group than it is in the 
follow-up group (estimate=-0.16, 95%CI, -0.20 to -0.12).  
 





















Table 9.3 Difference in mean scores at six months follow-up compared with initial scores 
 
A linear regression model was also used to investigate the association between 
outcome score for the intervention group and all scores at six months follow-up. 
There is a statistically significant difference between mean final-assessment questions 
score in the intervention versus scores at six months follow-up (global P 
value<0.0001). Mean final-assessment questions score for the intervention group is 
0.45 and for the follow-up group is 0.57. Mean final-assessment questions score is 
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0.12 units lower in the intervention group than it is in the follow-up group 
(estimate=-0.12, 95%CI, -0.17 to -0.07).  
Discussion 
 
We have shown that the introduction of an online VTE prophylaxis teaching module 
did not result in any statistically significant immediate benefits in terms of knowledge 
gained, however, repeat testing at six months demonstrated an improvement in test 
scores.  
  
Wolpin et al111 reported positive results from two online educational interventions, 
demonstrating a 14.5% increase in content mastery related to VTE guidelines, yet no 
additional increase in knowledge gain with additional question/response case studies, 
an alternate finding to that reported by Casebeer et al.111,137 Watt et al report the 
effect of educational interventions on thromboprophylaxis prescribing patterns 
among junior doctors. In this study, results of an audit around VTE prescribing 
practice were presented to Junior Doctors as part of a teaching session focussed on 
areas targeted for improvement. A further educational intervention (verbal 
feedback) was provided to senior medical staff. The authors report generally-
appropriate thromboprophylaxis prescribing (80.6-92.9%), but poor compliance with 
guidelines, and no improvement in teaching following educational interventions.118 
 
Computer- and technology-aided learning can be effective in improving skills and 
examination outcomes, with faster uptake of more material leading to a reduction in 
training time by up to one-third.96,138,139 E-learning has been demonstrated to be 
associated with fewer costs than traditional teaching modalities and has a high 
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degree of learner-satisfaction, although evidence of outcomes (in terms of 
knowledge-gain and knowledge-retention) has been variable.92 
 
In this study, there was no statistical difference in mean scores between control and 
intervention groups at baseline testing, or between the intervention group post-
online module and the control group. Performance in the baseline questions 
(questions 1-10 in the control group) did not appear to correlate with results in the 
final-assessment questions (questions 11-20 in the control group) in either group. 
The mean improvement score (MIS) (post-intervention MCQ minus pre-intervention 
score)135 was not statistically significantly different between groups. 
 
Interestingly, students followed up six months after completion of the module 
demonstrated a statistically significant improvement in scores, with follow-up group 
mean score rising to 0.57 compared to 0.41 for control group questions 11-20 
(p<0.0001) and 0.45 for intervention group final-assessment questions (p<0.0001). 
 
These results contrast with Wolpin et al’s findings that the use of an online learning 
tool lead to an improvement in total knowledge mastery around the topic of VTE 
prophylaxis, however they appear to support the finding that the use of case-based 
modules did not lead to an increase in knowledge.  
 
Students completed the module during Year 5 of their undergraduate medical degree 
program. At the University where this trial was conducted Year 5 is also the year in 
which students sit their final examinations. As per the tripartite model of learning, 
medical students tend to begin their training as deep learners, but may move 
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towards strategic learning approaches due to the demands of their course, with 
strategic learning demonstrating a positive correlation with final exam marks.96,140,141 
It is possible that students took a strategic approach to the module, as the content 
represents a small, yet examinable, component of the undergraduate curriculum. 
This may be reflected in the amount of time students spent on the modules, with 
students spending a longer period of time on pre-test questions (Control group, 
mean time 1056.8 seconds (17.61 minutes) [SD 804.14]; Intervention group, mean 
time 769 seconds (12.82 minutes) [SD 465.06]) than on post-test questions (Control 
group, mean time 791.26 seconds (13.19 minutes) [SD 975.20]; Intervention group, 
mean time 466.18 seconds (7.77 minutes) [SD 431.15].  
 
The results may also be partially explained by the cases included in the module. The 
module provided education and testing on cases in Oncology, General Surgery, 
General Medicine, Obstetrics & Gynaecology, and Orthopaedics. Variation in student 
and junior doctor knowledge surrounding VTE prophylaxis, and prescribing 
compliance, has been reported across medical and surgical specialties.118,142 It is 
possible that students’ scores on more familiar areas (particularly 
thromboprophylaxis in surgery and orthopaedics) confounded scores for less-
familiar specialties, such as obstetrics & gynaecology. 
 
The improvement in scores at six months post-study is difficult to explain, but may 
represent knowledge application in the ward environment (where students are 
exposed to junior medical staff considering and prescribing thromboprophylaxis in 
various scenarios). This suggests, in line with other reported studies,110,143 that a 
blended-learning approach (combining virtual learning environment and face-to-face 
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interactions)96 may lead to a greater improvement in knowledge surrounding 
thromboprophylaxis, however, our study was not designed to measure this effect. 
 
Our study has a number of strengths and limitations. This is a large, appropriately-
powered randomised controlled educational trial that aimed to examine the effect of 
an online educational intervention on knowledge surrounding VTE prophylaxis. It 
was adequately powered to detect an effect at a p-value of 0.05. Students were 
randomised into approximately equal groups (144 vs 148 students) and received an 
educational intervention as per the trial design. Analysis was conducted on an 
intention-to-treat basis. 
 
Our study was limited by potential bias in the form of students conducting additional 
reading outside the module, and seeking advice or input from senior staff or other 
students. This truly reflects real-world use of e-learning material, however, and 














The use of an online learning module on VTE prophylaxis across multiple specialties 
did not demonstrate a statistically significant improvement in mean scores in pre- 
and post- testing, or between intervention and control groups. Repeating the Final 
Assessment Module questions/Control Group-only Questions 11-20 at six months 
was associated with a statistically significant improvement in mean scores when 
compared to results for the control group (Control Group-only Questions 
questions 11-20) and the intervention group (Final Assessment Module questions). 
The study findings do suggest, however, that a blended-learning approach may result 































Chapter 10. Factors Associated With Test Performance In Venous 











Conducted in the Discipline of Surgery, School of Medicine, University 

































Introduction: A venous thromboembolism prophylaxis (VTE) e-learning module 
was developed and a randomised controlled educational trial was conducted to 
investigate its educational benefit in improving knowledge of thromboprophylaxis 
guidelines. 
 
Methods: Medical students were randomised into control (n=144) and 
intervention (n=148) groups. Pre- and post-test scores were compared within and 
between groups. Students were retested six months later. In order to determine the 
relevant effects of scores and times for completion for each case on overall 
performance, and correlation with performance in other cases and in the final 
assessments, a subgroup analysis was performed. 
 
Results: 292 Students completed the study. Mean baseline scores were similar 
between groups (40.8% vs. 41.6%, p=0.750; control vs. intervention). Students in the 
control group spent more time on the baseline assessment questions, and on the 
final assessment questions than the intervention group. Students in the intervention 
group out-performed students in the control group in scores for the medical and 
orthopaedic surgery cases. Analysis of correlation of performance between cases 
demonstrated that performance in the eMedici VTE Prophylaxis Module appears to 
be associated with performance in areas of medicine in which students had prior 
experience, or were currently rotating. 
 
Conclusion: Use of an online learning module was not immediately associated with 
improved scores relating to knowledge of thromboprophylaxis. Scores improved six 
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months post-intervention. While e-learning in isolation may not lead to immediate 
knowledge improvement among medical students, the use of e-learning in a blended 













































The Online Learning in Venous thrombombolism Education (OLIVE) study144 was a 
randomised controlled trial that aimed to measure the effect of e-learning 
intervention on the knowledge base regarding venous thromboembolism prophylaxis 
of medical students in their final examinable year of study. The trial, which was 
conducted at The University of Adelaide, South Australia, recruited 386 medical 
students in their final examinable year of training. The primary end point was 
comparison of post-intervention test scores. In this study, the use of an e-learning 
module did not appear to provide immediate improvement in student knowledge of 
VTE prophylaxis, however there were significant improvements in all students’ 
scores on repeat testing at 6 months follow-up. 
 
It was unclear as to why this increase in test scores occurred; while it may have 
represented an unintentional blended-learning effect (i.e. students were more 
cognoscente of VTE prophylaxis principles, and focused on those techniques while 
on clinical rotations), we were not certain that the initial results may have been 
skewed by students potentially performing very well in modules for specialty areas 
that have a traditionally high awareness of the role of VTE prophylaxis (e.g. the 
orthopaedic surgery case, or the oncology case), while under-performing in less-
familiar areas. In this article, we examine the sub-groups of the OLIVE trial with a 










The University of Adelaide Office of Research Ethics, Compliance and Integrity (H-
2012-057) and The University of Notre Dame, Australia, Human Research Ethics 
Committee (013093S) approved this study. 
 
A randomized controlled educational trial was designed and conducted based on 
methodologies described by Wolpin et al and Farah et al.111,125 Medical Students in 
their penultimate year at The University of Adelaide were asked to participate in a 
randomized controlled educational trial. Students were eligible for participation if 
they were a fifth-year (penultimate-year) medical student at The University of 
Adelaide. 
 
Students were excluded if they met any of the following criteria: 
 
1. They refused consent to participate in the study (however, students still had 
access to the educational material). 
2. They were currently enrolled in their obstetrics & gynaecology/paediatric 
medicine semester (due to the specific and high-volume workload of this 
semester, and associated end-of-rotation assessments). 
 
The online module was made available to two years of students, across 4 semesters. 
Students had to complete the module within a single semester. 
 
After consenting to participate in the study students were randomized to one of two 
groups (control vs. intervention) (Figure 10.1). 
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Figure 10.1 CONSORT Diagram. 
Recruitment and allocation of subjects to control and intervention groups 
 
The control group undertook an initial baseline-assessment case of twenty questions, 
assessing their knowledge surrounding VTE prophylaxis across the specialties of 
Oncology, Surgery, General Medicine, Obstetrics & Gynaecology, and Orthopaedics. 
They were then given access to the online educational modules. 
 
The intervention group undertook a baseline assessment case composed of ten 
questions assessing their knowledge surrounding VTE prophylaxis across the 
specialties of Oncology, Surgery, General Medicine, Obstetrics & Gynaecology, and 
Orthopaedics. These were identical to Questions 1-10 completed by the control 
group. The intervention group were then given access to five case-based modules 
teaching the fundamentals of VTE prophylaxis in Oncology, Surgery, General 
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Medicine, Obstetrics & Gynaecology, and Orthopaedics, according to national37 and 
international38 guidelines. Following completion of these modules, students 
completed a 10 question post-test, matched to questions 11-20 completed as a 
baseline assessment by the control group. Six months after completion of the 
course, all students were followed-up and asked to complete the 10 post-test 
questions/control group questions 11-20 again. The study was then completed.  
 
In order to determine the relevant effects of scores and times for completion for 
each case on overall performance, and correlation with performance in other cases 




All analyses were performed using SPSS version 24.0 (IBM Corp., Armonk, NY, 
USA). Group comparisons were conducted using linear regression, linear mixed-
effects models and Student’s t-tests for normally distributed data. Descriptive results 
are reported as frequencies (%), means (standard deviations) or medians 
[interquartile ranges]. Inferential statistics are presented with estimates, 95% 
confidence intervals and P values. For linear mixed-effects models (used for 
comparison of scores between baseline questions and final-assessment questions in 
the intervention group, or questions 1-10 vs 11-20 for the control group), 
assumptions of a linear model were upheld. A mixed effects model was used as 
scores within student would be more similar, more correlated, than scores between 







386 students were eligible for participation in the study. 94 students declined to 
participate, resulting in a total cohort of 292 students. No students actively 
withdrew from the study. Completion of modules was variable; some students 
completed all modules and cases, some completed only the initial module, regardless 
of randomization. Given that this likely represents real-world engagement with an e-
learning tool all analyses were completed on the basis of intention-to-treat.   
  
Scores and times 
 
144 students were randomized to the control arm of the study. Mean score for 
baseline questions 1-10 was 0.408 (40.8%) (SD, 0.175), and for baseline questions 11-
20 was 0.411 (41.1%) (SD, 0.215). 148 students were randomized to the intervention 
group. Mean score for baseline questions (equivalent to control-group baseline 
questions 1-10) was 0.416 (41.6%) (SD, 0.180), and mean score for final-assessment 
questions was 0.447 (44.7%) (SD, 0.278). Students in the control group spent almost 
double the amount of time on the baseline assessment case questions as the 
intervention group (1353.15 secs, or 22.6 mins, versus 771.6 secs, or 12.86 mins). 
 
Independent samples t-tests demonstrated a number of differences between the 
control and intervention groups. There was a statistically significant difference in 
time spent on baseline assessment questions between control and intervention 
groups (t4.916, p<0.001), and significant differences between the intervention and 
control groups for post-test scores in the medical (mean score 0.568 vs. 0.537, t-0.796, 




There was a statistically-significant difference between groups in the amount of time 
spent on the final assessment questions, with students in the intervention group 
spending less time on the questions compared with controls (469.34sec [7.8mins] vs 
791.26secs [13.2mins], p<0.01). 
 
Correlation Results  
 
Assessment of correlation between scores for individual cases by randomisation 
group was conducted using Pearson’s correlation coefficient for baseline assessment 
questions and final assessment questions for all participants, control group and 















































Baseline Assessment Questions,  
Score 
             
Baseline Assessment Questions, Time 0.018                         
Oncology Case, Score 0.120 -0.021            
Oncology Case, Time 0.064 0.147 0.193                     
Surgical Case, Score 0.096 0.072 0.143 0.096          
Surgical Case, Time -0.031 0.134 0.075 0.164 0.194                 
Medical Case, Score 0.110 0.149 0.380 0.272 0.341 0.176        
Medical Case. Time 0.010 0.263 0.158 0.318 0.185 0.364 0.468             
Obstetric & Gynaecology Case, Score 0.117 0.113 0.299 0.243 0.284 0.084 0.687 0.327      
Obstetric & Gynaecology Case, Time 0.005 0.083 0.067 0.095 0.059 0.051 0.145 0.120 0.154         
Orthopaedic Case, Score 0.067 -0.006 0.332 0.140 0.301 0.080 0.598 0.280 0.582 0.119    
Orthopaedic Case, Time -0.032 0.288 0.142 0.159 0.109 0.260 0.332 0.284 0.174 0.129 0.349     
Final Assessment Questions, Score 0.257 0.051 0.176 0.171 0.162 0.047 0.418 0.173 0.351 0.088 0.435 0.270  
Final Assessment Questions, Time -0.009 0.805 -0.051 0.093 0.016 0.020 0.066 0.202 0.092 0.028 0.028 0.135 0.156 
 
 
             
Control 
Group 
Baseline Assessment Questions,  
Score                           
Baseline Assessment Questions, Time -0.029                         
Oncology Case, Score 0.103 -0.044            
Oncology Case, Time 0.000 0.155 0.168                     
Surgical Case, Score 0.114 0.189 0.286 0.272          
Surgical Case, Time 0.070 0.186 0.136 0.414 0.326                 
Medical Case, Score 0.080 0.186 0.364 0.319 0.764 0.409        
Medical Case. Time 0.070 0.320 0.140 0.323 0.416 0.388 0.445             
Obstetric & Gynaecology Case, Score 0.109 0.182 0.292 0.212 0.685 0.283 0.693 0.296      
Obstetric & Gynaecology Case, Time 0.058 0.257 0.070 0.194 0.356 0.279 0.343 0.314 0.299         
Orthopaedic Case, Score 0.041 0.178 0.373 0.297 0.552 0.205 0.655 0.248 0.702 0.190    
Orthopaedic Case, Time -0.050 0.404 0.121 0.236 0.235 0.220 0.324 0.232 0.219 0.397 0.277     
Final Assessment Questions, Score 0.462 0.029 0.110 0.183 0.172 0.203 0.231 -0.001 0.106 0.084 0.139 0.188  




             
Intervention 
Group 
Baseline Assessment Questions,  
Score                           
Baseline Assessment Questions, Time 0.184                         
Oncology Case, Score 0.187 0.147            
Oncology Case, Time 0.144 0.200 0.291                     
Surgical Case, Score 0.091 0.087 0.071 0.000          
Surgical Case, Time -0.089 0.263 0.041 0.010 0.150                 
Medical Case, Score 0.140 0.178 0.496 0.206 0.144 0.046        
Medical Case. Time -0.059 0.275 0.232 0.311 0.070 0.384 0.495             
Obstetric & Gynaecology Case, Score 0.122 0.076 0.389 0.286 0.102 -0.025 0.680 0.359      
Obstetric & Gynaecology Case, Time -0.013 0.070 0.123 0.080 0.007 0.007 0.100 0.070 0.127         
Orthopaedic Case, Score 0.079 0.064 0.486 0.030 0.199 0.004 0.639 0.329 0.551 0.099    
Orthopaedic Case, Time -0.020 0.256 0.224 0.064 0.042 0.290 0.336 0.339 0.119 0.057 0.393     
Final Assessment Questions, Score 0.110 0.219 0.360 0.170 0.154 -0.024 0.582 0.328 0.532 0.092 0.598 0.328  
Final Assessment Questions, Time 0.001 0.299 0.296 0.230 0.127 0.023 0.419 0.376 0.392 0.060 0.387 0.280 0.539 
Table 10.1 Correlation between scores and times across the study cohort, control group and intervention group during the Online Learning in Venous 
thromboembolism Education (OLIVE) randomised controlled trial.  
Numbers in boldface type indicate p≤0.05; italiscised type indicates p≤0.01; a solid box indicated results with p≤0.001. Data shown are all correlation coefficients, so the 








Statistically significant correlations (p≤0.05) were widespread throughout the 
dataset, however correlation was generally only weakly positive (r 0.25-0.5), or very 
weakly positive (r=0.1 to 0.25).  
 
Moderate positive correlation (r=0.5-0.75) was present between the medical case 
score and the obstetric case score (r=0.687, p<0.001), and the orthopaedic case 
score (r=0.598, p<0.01). Moderate positive correlation was also present between 




Students in the control group had access to the e-learning modules after completion 
of the baseline assessment module. The scores for questions 11-20 in that module 
(identical to the ten final assessment questions in the intervention group)144, were 
then compared to scores for questions 1-10 (identical to the ten baseline assessment 
questions applied to the intervention group). There were again multiple weak or 
very weak correlations present within the control group dataset.  
 
Strongly positive correlations were present between performance in the surgical 
case and performance in the medical case (r=0.764, p<0.01) and time spent on 
baseline assessment questions and time spent on final assessment questions (r=0.76, 
p<0.01). Moderate positive correlations were present between performance in the 
surgical case and performance in the obstetric (r=0.685, p<0.01) and orthopaedic 
(r=0.552, P<0.01) cases, performance in the medical case and performance in the 
orthopaedic case (r=0.655, p<0.01), performance in the obstetric case and 
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performance in the orthopaedic case (r=0.702, p<0.01). There were no non-weak 
correlations between performance in any case, or amount of time spent on any case, 
and performance in the final assessment questions. 
 
Intervention group 
Multiple weak or very weak, yet statistically significant, correlations were present 
within the intervention group dataset. There were no strongly positive correlations 
present. 
 
Performance in the medical case demonstrated moderate positive correlation with 
performance in the obstetric (r=0.680, p<0.01) case. Performance in the obstetrics 
case was moderately correlated with performance in the orthopaedic case (r=0.551, 
p<0.01). 
 
Performance in the final assessment was moderately positively correlated with 
performance in the medical case (r=0.582, p<0.01), the obstetrics case (r=0.532, 
p<0.01), and the orthopaedic case (r=0.598, p<0.01). Time spent on the final 
assessment demonstrated moderate positive correlation with performance in the 















In the randomized controlled OLIVE study, the use of case-based e-learning modules 
did not demonstrate a statistically-significant improvement in student knowledge 
compared to controls, however all students across both groups significantly 
improved their scores on re-testing at six months. We hypothesised that this non-
difference in scores may relate to either differences in time spent on questions 
between the groups, and performance in specific cases in the intervention group, 
with students potentially performing very well in modules for specialty areas that 
have a traditionally high awareness of the role of VTE prophylaxis (e.g. the 
orthopaedic surgery case, or the oncology case), while under-performing in less-
familiar areas. 
 
Students in the intervention group spent significantly less time on the final 
assessment questions than students in the control group, and time spent on 
questions demonstrated a moderate positive correlation with outcomes in the final 
assessment for this group. By the time students completed the final assessment 
questions they had been able to access the eMedici system for six months, and had 
completed seven cases related to VTE prophylaxis. It may be that this result 
represents e-learning fatigue, and after prolonged exposure to the module students 
may have become bored of the learning material and rushed through the final 
assessment. Alternatively, students were given open access to the module for the 
duration of the semester, although it was clear to students that the module had to 
be completed by the end of semester; as a result, the reduced time spent on final 
assessment questions may represent last-minute module completion by students. It 
is a recognised limitation of e-learning that a high degree of motivation is required to 
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complete the educational tasks,94,95 and the duration of access to this module may 
have inadvertently reduced student motivation for completion by providing too 
much convenience in the context of their other studies. We suggest that future 
research into e-learning interventions in medical education should examine such 
instructional design factors. 
 
As hypothesised, performance in the medical and orthopaedics cases was 
moderately correlated with performance in the final assessment questions for the 
intervention group, as was performance in the obstetrics case. At the time of the 
study, all fourth year medical students at The University of Adelaide completed 
mandatory rotations in General Medicine, General Surgery and Orthopaedic 
Surgery, with the remainder of the year consisting of non-mandatory selective 
specialty rotations. This result may therefore represent pre-existing knowledge of 
the provision of VTE prophylaxs in general medicine and orthopaedic surgery among 
this cohort of students (who would have completed rotations in general medicine 
and orthopaedic surgery in the preceding year of their studies), and a possible 
confounding blended-learning effect, as the fifth year of the medical degree program 
is the year in which students undertake obstetrics and gynaecology terms at our 
institution.  
 
Students in the control group had access to the e-learning cases after completing 20 
questions in a baseline assessment module, with questions 1-10 identical to the 
baseline assessment questions completed by the intervention group, and questions 
11-20 identical to the final assessment questions completed by the intervention 
group. As a result, strong correlation between time spent on baseline and final 
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assessment questions in this group is unsurprising, as these questions were 
completed in the same sitting. Moderate correlation was present between 
performance in the surgical case and performance in the orthopaedic and obstetric 
cases in the control group, which may again represent application of knowledge 
gained from rotations in the previous academic year (general surgery and 
orthopaedics) and an unintended, confounding blended learning effect (obstetrics and 
gynaecology). 
 
Interestingly, analysis of pooled data for both groups indicated a strongly positive 
correlation between performance in the oncology case and performance in the final 
assessment questions. This result cannot be readily be explained, but may represent 
an area of practice that was not familiar to students, and hence attracted additional 
attention to the learning material, however this correlation was not duplicated in 
analysis of the control and intervention groups. 
 
In conclusion, performance in the eMedici VTE Prophylaxis Module appears to be 
associated with performance in areas of medicine in which students had prior 
experience, or were currently rotating. This fits with findings when students were 
followed up at six months, demonstrating global improvement in knowledge of VTE 
prophylaxis,144 and suggests that while e-learning in isolation may not lead to 
immediate knowledge improvement among medical students (a finding consistent 
with the results of a systematic review by Vaona et al105), the use of e-learning in a 
blended learning strategy with clinical exposure appears to lead to improvement in 
knowledge outcomes. We suggest that future research in this area should focus on 
the conduct of well-designed randomised controlled trials comparing the use of 
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Chapter 11. Computers in Medical Education: Evaluation of Instructional 
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The use of online learning has become ubiquitous in medical education, with broad 
uptake across a range of countries and healthcare systems. Despite this rapid uptake 
and implementation of e-learning facilities, there has been limited investigation of 
instructional ergonomics and human factors in the delivery of online medical 
education. The purpose of this study was to describe the instructional ergonomic 
factors associated with the use of an online module used to teach undergraduate 
medical students about venous thromboembolism prophylaxis.   
 
Method 
After completion of a six-month online course on venous thromboembolism 
prophylaxis students completed a questionnaire covering the domains of 
administration and support, access, usage, technical performance, general usability, 
student expectations, content and instructional design, and testing and assessment.  
 
Results 
Most of the students provided positive comments on the delivery of the course. 
Students predominantly studied at home, and preferred study location was 
associated with technical performance of the module. Some issues surrounding 
usability were reported, in keeping with issues previously reported in the literature. 
 
Conclusion 
The results indicate the importance of usability testing in designing online medical 
education resources, suggest the importance of supporting online learning through 
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the provision of physical learning spaces and infrastructure within the clinical setting, 
and highlight the importance of considering human factors in the design and 














































Twenty years ago members of this research group, and others, described the use of 
a computer-aided learning package developed to promote learning during a surgical 
rotation as part of an undergraduate medical curriculum. The study demonstrated 
that most students provided positive comments on the learning material, and were 
interested in seeing computer-aided learning introduced to the medical 
curriculum.124 At that time it was noted that computers and e-learning had a limited 
role in medical education due to difficulties with keeping pace with technological 
development, professional reluctance to embrace new technological methods of 
instruction, and low computer literacy amongst medical students.124 
 
Online learning has become a powerful and challenging tool in medical education, 
aimed at lowering the cost of education, increasing educational capacity and 
improving the sharing of learning resources.119 Uptake of e-learning has occurred 
globally and variation in per-capita income has been no barrier to the use of this 
medium.145 Usability is a key factor in the efficacy of e-learning, and e-learning 
material design must account for variations in abilities and disabilities amongst 
learners.146 Consideration must be given to the capabilities of the user, and technical 
support must be readily available.146 
 
Human factors, or ergonomics, is defined by the International Ergonomics 
Association as “…the scientific discipline concerned with the understanding of 
interactions among humans and other elements of a system, and the profession that 
applies theory, principles, data and methods to design in order to optimize human 
well-being and overall system performance”147 The concept of educational 
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ergonomics was proposed by Kao in 1976, who described the five concepts of 
learning ergonomics, instructional ergonomics, ergonomics of educational facilities, 
ergonomics of educational equipment and the ergonomics of educational 
environment148 According to Kao, instructional ergonomics is a sub-set of 
educational ergonomics addressing delivery, presentation and communication of 
knowledge, and includes the ergonomics of “teaching machines and self-instructional 
devices”148 Since Kao’s original paper, the use of multimedia and the design of 
educational technology has received significant attention, yet there remains an 
ongoing need for how student interaction with new technologies influences 
performance and learning.149  
 
eMedici is a website providing an open-ended series of case-studies across medical 
and surgical specialties, primarily aimed at medical students, at our institution.122 We 
conducted an educational randomized controlled trial (the Online Leaning In Venous 
thromboembolism Education (OLIVE) Study) that aimed to investigate a new 
module’s utility in improving knowledge of thromboprophylaxis guidelines.144 As part 
of this trial we collected descriptive data surrounding the usability of the eMedici 
module. This paper reports the results of our analysis of human factors associated 









The University of Adelaide Office of Research Ethics, Compliance and Integrity (H-
2012-057) and The University of Notre Dame, Australia, Human Research Ethics 
Committee (013093S) approved this study. 
 
A six-month online course on venous thromboembolism prophylaxis was provided 
to fifth year medical students at The University of Adelaide for each six-month 
semester, for two consecutive years. All fifth year medical students were enrolled in 
the course (published on www.emedici.com) in each year, and the content of the 
course was examinable in the end of year ‘barrier’ examination. Enrolment in the 
course was not contingent upon participation in the OLIVE study, and all students 
ultimately had access to the same learning material.  
 
A questionnaire was developed based on a modification of the student reaction 
questionnaire proposed by Pike and Huddleston.131 Students were asked to complete 
the questionnaire on completion of the eMedici module. The questionnaire covered 
the domains of administration and support, access, usage, technical performance, 
general usability, student expectations, content and instructional design and testing 
and assessment. At the end of the questionnaire students were asked to provide an 
overall rating for the course. Data was collected through a combination of Likert 
scales and drop-down options.  
 
Five-point Likert scales were used for the majority of questions, with a score of one 
representing total disagreement with the questions, and a score of five representing 
strong agreement. Where no answer was provided a score of zero was allocated, 
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and data was not included in the analysis. Three questions relating to location of 
study, module completion and formal assessment of the information contained 
within the module used drop-down text options. 
 
All forms were de-identified and then reviewed by the lead author. Statistical advice 
was provided by a qualified statistician, and analysis was performed using SPSS 
version 24.0 (IBM Corp., Armonk, NY, USA). Descriptive statistics were used for 
presentation and analysis of ordinal data 136. Independent associations between 
categorical data were explored by the chi-square test, with statistical significance set 
at a p value of ≤0.05. 
 
The survey form, and associated descriptive statistics for this study are presented in 















Administration and support 
The majority of students agreed or strongly agreed that they received 
comprehensive registration and login instructions (75.9%), that help was available in 
resolving issues relating to connection to eMedici (76.1%), and that help was available 
to manage issues regarding the course software (54.3%). 40.3% of students were 
uncertain, or had no opinion, as to the fact that an instructor or mentor was 
available as course support. 
 
Access to eMedici 
66.4% of students agreed or strongly agreed that they had physical facilities available 
to the to access eMedici. Almost all students (87.9%) found it easy to log in to 
eMedici. Most students felt that support was available when they encountered 
problems with the software, and that support helped resolve problems.  
 
EMedici usage 
The majority of students undertook the online learning tasks in their own home 
(77.3%). The next most frequent approach was to study at a combination of home, 
on-campus or at university-affiliated hospitals (6%) (Figure 1). 87.3% of students 
completed all cases within the eMedici module. The vast majority of students felt 
that they were able to set the pace of their learning (92.6%) and were free from 
interruptions during their study (79.9%). There was significant variability in whether 
students felt they received allocated work or study time to complete the module. 




The majority of students felt that the eMedici program ran quickly on the machine 
they used (87.2%) and without any technical glitches (71%). 30.9% of students 
reported the eMedici platform crashing or ‘freezing up’ during use.  
A chi-square analysis was performed to assess the association between location of 
study and technical performance. There was no association between reported 
location of study and the speed at which eMedici ran on the machine used (p = 
0.447). Studying at home was associated with the eMedici module running without 
any technical glitches (p = 0.01) and never crashing (p = 0).  
 
General usability 
The majority of students found the eMedici module usable, with a clear on-screen 
layout, legible text on-screen, easy-to-understand and operate navigation controls, 
and easy course navigability. While the majority of students reported that they never 
accidentally exited the course, the number who did was surprisingly high (39.6%). 
 
Student expectations 
Students did not expect the course to be difficult (66.5%), and most reported that 
the subject-matter (venous thromboprophylaxis across multiple specialties) was 
interesting (79.1%). The majority of students found the module engaging (75.1%) and 
relevant to their future practice (93.3%). Students anticipated using the material 





Content and Instructional Design 
Student expectations of statements of case objectives, case structure, level of 
module content, case context, content presentation, currency, image quality and 
sequencing were met for the majority of students. Students reported a high degree 
of interaction with the module (65.7%) and found those interactions meaningful 
(69.2%). 53% of students disagreed with the statement that “There was opportunity 
for skills practice associated with the module. 
 
Testing and Assessment 
The majority of students felt that the length of the module was sufficient to meet the 
stated objectives of the module. 54.7% of students did not believe the cases were 
formally assessed, and 59.7% did not feel that they were informed as to how the test 
results were used. 
 
Overall rating 













Our study describes the ergonomic factors related to the delivery of a venous 
thromboembolism prevention program via an e-learning modality. Most students 
were satisfied with the course delivery and content, however a number of usability 
and browsing problems were detected, consistent with previously reported findings 
150. 
 
Usability problems in the e-learning environment bear similarities to usability 
problems in other systems, and relate to compatibility, consistency, feedback, error 
management and satisfaction 150. It appears that a large number of students were 
unaware of the administrative support available to them, and that the majority of 
students were unaware of the module’s assessment requirements, and how the 
results of the module were being used, despite this information being displayed on 
the opening screen of the module, and informed consent being required to access 
the remainder of the module. A surprising number of students accidently exited the 
module during use. These findings may indicate a recall error on the part of the 
students, however, it is more likely that they represent the effects of extraneous 
cognitive load (for example, whilst 80% of students stated that they were free from 
distractions in the home environment, this is a subjective assessment susceptible to 
recall bias, and the number of distractions may be higher) and demonstrate the 
importance of usability and usability testing.  Cognitive load theory (CLT) aims to 
use a model of human cognitive architecture to design instructional principles and 
strategies and is becoming more apparent in medical education, particularly in the 
application of teaching complex tasks 151. CLT assumes that intrinsic and extraneous 
cognitive loads are additive, and the sum of these loads may surpass working 
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memory capacity during complex task learning 151. Similarly, the cognitive theory of 
multimedia learning highlights the importance of the working memory in learning, 
and emphasizes it’s short-term (<30 secs), limited capacity for processing 
information 152. Mayer recommends the elimination of extraneous material, 
highlighting essential material and placing printed words near corresponding graphics 
as principles for reducing extraneous processing in the design of online learning 
material. He also recommends the combined use of words and pictures, the 
presentation of words in conversational or polite style and the use (where 
appropriate) of a human voice rather than a machine voice to foster generative 
processing when using multimedia lessons 152.  
 
Usability testing is not widely recognised in the development of medical education 
resources 153,154. Usability testing across the technological approach (navigation, 
learnability, accessibility, consistency and visual design) and the instructional design 
(interactivity, content and resources, media use, learning strategies design and 
learner guidance and support) of e-learning material has been recommended in the 
literature 154 and has been demonstrated to result in significant improvements in 
usability 153. As such, formal usability testing should form a component of 
instructional design. 
 
Chi-squared analysis demonstrated that studying at home was associated with the 
eMedici module running without any technical glitches (p = 0.01) and never crashing 
(p = 0). Information technology infrastructure has been demonstrated to be a 
requirement for e-learning system success, and impacts on the perceived usefulness, 
user satisfaction, customer value and organizational value associated with the 
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learning system. Development and maintenance of IT infrastructure is key to the 
outcomes of e-learning systems, and requires careful investment and support. 155 The 
findings of our study may demonstrate inadequate information technology 
infrastructure support, and provision of physical learning spaces, for e-learning 
systems outside of the students’ home study environment.  
 
This study has a number of strengths. As a descriptive study of human factors 
impacting on e-learning delivery, it assesses eight ergonomic domains; administration 
and support, access, usage, technical performance, general usability, student 
expectations, content and instructional design, and testing and assessment. The study 
has value as a measure of human factors related to the use of this educational 
module, and is reproducible, allowing for trends analysis and future usability testing. 
The study has also identified a potential area for further study in medical e-learning, 
namely the role of information technology infrastructure. 
 
The study is limited as a descriptive study, and as such can only report our direct 
findings and cannot draw causal inferences. The human factors survey was conducted 
on completion of the online module, and as a result may be subject to recall bias 
from the participants.  
 
In conclusion, this study demonstrates the importance of usability testing in the 
development of e-learning material, the importance of the consideration of human 
factors and instructional ergonomics in the construction of online courses, and has 
highlighted the importance of information technology infrastructure and study 
location as areas of potential future research in the field of online medical education. 
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It also highlights the positive approach that most students have to on-line learning as 










Median 25th 75th 
Q1: I received comprehensive eMedici 
registration/log-in instructions 
149 3.78 0.829 4 4 4 
Q2: Help was available in resolving issues 
with connection to eMedici 
149 3.79 0.903 4 3 4 
Q3: Help was available in issues running the 
courseware 
149 3.58 0.871 4 3 4 
Q4: An instructor or mentor was available 
to support the course 149 3.19 0.911 3 3 4 
Q5: Physical facilities to access eMedici 
were available 
149 3.64 0.987 4 3 4 
Q6: It was easy logging into eMedici 149 4.11 0.737 4 4 5 
Q7: Support was available on encountered 
problems 149 3.71 0.824 4 3 4 
Q8: The support helped resolve problems 149 3.69 0.821 4 3 4 
Q11: I was able to go at my own pace 149 4.17 0.566 4 4 5 
Q12: I was free from interruptions during 
the module 149 3.86 0.771 4 4 4 
Q13: I was allocated work/study time to 
complete the module 149 2.79 1.043 3 2 4 
Q14: The allowed time (4 months) was 
sufficient for the program content 
148 3.87 0.703 4 3 4 
Q15: The eMedici program ran quickly on 
the machine I used 149 4.05 0.645 4 4 4 
Q16: The module ran without any technical 
glitches 
148 3.74 0.927 4 3 4 
Q17: The module never crashed or ‘froze 
up’ 
149 3.66 0.949 4 3 4 
Q18: The screen layout was clear 149 3.93 0.736 4 4 4 
Q19: Text on screen was legible 149 4.13 0.596 4 4 4 
Q20: The navigation controls were easy to 
understand 
149 4.04 0.656 4 4 4 
Q21: The controls were straightforward to 
operate 
149 4.03 0.62 4 4 4 
Q22: It was easy to navigate around the 
course 
149 3.96 0.706 4 4 4 
Q23: It was easy to return to pieces of 
content already viewed 
149 3.71 0.872 4 3 4 
Q24: I never accidently exited the course 149 3.46 1.056 4 3 4 
Q25: The module was consistent with my 
expectations 
149 3.88 0.58 4 4 4 
Q26: The module is known to be a difficult 
module 
149 3.28 0.752 3 3 4 
Q27: The subject-matter of the module was 
interesting 
148 3.84 0.625 4 4 4 
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Q28: The module held my attention 149 3.77 0.641 4 3.5 4 
Q29: The module is relevant to my future 
work as a Doctor 
149 4.41 0.637 4 4 5 
Q30: I anticipate using what I learnt on this 
course 149 4.18 0.668 4 4 5 
Q31: I would be confident in applying what 
was learnt on this course 
149 3.58 0.823 4 3 4 
Q32: Module and case objectives were 
clearly stated 
149 3.95 0.585 4 4 4 
Q33: Cases were well-structured 149 3.9 0.685 4 4 4 
Q34: The breakdown of content in the 
course was logical 
149 3.89 0.642 4 4 4 
Q35: The content of the module was at an 
appropriate level of detail 
149 3.83 0.672 4 4 4 
Q36: The content of the module was 
presented in the right context 
149 3.95 0.602 4 4 4 
Q37: The content was presented and 
explained clearly 
149 3.88 0.636 4 4 4 
Q38: The content was up to date 149 3.91 0.63 4 4 4 
Q39: Still images were of good quality 149 3.7 0.913 4 3 4 
Q40: Content sequencing was logical 149 3.92 0.61 4 4 4 
Q41: There was a high degree of interaction 
with the module 
149 3.68 0.717 4 3 4 
Q42: The interactions with the module 
were meaningful 
149 3.77 0.748 4 3 4 
Q43: There was opportunity for skills 
practice associated with the module 
149 3.28 0.886 3 3 4 
Q44: The length of the module was 
sufficient for the module objectives 
149 3.81 0.619 4 4 4 
Q46: The test instructions were easy to 
understand 
149 3.93 0.534 4 4 4 
Q47: The mechanism for answering 
questions was straight-forward 
149 3.89 0.628 4 4 4 
Q48: The assessment was a fair reflection of 
the information covered in the cases 
149 3.59 0.814 4 3 4 
Q49: Notification of whether test results 
were recorded (or not) was given 
149 3.46 0.889 4 3 4 
Q50: I was informed as to how the test 
results were used 
149 3.14 0.987 3 3 4 
Q51: There was post-test feedback 149 3.5 0.991 4 3 4 
Q52: Overall course rating (1 = totally 
unsatisfactory, 5 = Totally satisfactory) 148 3.81 0.732 4 4 4 
Table 11.1 Descriptive data (mean score, median score and scores at 25th and 75th 
percentiles) for completed survey 
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Chapter 12. Thesis Synopsis 
 
The outcomes of the research contained within this PhD thesis have advanced our 
understanding of online educational methodologies and the utility of online learning 
in delivering clinical practice outcomes in isolation, although much work still remains 
before we are able to delineate the precise role of online learning in a blended 
model of medical education. 
 
The basis of this work was an understanding that online learning was associated with 
an increase in knowledge gain and retention by resident medical officers, resulting in 
an increase in content mastery related to VTE guidelines. The original study 
underlying this work demonstrated a 14.5% increase in in content mastery among 
resident medical officers, although this occurred with a small effect size (0.23).111 The 
authors of this original study demonstrated an overall improvement in knowledge 
mastery relating to VTE prophylaxis between pre- and post-tests, however, no 
additional knowledge gain through use of question/response cases was 
demonstrated. 
 
In the late 1990 ‘Medici’ was released at the University of Adelaide as an e-learning 
tool. This CD-ROM-based learning program was designed to provide students with 
educational material related to their surgical terms.124 This program was translated 
to the online environment in the early 2000s, resulting in the publication, and use, of 




The aim of this body of work was to assess the educational benefit of using an online 
case-based learning system (eMedici) to deliver material relating to VTE prophylaxis  
across multiple disciplines with a view to improving understanding of VTE 
prophylaxis requirements in fifth-year medical students at The University of 
Adelaide. 
 
The first step in this project was characterising the utility of online education in the 
medical education literature. E-learning has been readily absorbed into medical 
education, and is now a key component of many courses, at both the undergraduate 
and graduate level. There is a suggestion in the evidence that e-learning brings 
multiple non-learning based benefits, including flexibility, cost savings and the 
opportunity for deliberate and distributed practice, that traditional learning cannot 
provide.  
 
We conducted a randomised controlled trial determing the efficacy of online 
learning on application of knowledge related to VTE among medical students 
approaching their final examinations (of which this subject was included). 
 
A venous thromboembolism prophylaxis (VTE) e-learning module was developed 
and a randomised controlled trial was conducted to investigate its educational 
benefit in improving knowledge of thromboprophylaxis guidelines. Medical students 
were randomised into control and intervention groups. We demonstrated that mean 
baseline scores were similar between groups, and that no statistically significant 
improvement was observed between groups or between baseline and post-
intervention scores in the intervention group. Re-testing at six months 
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demonstrated improvement in all scores. 
 
In conclusion, use of an online learning module was not immediately associated with 
improved scores relating to knowledge of thromboprophylaxis. Scores improved six 
months post-intervention, suggesting a possible role for blended learning in this field. 
 
Our second paper describes a subgroup analysis of a randomised controlled 
educational trial, performed with a view to determine the relevant effects of scores 
and times for completion for each case on overall performance, and correlation with 
performance in other cases and in the final assessments. We demonstrated that that 
performance in the eMedici VTE Prophylaxis Module appears to be associated with 
performance in areas of medicine in which students had prior experience, or were 
currently rotating. This supports our finding in the first article that e-learning may be 
of limited utility when used in isolation, but may represent an important component 
of a blended learning strategy to teach clinical material. 
 
In our third paper, we describe the results of a survey of human factors and 
instructional ergonomics, conducted as part of a project to assess the utility of e-
learning material in teaching medical students about venous thromboembolism 
prophylaxis. This project was designed following the WolpinStudy111, which appeared 
to demonstrate that the use of an online VTE education package resulted in 
increased knowledge mastery among Medical Residents. We elected to include 
research around human factors in the online delivery of medical education in our 
project, as this is an under-investigated area in medical training. In short, we 
demonstrated that usability testing is important in designing online medical education 
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resources, the importance of supporting online learning through the provision of 
physical learning spaces and infrastructure, and highlight the importance of 
considering human factors in the design of e-learning material. 
 
We have characterised the use of online education in the instruction of clinical 
undergraduate medical students in their learning around VTE prophylaxis. In 
summary, we suggest that online learning material related to the provision of VTE 
prophylaxis is provided as part of a blended learning environment, wherein students 
are able to apply their theoretical knowledge of VTE prophylaxis to simulated real-
world scenarios.  
 
The importance of this project will only become clear in the fullness of time, with 
repeated assessment of the role of online learning in undergraduate medical 
knowledge and the utility of e-learning in broader medical education. Application of 
e-learning resources to medical education will inevitably continue, and the 
measurement of the effectiveness of these resources will inevitably lead to improved 
educational delivery. 
 
Until that time, additional questions have been generated from this research. It is 
unclear as to whether the benefits of blended learning occur with early exposure to 
clinical scenarios, versus exposure after absorption of theoretical knowledge, 
particularly in e-learning scenarios. An important question is, is association between 
completion of e-learning and completion of clinical rotation related to outcomes? 
Similarly, well-designed randomised controlled trials comparing the use of blended e-
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learning and clinical teaching strategies with traditional clinical teaching methods are 
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